value_set_id|value_set_subgroup|value_set_item|code_type|code_version|code|description|attribute_type|attribute_value
ASCVD|ASCVD||ICD_10|2020|G45.0|Vertebro-basilar artery syndrome||
ASCVD|ASCVD||ICD_10|2020|G45.1|Carotid artery syndrome (hemispheric)||
ASCVD|ASCVD||ICD_10|2020|G45.2|Multiple and bilateral precerebral artery syndromes||
ASCVD|ASCVD||ICD_10|2020|G45.8|Other transient cerebral ischemic attacks and related syndromes||
ASCVD|ASCVD||ICD_10|2020|G45.9|Transient cerebral ischemic attack, unspecified||
ASCVD|ASCVD||ICD_10|2020|G46.3|Brain stem stroke syndrome||
ASCVD|ASCVD||ICD_10|2020|G46.4|Cerebellar stroke syndrome||
ASCVD|ASCVD||ICD_10|2020|G46.8|Other vascular syndromes of brain in cerebrovascular diseases||
ASCVD|ASCVD||ICD_10|2020|I20.0|Unstable angina||
ASCVD|ASCVD||ICD_10|2020|I20.1|Angina pectoris with documented spasm||
ASCVD|ASCVD||ICD_10|2020|I20.8|Other forms of angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I20.9|Angina pectoris, unspecified||
ASCVD|ASCVD||ICD_10|2020|I21.01|STEMI involving left main coronary artery||
ASCVD|ASCVD||ICD_10|2020|I21.02|STEMI involving left anterior descending coronary artery||
ASCVD|ASCVD||ICD_10|2020|I21.09|STEMI involving oth coronary artery of anterior wall||
ASCVD|ASCVD||ICD_10|2020|I21.11|STEMI involving right coronary artery||
ASCVD|ASCVD||ICD_10|2020|I21.19|STEMI involving oth coronary artery of inferior wall||
ASCVD|ASCVD||ICD_10|2020|I21.21|STEMI involving left circumflex coronary artery||
ASCVD|ASCVD||ICD_10|2020|I21.29|STEMI involving other sites||
ASCVD|ASCVD||ICD_10|2020|I21.3|ST elevation (STEMI) myocardial infarction of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I21.4|Non-ST elevation (NSTEMI) myocardial infarction||
ASCVD|ASCVD||ICD_10|2020|I21.9|Acute myocardial infarction, unspecified||
ASCVD|ASCVD||ICD_10|2020|I21.A1|Myocardial infarction type 2||
ASCVD|ASCVD||ICD_10|2020|I21.A9|Other myocardial infarction type||
ASCVD|ASCVD||ICD_10|2020|I22.0|Subsequent STEMI of anterior wall||
ASCVD|ASCVD||ICD_10|2020|I22.1|Subsequent STEMI of inferior wall||
ASCVD|ASCVD||ICD_10|2020|I22.2|Subsequent non-ST elevation (NSTEMI) myocardial infarction||
ASCVD|ASCVD||ICD_10|2020|I22.8|Subsequent STEMI of sites||
ASCVD|ASCVD||ICD_10|2020|I22.9|Subsequent STEMI of unspecified  site||
ASCVD|ASCVD||ICD_10|2020|I23.0|Hemopericardium as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.1|Atrial septal defect as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.2|Ventricular septal defect as current comp following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.3|Rupture of cardiac wall w/o hemopericardium as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.4|Rupture of chord tendne as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.5|Rupture of papillary muscle as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.6|Thombosis of atrium/auric append/ventr as current complication following AMI||
ASCVD|ASCVD||ICD_10|2020|I23.7|Postinfarction angina||
ASCVD|ASCVD||ICD_10|2020|I23.8|Other current complications following AMI||
ASCVD|ASCVD||ICD_10|2020|I24.0|Acute coronary thrombosis not resulting in myocardial infrc||
ASCVD|ASCVD||ICD_10|2020|I24.8|Other forms of acute ischemic heart disease||
ASCVD|ASCVD||ICD_10|2020|I24.9|Acute ischemic heart disease, unspecified||
ASCVD|ASCVD||ICD_10|2020|I25.10|Athscl heart disease of native coronary artery w/o ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.110|Athscl heart disease of native cor art w unstable ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.111|Athscl heart disease of native cor art w ang pctrs w spasm||
ASCVD|ASCVD||ICD_10|2020|I25.118|Athscl heart disease of native cor art w oth ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.119|Athscl heart disease of native cor art w unsp ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.2|Old myocardial infarction||
ASCVD|ASCVD||ICD_10|2020|I25.3|Aneurysm of heart||
ASCVD|ASCVD||ICD_10|2020|I25.41|Coronary artery aneurysm||
ASCVD|ASCVD||ICD_10|2020|I25.42|Coronary artery dissection||
ASCVD|ASCVD||ICD_10|2020|I25.5|Ischemic cardiomyopathy||
ASCVD|ASCVD||ICD_10|2020|I25.6|Silent myocardial ischemia||
ASCVD|ASCVD||ICD_10|2020|I25.700|Atherosclerosis of CABG, unsp, w unstable angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.701|Athscl CABG, unsp, w angina pectoris w documented spasm||
ASCVD|ASCVD||ICD_10|2020|I25.708|Atherosclerosis of CABG, unsp, w oth angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.709|Atherosclerosis of CABG, unsp, w unsp angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.710|Athscl autologous vein CABG w unstable angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.711|Athscl autologous vein CABG w ang pctrs w documented spasm||
ASCVD|ASCVD||ICD_10|2020|I25.718|Athscl autologous vein CABG w oth angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.719|Athscl autologous vein CABG w unsp angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.720|Athscl autologous artery CABG w unstable angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.721|Athscl autologous artery CABG w ang pctrs w documented spasm||
ASCVD|ASCVD||ICD_10|2020|I25.728|Athscl autologous artery CABG w oth angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.729|Athscl autologous artery CABG w unsp angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.730|Athscl nonautologous biological CABG w unstable ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.731|Athscl nonaut biological CABG w ang pctrs w documented spasm||
ASCVD|ASCVD||ICD_10|2020|I25.738|Athscl nonautologous biological CABG w oth angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.739|Athscl nonautologous biological CABG w unsp angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.750|Athscl native cor art of txplt heart w unstable angina||
ASCVD|ASCVD||ICD_10|2020|I25.751|Athscl native cor art of txplt heart w ang pctrs w spasm||
ASCVD|ASCVD||ICD_10|2020|I25.758|Athscl native cor art of transplanted heart w oth ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.759|Athscl native cor art of transplanted heart w unsp ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.760|Athscl bypass of cor art of txplt heart w unstable angina||
ASCVD|ASCVD||ICD_10|2020|I25.761|Athscl bypass of cor art of txplt heart w ang pctrs w spasm||
ASCVD|ASCVD||ICD_10|2020|I25.768|Athscl bypass of cor art of txplt heart w oth ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.769|Athscl bypass of cor art of txplt heart w unsp ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.790|Atherosclerosis of CABG w unstable angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.791|Atherosclerosis of CABG w angina pectoris w documented spasm||
ASCVD|ASCVD||ICD_10|2020|I25.798|Atherosclerosis of CABG w oth angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.799|Atherosclerosis of CABG w unsp angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.810|Atherosclerosis of CABG w/o angina pectoris||
ASCVD|ASCVD||ICD_10|2020|I25.811|Athscl native cor art of transplanted heart w/o ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.812|Athscl bypass of cor art of transplanted heart w/o ang pctrs||
ASCVD|ASCVD||ICD_10|2020|I25.82|Chronic total occlusion of coronary artery||
ASCVD|ASCVD||ICD_10|2020|I25.83|Coronary atherosclerosis due to lipid rich plaque||
ASCVD|ASCVD||ICD_10|2020|I25.84|Coronary atherosclerosis due to calcified coronary lesion||
ASCVD|ASCVD||ICD_10|2020|I25.89|Other forms of chronic ischemic heart disease||
ASCVD|ASCVD||ICD_10|2020|I25.9|Chronic ischemic heart disease, unspecified||
ASCVD|ASCVD||ICD_10|2020|I63.00|Cerebral infarction due to thrombosis of unspecified precerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.011|Cerebral infarction due to thrombosis of right vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.012|Cerebral infarction due to thrombosis of left vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.013|Cerebral infarction due to thrombosis of bilateral vertebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.019|Cerebral infarction due to thrombosis of unspecified vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.02|Cerebral infarction due to thrombosis of basilar artery||
ASCVD|ASCVD||ICD_10|2020|I63.031|Cerebral infarction due to thrombosis of right carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.032|Cerebral infarction due to thrombosis of left carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.033|Cerebral infarction due to thrombosis of bilateral carotid arteries||
ASCVD|ASCVD||ICD_10|2020|I63.039|Cerebral infarction due to thrombosis of unspecified carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.09|Cerebral infarction due to thrombosis of other precerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.10|Cerebral infarction due to embolism of unspecified precerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.111|Cerebral infarction due to embolism of right vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.112|Cerebral infarction due to embolism of left vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.113|Cerebral infarction due to embolism of bilateral vertebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.119|Cerebral infarction due to embolism of unspecified vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.12|Cerebral infarction due to embolism of basilar artery||
ASCVD|ASCVD||ICD_10|2020|I63.131|Cerebral infarction due to embolism of right carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.132|Cerebral infarction due to embolism of left carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.133|Cerebral infarction due to embolism of bilateral carotid arteries||
ASCVD|ASCVD||ICD_10|2020|I63.139|Cerebral infarction due to embolism of unspecified carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.19|Cerebral infarction due to embolism of other precerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.20|Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.211|Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.212|Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.213|Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.219|Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.22|Cerebral infarction due to unspecified occlusion or stenosis of basilar artery||
ASCVD|ASCVD||ICD_10|2020|I63.231|Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries||
ASCVD|ASCVD||ICD_10|2020|I63.232|Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries||
ASCVD|ASCVD||ICD_10|2020|I63.233|Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries||
ASCVD|ASCVD||ICD_10|2020|I63.239|Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery||
ASCVD|ASCVD||ICD_10|2020|I63.29|Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.30|Cerebral infarction due to thrombosis of unspecified cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.311|Cerebral infarction due to thrombosis of right middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.312|Cerebral infarction due to thrombosis of left middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.313|Cerebral infarction due to thrombosis of bilateral middle cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.319|Cerebral infarction due to thrombosis of unspecified middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.321|Cerebral infarction due to thrombosis of right anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.322|Cerebral infarction due to thrombosis of left anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.323|Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.329|Cerebral infarction due to thrombosis of unspecified anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.331|Cerebral infarction due to thrombosis of right posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.332|Cerebral infarction due to thrombosis of left posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.333|Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.339|Cerebral infarction due to thrombosis of unspecified posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.341|Cerebral infarction due to thrombosis of right cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.342|Cerebral infarction due to thrombosis of left cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.343|Cerebral infarction due to thrombosis of bilateral cerebellar arteries||
ASCVD|ASCVD||ICD_10|2020|I63.349|Cerebral infarction due to thrombosis of unspecified cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.39|Cerebral infarction due to thrombosis of other cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.40|Cerebral infarction due to embolism of unspecified cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.411|Cerebral infarction due to embolism of right middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.412|Cerebral infarction due to embolism of left middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.413|Cerebral infarction due to embolism of bilateral middle cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.419|Cerebral infarction due to embolism of unspecified middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.421|Cerebral infarction due to embolism of right anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.422|Cerebral infarction due to embolism of left anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.423|Cerebral infarction due to embolism of bilateral anterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.429|Cerebral infarction due to embolism of unspecified anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.431|Cerebral infarction due to embolism of right posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.432|Cerebral infarction due to embolism of left posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.433|Cerebral infarction due to embolism of bilateral posterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.439|Cerebral infarction due to embolism of unspecified posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.441|Cerebral infarction due to embolism of right cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.442|Cerebral infarction due to embolism of left cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.443|Cerebral infarction due to embolism of bilateral cerebellar arteries||
ASCVD|ASCVD||ICD_10|2020|I63.449|Cerebral infarction due to embolism of unspecified cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.49|Cerebral infarction due to embolism of other cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.50|Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.511|Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.512|Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.513|Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.519|Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.521|Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.522|Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.523|Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.529|Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.531|Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.532|Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.533|Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I63.539|Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.541|Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.542|Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.543|Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries||
ASCVD|ASCVD||ICD_10|2020|I63.549|Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery||
ASCVD|ASCVD||ICD_10|2020|I63.59|Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I63.6|Cerebral infarction due to cerebral venous thrombosis, nonpyogenic||
ASCVD|ASCVD||ICD_10|2020|I63.81|Other cerebral infarction due to occlusion or stenosis of small artery||
ASCVD|ASCVD||ICD_10|2020|I63.89|Other cerebral infarction||
ASCVD|ASCVD||ICD_10|2020|I63.9|Cerebral infarction, unspecified||
ASCVD|ASCVD||ICD_10|2020|I65.01|Occlusion and stenosis of right vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I65.02|Occlusion and stenosis of left vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I65.03|Occlusion and stenosis of unspecified vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I65.09|Occlusion and stenosis of unspecified vertebral artery||
ASCVD|ASCVD||ICD_10|2020|I65.1|Â Occlusion and stenosis of basilar artery||
ASCVD|ASCVD||ICD_10|2020|I65.21|Occlusion and stenosis of right carotid artery||
ASCVD|ASCVD||ICD_10|2020|I65.22|Occlusion and stenosis of left carotid artery||
ASCVD|ASCVD||ICD_10|2020|I65.23|Occlusion and stenosis of bilateral carotid artery||
ASCVD|ASCVD||ICD_10|2020|I65.29|Occlusion and stenosis of unspecified carotid artery||
ASCVD|ASCVD||ICD_10|2020|I65.8|Occlusion and stenosis of other precerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I65.9|Occlusion and stenosis of unspecified precerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I66.01|Occlusion and stenosis of right middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.02|Occlusion and stenosis of left middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.03|Occlusion and stenosis of bilateral middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.09|Occlusion and stenosis of unspecified middle cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.11|Occlusion and stenosis of right anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.12|Occlusion and stenosis of left anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.13|Occlusion and stenosis of bilateral anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.19|Occlusion and stenosis of unspecified anterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.21|Occlusion and stenosis of right posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.22|Occlusion and stenosis of left posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.23|Occlusion and stenosis of bilateral posterior cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I66.29|Occlusion and stenosis of unspecified posterior cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I66.3|Occlusion and stenosis of cerebellar arteries||
ASCVD|ASCVD||ICD_10|2020|I66.8|Occlusion and stenosis of other cerebral arteries||
ASCVD|ASCVD||ICD_10|2020|I66.9|Occlusion and stenosis of unspecified cerebral artery||
ASCVD|ASCVD||ICD_10|2020|I67.2|Cerebral Atherosclerosis||
ASCVD|ASCVD||ICD_10|2020|I70.0|Atherosclerosis of aorta||
ASCVD|ASCVD||ICD_10|2020|I70.1|Atherosclerosis of renal artery||
ASCVD|ASCVD||ICD_10|2020|I70.201|Unspecified atherosclerosis of native arteries of extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.202|Unspecified atherosclerosis of native arteries of extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.203|Unspecified atherosclerosis of native arteries of extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.208|Unspecified atherosclerosis of native arteries of extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.209|Unspecified atherosclerosis of native arteries of extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.211|Atherosclerosis of native arteries of extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.212|Atherosclerosis of native arteries of extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.213|Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.218|Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.219|Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.221|Atherosclerosis of native arteries of extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.222|Atherosclerosis of native arteries of extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.223|Atherosclerosis of native arteries of extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.228|Atherosclerosis of native arteries of extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.229|Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.231|Atherosclerosis of native arteries of right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.232|Atherosclerosis of native arteries of right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.233|Atherosclerosis of native arteries of right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.234|Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.235|Atherosclerosis of native arteries of right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.238|Atherosclerosis of native arteries of right leg with ulceration of other part of lower right leg||
ASCVD|ASCVD||ICD_10|2020|I70.239|Atherosclerosis of native arteries of right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.241|Atherosclerosis of native arteries of left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.242|Atherosclerosis of native arteries of left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.243|Atherosclerosis of native arteries of left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.244|Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.245|Atherosclerosis of native arteries of left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.248|Atherosclerosis of native arteries of left leg with ulceration of other part of lower left leg||
ASCVD|ASCVD||ICD_10|2020|I70.249|Atherosclerosis of native arteries of left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.25|Atherosclerosis of native arteries of other extremities with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.261|Atherosclerosis of native arteries of extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.262|Atherosclerosis of native arteries of extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.263|Atherosclerosis of native arteries of extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.268|Atherosclerosis of native arteries of extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.269|Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.291|Other atherosclerosis of native arteries of extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.292|Other atherosclerosis of native arteries of extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.293|Other atherosclerosis of native arteries of extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.298|Other atherosclerosis of native arteries of extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.299|Other atherosclerosis of native arteries of extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.301|Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.302|Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.303|Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.308|Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.309|Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.311|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.312|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.313|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.318|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.319|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.321|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.322|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.323|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.328|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.329|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.331|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.332|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.333|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.334|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.335|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.338|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.339|Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.341|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.342|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.343|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.344|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.345|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.348|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.349|Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.35|Atherosclerosis of unspecified type of bypass graft(s) of other extremity with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.361|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.362|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.363|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.368|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.369|Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.391|Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.392|Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.393|Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.398|Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.399|Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.401|Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.402|Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.403|Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.408|Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.409|Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.411|Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.412|Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.413|Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.418|Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.419|Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.421|Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.422|Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.423|Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.428|Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.429|Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.431|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.432|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.433|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.434|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.435|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.438|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.439|Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.441|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.442|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.443|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.444|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.445|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.448|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.449|Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.45|Atherosclerosis of autologous vein bypass graft(s) of other extremity with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.461|Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.462|Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.463|Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.468|Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.469|Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.491|Other atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.492|Other atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.493|Other atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.498|Other atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.499|Other atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.501|Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.502|Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.503|Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.508|Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.509|Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.511|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.512|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.513|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.518|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.519|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.521|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.522|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.523|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.528|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.529|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.531|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.532|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.533|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.534|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.535|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.538|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.539|Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.541|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.542|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.543|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.544|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.545|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.548|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.549|Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.55|Atherosclerosis of nonautologous biological bypass graft(s) of other extremity with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.561|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.562|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.563|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.568|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.569|Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.591|Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.592|Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.593|Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.598|Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.599|Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.601|Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.602|Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.603|Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.608|Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.609|Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.611|Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.612|Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.613|Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.618|Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.619|Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.621|Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.622|Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.623|Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.628|Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.629|Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.631|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.632|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.633|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.634|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.635|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.638|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.639|Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.641|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.642|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.643|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.644|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.645|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.648|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.649|Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.65|Atherosclerosis of nonbiological bypass graft(s) of other extremity with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.661|Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.662|Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.663|Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.668|Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.669|Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.691|Other atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.692|Other atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.693|Other atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.698|Other atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.699|Other atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.701|Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.702|Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.703|Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.708|Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.709|Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.711|Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.712|Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.713|Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.718|Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.719|Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.721|Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.722|Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.723|Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.728|Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.729|Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.731|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.732|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.733|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.734|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.735|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.738|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.739|Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.741|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of thigh||
ASCVD|ASCVD||ICD_10|2020|I70.742|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of calf||
ASCVD|ASCVD||ICD_10|2020|I70.743|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of ankle||
ASCVD|ASCVD||ICD_10|2020|I70.744|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot||
ASCVD|ASCVD||ICD_10|2020|I70.745|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of foot||
ASCVD|ASCVD||ICD_10|2020|I70.748|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of lower leg||
ASCVD|ASCVD||ICD_10|2020|I70.749|Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site||
ASCVD|ASCVD||ICD_10|2020|I70.75|Atherosclerosis of other type of bypass graft(s) of other extremity with ulceration||
ASCVD|ASCVD||ICD_10|2020|I70.761|Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.762|Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.763|Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.768|Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.769|Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.791|Other atherosclerosis of other type of bypass graft(s) of the extremities, right leg||
ASCVD|ASCVD||ICD_10|2020|I70.792|Other atherosclerosis of other type of bypass graft(s) of the extremities, left leg||
ASCVD|ASCVD||ICD_10|2020|I70.793|Other atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs||
ASCVD|ASCVD||ICD_10|2020|I70.798|Other atherosclerosis of other type of bypass graft(s) of the extremities, other extremity||
ASCVD|ASCVD||ICD_10|2020|I70.799|Other atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity||
ASCVD|ASCVD||ICD_10|2020|I70.8|Atherosclerosis of other arteries||
ASCVD|ASCVD||ICD_10|2020|I70.90|Unspecified atherosclerosis||
ASCVD|ASCVD||ICD_10|2020|I70.91|Generalized atherosclerosis||
ASCVD|ASCVD||ICD_10|2020|I70.92|Chronic total occlusion of artery of the extremities||
CANCER|CANCER||ICD_10|2020|C00.0|Malignant neoplasm of external upper lip||
CANCER|CANCER||ICD_10|2020|C00.1|Malignant neoplasm of external lower lip||
CANCER|CANCER||ICD_10|2020|C00.2|Malignant neoplasm of external lip, unspecified||
CANCER|CANCER||ICD_10|2020|C00.3|Malignant neoplasm of upper lip, inner aspect||
CANCER|CANCER||ICD_10|2020|C00.4|Malignant neoplasm of lower lip, inner aspect||
CANCER|CANCER||ICD_10|2020|C00.5|Malignant neoplasm of lip, unspecified, inner aspect||
CANCER|CANCER||ICD_10|2020|C00.6|Malignant neoplasm of commissure of lip, unspecified||
CANCER|CANCER||ICD_10|2020|C00.8|Malignant neoplasm of overlapping sites of lip||
CANCER|CANCER||ICD_10|2020|C00.9|Malignant neoplasm of lip, unspecified||
CANCER|CANCER||ICD_10|2020|C01|Malignant neoplasm of base of tongue||
CANCER|CANCER||ICD_10|2020|C02.0|Malignant neoplasm of dorsal surface of tongue||
CANCER|CANCER||ICD_10|2020|C02.1|Malignant neoplasm of border of tongue||
CANCER|CANCER||ICD_10|2020|C02.2|Malignant neoplasm of ventral surface of tongue||
CANCER|CANCER||ICD_10|2020|C02.3|Malignant neoplasm of anterior two-thirds of tongue, part unspecified||
CANCER|CANCER||ICD_10|2020|C02.4|Malignant neoplasm of lingual tonsil||
CANCER|CANCER||ICD_10|2020|C02.8|Malignant neoplasm of overlapping sites of tongue||
CANCER|CANCER||ICD_10|2020|C02.9|Malignant neoplasm of tongue, unspecified||
CANCER|CANCER||ICD_10|2020|C03.0|Malignant neoplasm of upper gum||
CANCER|CANCER||ICD_10|2020|C03.1|Malignant neoplasm of lower gum||
CANCER|CANCER||ICD_10|2020|C03.9|Malignant neoplasm of gum, unspecified||
CANCER|CANCER||ICD_10|2020|C04.0|Malignant neoplasm of anterior floor of mouth||
CANCER|CANCER||ICD_10|2020|C04.1|Malignant neoplasm of lateral floor of mouth||
CANCER|CANCER||ICD_10|2020|C04.8|Malignant neoplasm of overlapping sites of floor of mouth||
CANCER|CANCER||ICD_10|2020|C04.9|Malignant neoplasm of floor of mouth, unspecified||
CANCER|CANCER||ICD_10|2020|C05.0|Malignant neoplasm of hard palate||
CANCER|CANCER||ICD_10|2020|C05.1|Malignant neoplasm of soft palate||
CANCER|CANCER||ICD_10|2020|C05.2|Malignant neoplasm of uvula||
CANCER|CANCER||ICD_10|2020|C05.8|Malignant neoplasm of overlapping sites of palate||
CANCER|CANCER||ICD_10|2020|C05.9|Malignant neoplasm of palate, unspecified||
CANCER|CANCER||ICD_10|2020|C06.0|Malignant neoplasm of cheek mucosa||
CANCER|CANCER||ICD_10|2020|C06.1|Malignant neoplasm of vestibule of mouth||
CANCER|CANCER||ICD_10|2020|C06.2|Malignant neoplasm of retromolar area||
CANCER|CANCER||ICD_10|2020|C06.80|Malignant neoplasm of overlapping sites of unspecified parts of mouth||
CANCER|CANCER||ICD_10|2020|C06.89|Malignant neoplasm of overlapping sites of other parts of mouth||
CANCER|CANCER||ICD_10|2020|C06.9|Malignant neoplasm of mouth, unspecified||
CANCER|CANCER||ICD_10|2020|C07|Malignant neoplasm of parotid gland||
CANCER|CANCER||ICD_10|2020|C08.0|Malignant neoplasm of submandibular gland||
CANCER|CANCER||ICD_10|2020|C08.1|Malignant neoplasm of sublingual gland||
CANCER|CANCER||ICD_10|2020|C08.9|Malignant neoplasm of major salivary gland, unspecified||
CANCER|CANCER||ICD_10|2020|C09.0|Malignant neoplasm of tonsillar fossa||
CANCER|CANCER||ICD_10|2020|C09.1|Malignant neoplasm of tonsillar pillar (anterior) (posterior)||
CANCER|CANCER||ICD_10|2020|C09.8|Malignant neoplasm of overlapping sites of tonsil||
CANCER|CANCER||ICD_10|2020|C09.9|Malignant neoplasm of tonsil, unspecified||
CANCER|CANCER||ICD_10|2020|C10.0|Malignant neoplasm of vallecula||
CANCER|CANCER||ICD_10|2020|C10.1|Malignant neoplasm of anterior surface of epiglottis||
CANCER|CANCER||ICD_10|2020|C10.2|Malignant neoplasm of lateral wall of oropharynx||
CANCER|CANCER||ICD_10|2020|C10.3|Malignant neoplasm of posterior wall of oropharynx||
CANCER|CANCER||ICD_10|2020|C10.4|Malignant neoplasm of branchial cleft||
CANCER|CANCER||ICD_10|2020|C10.8|Malignant neoplasm of overlapping sites of oropharynx||
CANCER|CANCER||ICD_10|2020|C10.9|Malignant neoplasm of oropharynx, unspecified||
CANCER|CANCER||ICD_10|2020|C11.0|Malignant neoplasm of superior wall of nasopharynx||
CANCER|CANCER||ICD_10|2020|C11.1|Malignant neoplasm of posterior wall of nasopharynx||
CANCER|CANCER||ICD_10|2020|C11.2|Malignant neoplasm of lateral wall of nasopharynx||
CANCER|CANCER||ICD_10|2020|C11.3|Malignant neoplasm of anterior wall of nasopharynx||
CANCER|CANCER||ICD_10|2020|C11.8|Malignant neoplasm of overlapping sites of nasopharynx||
CANCER|CANCER||ICD_10|2020|C11.9|Malignant neoplasm of nasopharynx, unspecified||
CANCER|CANCER||ICD_10|2020|C12|Malignant neoplasm of pyriform sinus||
CANCER|CANCER||ICD_10|2020|C13.0|Malignant neoplasm of postcricoid region||
CANCER|CANCER||ICD_10|2020|C13.1|Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect||
CANCER|CANCER||ICD_10|2020|C13.2|Malignant neoplasm of posterior wall of hypopharynx||
CANCER|CANCER||ICD_10|2020|C13.8|Malignant neoplasm of overlapping sites of hypopharynx||
CANCER|CANCER||ICD_10|2020|C13.9|Malignant neoplasm of hypopharynx, unspecified||
CANCER|CANCER||ICD_10|2020|C14.0|Malignant neoplasm of pharynx, unspecified||
CANCER|CANCER||ICD_10|2020|C14.2|Malignant neoplasm of Waldeyer's ring||
CANCER|CANCER||ICD_10|2020|C14.8|Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx||
CANCER|CANCER||ICD_10|2020|C15.3|Malignant neoplasm of upper third of esophagus||
CANCER|CANCER||ICD_10|2020|C15.4|Malignant neoplasm of middle third of esophagus||
CANCER|CANCER||ICD_10|2020|C15.5|Malignant neoplasm of lower third of esophagus||
CANCER|CANCER||ICD_10|2020|C15.8|Malignant neoplasm of overlapping sites of esophagus||
CANCER|CANCER||ICD_10|2020|C15.9|Malignant neoplasm of esophagus, unspecified||
CANCER|CANCER||ICD_10|2020|C16.0|Malignant neoplasm of cardia||
CANCER|CANCER||ICD_10|2020|C16.1|Malignant neoplasm of fundus of stomach||
CANCER|CANCER||ICD_10|2020|C16.2|Malignant neoplasm of body of stomach||
CANCER|CANCER||ICD_10|2020|C16.3|Malignant neoplasm of pyloric antrum||
CANCER|CANCER||ICD_10|2020|C16.4|Malignant neoplasm of pylorus||
CANCER|CANCER||ICD_10|2020|C16.5|Malignant neoplasm of lesser curvature of stomach, unspecified||
CANCER|CANCER||ICD_10|2020|C16.6|Malignant neoplasm of greater curvature of stomach, unspecified||
CANCER|CANCER||ICD_10|2020|C16.8|Malignant neoplasm of overlapping sites of stomach||
CANCER|CANCER||ICD_10|2020|C16.9|Malignant neoplasm of stomach, unspecified||
CANCER|CANCER||ICD_10|2020|C17.0|Malignant neoplasm of duodenum||
CANCER|CANCER||ICD_10|2020|C17.1|Malignant neoplasm of jejunum||
CANCER|CANCER||ICD_10|2020|C17.2|Malignant neoplasm of ileum||
CANCER|CANCER||ICD_10|2020|C17.3|Meckel's diverticulum, malignant||
CANCER|CANCER||ICD_10|2020|C17.8|Malignant neoplasm of overlapping sites of small intestine||
CANCER|CANCER||ICD_10|2020|C17.9|Malignant neoplasm of small intestine, unspecified||
CANCER|CANCER||ICD_10|2020|C18.0|Malignant neoplasm of cecum||
CANCER|CANCER||ICD_10|2020|C18.1|Malignant neoplasm of appendix||
CANCER|CANCER||ICD_10|2020|C18.2|Malignant neoplasm of ascending colon||
CANCER|CANCER||ICD_10|2020|C18.3|Malignant neoplasm of hepatic flexure||
CANCER|CANCER||ICD_10|2020|C18.4|Malignant neoplasm of transverse colon||
CANCER|CANCER||ICD_10|2020|C18.5|Malignant neoplasm of splenic flexure||
CANCER|CANCER||ICD_10|2020|C18.6|Malignant neoplasm of descending colon||
CANCER|CANCER||ICD_10|2020|C18.7|Malignant neoplasm of sigmoid colon||
CANCER|CANCER||ICD_10|2020|C18.8|Malignant neoplasm of overlapping sites of colon||
CANCER|CANCER||ICD_10|2020|C18.9|Malignant neoplasm of colon, unspecified||
CANCER|CANCER||ICD_10|2020|C19|Malignant neoplasm of rectosigmoid junction||
CANCER|CANCER||ICD_10|2020|C20|Malignant neoplasm of rectum||
CANCER|CANCER||ICD_10|2020|C21.0|Malignant neoplasm of anus, unspecified||
CANCER|CANCER||ICD_10|2020|C21.1|Malignant neoplasm of anal canal||
CANCER|CANCER||ICD_10|2020|C21.2|Malignant neoplasm of cloacogenic zone||
CANCER|CANCER||ICD_10|2020|C21.8|Malignant neoplasm of overlapping sites of rectum, anus and anal canal||
CANCER|CANCER||ICD_10|2020|C22.0|Liver cell carcinoma||
CANCER|CANCER||ICD_10|2020|C22.1|Intrahepatic bile duct carcinoma||
CANCER|CANCER||ICD_10|2020|C22.2|Hepatoblastoma||
CANCER|CANCER||ICD_10|2020|C22.3|Angiosarcoma of liver||
CANCER|CANCER||ICD_10|2020|C22.4|Other sarcomas of liver||
CANCER|CANCER||ICD_10|2020|C22.7|Other specified carcinomas of liver||
CANCER|CANCER||ICD_10|2020|C22.8|Malignant neoplasm of liver, primary, unspecified as to type||
CANCER|CANCER||ICD_10|2020|C22.9|Malignant neoplasm of liver, not specified as primary or secondary||
CANCER|CANCER||ICD_10|2020|C23|Malignant neoplasm of gallbladder||
CANCER|CANCER||ICD_10|2020|C24.0|Malignant neoplasm of extrahepatic bile duct||
CANCER|CANCER||ICD_10|2020|C24.1|Malignant neoplasm of ampulla of Vater||
CANCER|CANCER||ICD_10|2020|C24.8|Malignant neoplasm of overlapping sites of biliary tract||
CANCER|CANCER||ICD_10|2020|C24.9|Malignant neoplasm of biliary tract, unspecified||
CANCER|CANCER||ICD_10|2020|C25.0|Malignant neoplasm of head of pancreas||
CANCER|CANCER||ICD_10|2020|C25.1|Malignant neoplasm of body of pancreas||
CANCER|CANCER||ICD_10|2020|C25.2|Malignant neoplasm of tail of pancreas||
CANCER|CANCER||ICD_10|2020|C25.3|Malignant neoplasm of pancreatic duct||
CANCER|CANCER||ICD_10|2020|C25.4|Malignant neoplasm of endocrine pancreas||
CANCER|CANCER||ICD_10|2020|C25.7|Malignant neoplasm of other parts of pancreas||
CANCER|CANCER||ICD_10|2020|C25.8|Malignant neoplasm of overlapping sites of pancreas||
CANCER|CANCER||ICD_10|2020|C25.9|Malignant neoplasm of pancreas, unspecified||
CANCER|CANCER||ICD_10|2020|C26.0|Malignant neoplasm of intestinal tract, part unspecified||
CANCER|CANCER||ICD_10|2020|C26.1|Malignant neoplasm of spleen||
CANCER|CANCER||ICD_10|2020|C26.9|Malignant neoplasm of ill-defined sites within the digestive system||
CANCER|CANCER||ICD_10|2020|C30.0|Malignant neoplasm of nasal cavity||
CANCER|CANCER||ICD_10|2020|C30.1|Malignant neoplasm of middle ear||
CANCER|CANCER||ICD_10|2020|C31.0|Malignant neoplasm of maxillary sinus||
CANCER|CANCER||ICD_10|2020|C31.1|Malignant neoplasm of ethmoidal sinus||
CANCER|CANCER||ICD_10|2020|C31.2|Malignant neoplasm of frontal sinus||
CANCER|CANCER||ICD_10|2020|C31.3|Malignant neoplasm of sphenoid sinus||
CANCER|CANCER||ICD_10|2020|C31.8|Malignant neoplasm of overlapping sites of accessory sinuses||
CANCER|CANCER||ICD_10|2020|C31.9|Malignant neoplasm of accessory sinus, unspecified||
CANCER|CANCER||ICD_10|2020|C32.0|Malignant neoplasm of glottis||
CANCER|CANCER||ICD_10|2020|C32.1|Malignant neoplasm of supraglottis||
CANCER|CANCER||ICD_10|2020|C32.2|Malignant neoplasm of subglottis||
CANCER|CANCER||ICD_10|2020|C32.3|Malignant neoplasm of laryngeal cartilage||
CANCER|CANCER||ICD_10|2020|C32.8|Malignant neoplasm of overlapping sites of larynx||
CANCER|CANCER||ICD_10|2020|C32.9|Malignant neoplasm of larynx, unspecified||
CANCER|CANCER||ICD_10|2020|C33|Malignant neoplasm of trachea||
CANCER|CANCER||ICD_10|2020|C34.00|Malignant neoplasm of unspecified main bronchus||
CANCER|CANCER||ICD_10|2020|C34.01|Malignant neoplasm of right main bronchus||
CANCER|CANCER||ICD_10|2020|C34.02|Malignant neoplasm of left main bronchus||
CANCER|CANCER||ICD_10|2020|C34.10|Malignant neoplasm of upper lobe, unspecified bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.11|Malignant neoplasm of upper lobe, right bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.12|Malignant neoplasm of upper lobe, left bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.2|Malignant neoplasm of middle lobe, bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.30|Malignant neoplasm of lower lobe, unspecified bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.31|Malignant neoplasm of lower lobe, right bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.32|Malignant neoplasm of lower lobe, left bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.80|Malignant neoplasm of overlapping sites of unspecified bronchus and lung||
CANCER|CANCER||ICD_10|2020|C34.81|Malignant neoplasm of overlapping sites of right bronchus and lung||
CANCER|CANCER||ICD_10|2020|C34.82|Malignant neoplasm of overlapping sites of left bronchus and lung||
CANCER|CANCER||ICD_10|2020|C34.90|Malignant neoplasm of unspecified part of unspecified bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.91|Malignant neoplasm of unspecified part of right bronchus or lung||
CANCER|CANCER||ICD_10|2020|C34.92|Malignant neoplasm of unspecified part of left bronchus or lung||
CANCER|CANCER||ICD_10|2020|C37|Malignant neoplasm of thymus||
CANCER|CANCER||ICD_10|2020|C38.0|Malignant neoplasm of heart||
CANCER|CANCER||ICD_10|2020|C38.1|Malignant neoplasm of anterior mediastinum||
CANCER|CANCER||ICD_10|2020|C38.2|Malignant neoplasm of posterior mediastinum||
CANCER|CANCER||ICD_10|2020|C38.3|Malignant neoplasm of mediastinum, part unspecified||
CANCER|CANCER||ICD_10|2020|C38.4|Malignant neoplasm of pleura||
CANCER|CANCER||ICD_10|2020|C38.8|Malignant neoplasm of overlapping sites of heart, mediastinum and pleura||
CANCER|CANCER||ICD_10|2020|C39.0|Malignant neoplasm of upper respiratory tract, part unspecified||
CANCER|CANCER||ICD_10|2020|C39.9|Malignant neoplasm of lower respiratory tract, part unspecified||
CANCER|CANCER||ICD_10|2020|C40.00|Malignant neoplasm of scapula and long bones of unspecified upper limb||
CANCER|CANCER||ICD_10|2020|C40.01|Malignant neoplasm of scapula and long bones of right upper limb||
CANCER|CANCER||ICD_10|2020|C40.02|Malignant neoplasm of scapula and long bones of left upper limb||
CANCER|CANCER||ICD_10|2020|C40.10|Malignant neoplasm of short bones of unspecified upper limb||
CANCER|CANCER||ICD_10|2020|C40.11|Malignant neoplasm of short bones of right upper limb||
CANCER|CANCER||ICD_10|2020|C40.12|Malignant neoplasm of short bones of left upper limb||
CANCER|CANCER||ICD_10|2020|C40.20|Malignant neoplasm of long bones of unspecified lower limb||
CANCER|CANCER||ICD_10|2020|C40.21|Malignant neoplasm of long bones of right lower limb||
CANCER|CANCER||ICD_10|2020|C40.22|Malignant neoplasm of long bones of left lower limb||
CANCER|CANCER||ICD_10|2020|C40.30|Malignant neoplasm of short bones of unspecified lower limb||
CANCER|CANCER||ICD_10|2020|C40.31|Malignant neoplasm of short bones of right lower limb||
CANCER|CANCER||ICD_10|2020|C40.32|Malignant neoplasm of short bones of left lower limb||
CANCER|CANCER||ICD_10|2020|C40.80|Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb||
CANCER|CANCER||ICD_10|2020|C40.81|Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb||
CANCER|CANCER||ICD_10|2020|C40.82|Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb||
CANCER|CANCER||ICD_10|2020|C40.90|Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb||
CANCER|CANCER||ICD_10|2020|C40.91|Malignant neoplasm of unspecified bones and articular cartilage of right limb||
CANCER|CANCER||ICD_10|2020|C40.92|Malignant neoplasm of unspecified bones and articular cartilage of left limb||
CANCER|CANCER||ICD_10|2020|C41.0|Malignant neoplasm of bones of skull and face||
CANCER|CANCER||ICD_10|2020|C41.1|Malignant neoplasm of mandible||
CANCER|CANCER||ICD_10|2020|C41.2|Malignant neoplasm of vertebral column||
CANCER|CANCER||ICD_10|2020|C41.3|Malignant neoplasm of ribs, sternum and clavicle||
CANCER|CANCER||ICD_10|2020|C41.4|Malignant neoplasm of pelvic bones, sacrum and coccyx||
CANCER|CANCER||ICD_10|2020|C41.9|Malignant neoplasm of bone and articular cartilage, unspecified||
CANCER|CANCER||ICD_10|2020|C43.0|Malignant melanoma of lip||
CANCER|CANCER||ICD_10|2020|C43.10|Malignant melanoma of unspecified eyelid, including canthus||
CANCER|CANCER||ICD_10|2019|C43.11|Malignant melanoma of right eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C43.111|Malignant melanoma of right upper eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C43.112|Malignant melanoma of right lower eyelid, including canthus||
CANCER|CANCER||ICD_10|2019|C43.12|Malignant melanoma of left eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C43.121|Malignant melanoma of left upper eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C43.122|Malignant melanoma of left lower eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C43.20|Malignant melanoma of unspecified ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C43.21|Malignant melanoma of right ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C43.22|Malignant melanoma of left ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C43.30|Malignant melanoma of unspecified part of face||
CANCER|CANCER||ICD_10|2020|C43.31|Malignant melanoma of nose||
CANCER|CANCER||ICD_10|2020|C43.39|Malignant melanoma of other parts of face||
CANCER|CANCER||ICD_10|2020|C43.4|Malignant melanoma of scalp and neck||
CANCER|CANCER||ICD_10|2020|C43.51|Malignant melanoma of anal skin||
CANCER|CANCER||ICD_10|2020|C43.52|Malignant melanoma of skin of breast||
CANCER|CANCER||ICD_10|2020|C43.59|Malignant melanoma of other part of trunk||
CANCER|CANCER||ICD_10|2020|C43.60|Malignant melanoma of unspecified upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C43.61|Malignant melanoma of right upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C43.62|Malignant melanoma of left upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C43.70|Malignant melanoma of unspecified lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C43.71|Malignant melanoma of right lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C43.72|Malignant melanoma of left lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C43.8|Malignant melanoma of overlapping sites of skin||
CANCER|CANCER||ICD_10|2020|C43.9|Malignant melanoma of skin, unspecified||
CANCER|CANCER||ICD_10|2020|C45.0|Mesothelioma of pleura||
CANCER|CANCER||ICD_10|2020|C45.1|Mesothelioma of peritoneum||
CANCER|CANCER||ICD_10|2020|C45.2|Mesothelioma of pericardium||
CANCER|CANCER||ICD_10|2020|C45.7|Mesothelioma of other sites||
CANCER|CANCER||ICD_10|2020|C45.9|Mesothelioma, unspecified||
CANCER|CANCER||ICD_10|2020|C46.0|Kaposi's sarcoma of skin||
CANCER|CANCER||ICD_10|2020|C46.1|Kaposi's sarcoma of soft tissue||
CANCER|CANCER||ICD_10|2020|C46.2|Kaposi's sarcoma of palate||
CANCER|CANCER||ICD_10|2020|C46.3|Kaposi's sarcoma of lymph nodes||
CANCER|CANCER||ICD_10|2020|C46.4|Kaposi's sarcoma of gastrointestinal sites||
CANCER|CANCER||ICD_10|2020|C46.50|Kaposi's sarcoma of unspecified lung||
CANCER|CANCER||ICD_10|2020|C46.51|Kaposi's sarcoma of right lung||
CANCER|CANCER||ICD_10|2020|C46.52|Kaposi's sarcoma of left lung||
CANCER|CANCER||ICD_10|2020|C46.7|Kaposi's sarcoma of other sites||
CANCER|CANCER||ICD_10|2020|C46.9|Kaposi's sarcoma, unspecified||
CANCER|CANCER||ICD_10|2020|C47.0|Malignant neoplasm of peripheral nerves of head, face and neck||
CANCER|CANCER||ICD_10|2020|C47.10|Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C47.11|Malignant neoplasm of peripheral nerves of right upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C47.12|Malignant neoplasm of peripheral nerves of left upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C47.20|Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C47.21|Malignant neoplasm of peripheral nerves of right lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C47.22|Malignant neoplasm of peripheral nerves of left lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C47.3|Malignant neoplasm of peripheral nerves of thorax||
CANCER|CANCER||ICD_10|2020|C47.4|Malignant neoplasm of peripheral nerves of abdomen||
CANCER|CANCER||ICD_10|2020|C47.5|Malignant neoplasm of peripheral nerves of pelvis||
CANCER|CANCER||ICD_10|2020|C47.6|Malignant neoplasm of peripheral nerves of trunk, unspecified||
CANCER|CANCER||ICD_10|2020|C47.8|Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system||
CANCER|CANCER||ICD_10|2020|C47.9|Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified||
CANCER|CANCER||ICD_10|2020|C48.0|Malignant neoplasm of retroperitoneum||
CANCER|CANCER||ICD_10|2020|C48.1|Malignant neoplasm of specified parts of peritoneum||
CANCER|CANCER||ICD_10|2020|C48.2|Malignant neoplasm of peritoneum, unspecified||
CANCER|CANCER||ICD_10|2020|C48.8|Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum||
CANCER|CANCER||ICD_10|2020|C49.0|Malignant neoplasm of connective and soft tissue of head, face and neck||
CANCER|CANCER||ICD_10|2020|C49.10|Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C49.11|Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C49.12|Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C49.20|Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C49.21|Malignant neoplasm of connective and soft tissue of right lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C49.22|Malignant neoplasm of connective and soft tissue of left lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C49.3|Malignant neoplasm of connective and soft tissue of thorax||
CANCER|CANCER||ICD_10|2020|C49.4|Malignant neoplasm of connective and soft tissue of abdomen||
CANCER|CANCER||ICD_10|2020|C49.5|Malignant neoplasm of connective and soft tissue of pelvis||
CANCER|CANCER||ICD_10|2020|C49.6|Malignant neoplasm of connective and soft tissue of trunk, unspecified||
CANCER|CANCER||ICD_10|2020|C49.8|Malignant neoplasm of overlapping sites of connective and soft tissue||
CANCER|CANCER||ICD_10|2020|C49.9|Malignant neoplasm of connective and soft tissue, unspecified||
CANCER|CANCER||ICD_10|2020|C49.A0|Gastrointestinal stromal tumor, unspecified site||
CANCER|CANCER||ICD_10|2020|C49.A1|Gastrointestinal stromal tumor of esophagus||
CANCER|CANCER||ICD_10|2020|C49.A2|Gastrointestinal stromal tumor of stomach||
CANCER|CANCER||ICD_10|2020|C49.A3|Gastrointestinal stromal tumor of small intestine||
CANCER|CANCER||ICD_10|2020|C49.A4|Gastrointestinal stromal tumor of large intestine||
CANCER|CANCER||ICD_10|2020|C49.A5|Gastrointestinal stromal tumor of rectum||
CANCER|CANCER||ICD_10|2020|C49.A9|Gastrointestinal stromal tumor of other sites||
CANCER|CANCER||ICD_10|2020|C4A.0|Merkel cell carcinoma of lip||
CANCER|CANCER||ICD_10|2020|C4A.10|Merkel cell carcinoma of unspecified eyelid, including canthus||
CANCER|CANCER||ICD_10|2019|C4A.11|Merkel cell carcinoma of right eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C4A.111|Merkel cell carcinoma of right upper eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C4A.112|Merkel cell carcinoma of right lower eyelid, including canthus||
CANCER|CANCER||ICD_10|2019|C4A.12|Merkel cell carcinoma of left eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C4A.121|Merkel cell carcinoma of left upper eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C4A.122|Merkel cell carcinoma of left lower eyelid, including canthus||
CANCER|CANCER||ICD_10|2020|C4A.20|Merkel cell carcinoma of unspecified ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C4A.21|Merkel cell carcinoma of right ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C4A.22|Merkel cell carcinoma of left ear and external auricular canal||
CANCER|CANCER||ICD_10|2020|C4A.30|Merkel cell carcinoma of unspecified part of face||
CANCER|CANCER||ICD_10|2020|C4A.31|Merkel cell carcinoma of nose||
CANCER|CANCER||ICD_10|2020|C4A.39|Merkel cell carcinoma of other parts of face||
CANCER|CANCER||ICD_10|2020|C4A.4|Merkel cell carcinoma of scalp and neck||
CANCER|CANCER||ICD_10|2020|C4A.51|Merkel cell carcinoma of anal skin||
CANCER|CANCER||ICD_10|2020|C4A.52|Merkel cell carcinoma of skin of breast||
CANCER|CANCER||ICD_10|2020|C4A.59|Merkel cell carcinoma of other part of trunk||
CANCER|CANCER||ICD_10|2020|C4A.60|Merkel cell carcinoma of unspecified upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C4A.61|Merkel cell carcinoma of right upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C4A.62|Merkel cell carcinoma of left upper limb, including shoulder||
CANCER|CANCER||ICD_10|2020|C4A.70|Merkel cell carcinoma of unspecified lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C4A.71|Merkel cell carcinoma of right lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C4A.72|Merkel cell carcinoma of left lower limb, including hip||
CANCER|CANCER||ICD_10|2020|C4A.8|Merkel cell carcinoma of overlapping sites||
CANCER|CANCER||ICD_10|2020|C4A.9|Merkel cell carcinoma, unspecified||
CANCER|CANCER||ICD_10|2020|C50.011|Malignant neoplasm of nipple and areola, right female breast||
CANCER|CANCER||ICD_10|2020|C50.012|Malignant neoplasm of nipple and areola, left female breast||
CANCER|CANCER||ICD_10|2020|C50.019|Malignant neoplasm of nipple and areola, unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.021|Malignant neoplasm of nipple and areola, right male breast||
CANCER|CANCER||ICD_10|2020|C50.022|Malignant neoplasm of nipple and areola, left male breast||
CANCER|CANCER||ICD_10|2020|C50.029|Malignant neoplasm of nipple and areola, unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.111|Malignant neoplasm of central portion of right female breast||
CANCER|CANCER||ICD_10|2020|C50.112|Malignant neoplasm of central portion of left female breast||
CANCER|CANCER||ICD_10|2020|C50.119|Malignant neoplasm of central portion of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.121|Malignant neoplasm of central portion of right male breast||
CANCER|CANCER||ICD_10|2020|C50.122|Malignant neoplasm of central portion of left male breast||
CANCER|CANCER||ICD_10|2020|C50.129|Malignant neoplasm of central portion of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.211|Malignant neoplasm of upper-inner quadrant of right female breast||
CANCER|CANCER||ICD_10|2020|C50.212|Malignant neoplasm of upper-inner quadrant of left female breast||
CANCER|CANCER||ICD_10|2020|C50.219|Malignant neoplasm of upper-inner quadrant of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.221|Malignant neoplasm of upper-inner quadrant of right male breast||
CANCER|CANCER||ICD_10|2020|C50.222|Malignant neoplasm of upper-inner quadrant of left male breast||
CANCER|CANCER||ICD_10|2020|C50.229|Malignant neoplasm of upper-inner quadrant of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.311|Malignant neoplasm of lower-inner quadrant of right female breast||
CANCER|CANCER||ICD_10|2020|C50.312|Malignant neoplasm of lower-inner quadrant of left female breast||
CANCER|CANCER||ICD_10|2020|C50.319|Malignant neoplasm of lower-inner quadrant of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.321|Malignant neoplasm of lower-inner quadrant of right male breast||
CANCER|CANCER||ICD_10|2020|C50.322|Malignant neoplasm of lower-inner quadrant of left male breast||
CANCER|CANCER||ICD_10|2020|C50.329|Malignant neoplasm of lower-inner quadrant of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.411|Malignant neoplasm of upper-outer quadrant of right female breast||
CANCER|CANCER||ICD_10|2020|C50.412|Malignant neoplasm of upper-outer quadrant of left female breast||
CANCER|CANCER||ICD_10|2020|C50.419|Malignant neoplasm of upper-outer quadrant of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.421|Malignant neoplasm of upper-outer quadrant of right male breast||
CANCER|CANCER||ICD_10|2020|C50.422|Malignant neoplasm of upper-outer quadrant of left male breast||
CANCER|CANCER||ICD_10|2020|C50.429|Malignant neoplasm of upper-outer quadrant of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.511|Malignant neoplasm of lower-outer quadrant of right female breast||
CANCER|CANCER||ICD_10|2020|C50.512|Malignant neoplasm of lower-outer quadrant of left female breast||
CANCER|CANCER||ICD_10|2020|C50.519|Malignant neoplasm of lower-outer quadrant of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.521|Malignant neoplasm of lower-outer quadrant of right male breast||
CANCER|CANCER||ICD_10|2020|C50.522|Malignant neoplasm of lower-outer quadrant of left male breast||
CANCER|CANCER||ICD_10|2020|C50.529|Malignant neoplasm of lower-outer quadrant of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.611|Malignant neoplasm of axillary tail of right female breast||
CANCER|CANCER||ICD_10|2020|C50.612|Malignant neoplasm of axillary tail of left female breast||
CANCER|CANCER||ICD_10|2020|C50.619|Malignant neoplasm of axillary tail of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.621|Malignant neoplasm of axillary tail of right male breast||
CANCER|CANCER||ICD_10|2020|C50.622|Malignant neoplasm of axillary tail of left male breast||
CANCER|CANCER||ICD_10|2020|C50.629|Malignant neoplasm of axillary tail of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.811|Malignant neoplasm of overlapping sites of right female breast||
CANCER|CANCER||ICD_10|2020|C50.812|Malignant neoplasm of overlapping sites of left female breast||
CANCER|CANCER||ICD_10|2020|C50.819|Malignant neoplasm of overlapping sites of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.821|Malignant neoplasm of overlapping sites of right male breast||
CANCER|CANCER||ICD_10|2020|C50.822|Malignant neoplasm of overlapping sites of left male breast||
CANCER|CANCER||ICD_10|2020|C50.829|Malignant neoplasm of overlapping sites of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C50.911|Malignant neoplasm of unspecified site of right female breast||
CANCER|CANCER||ICD_10|2020|C50.912|Malignant neoplasm of unspecified site of left female breast||
CANCER|CANCER||ICD_10|2020|C50.919|Malignant neoplasm of unspecified site of unspecified female breast||
CANCER|CANCER||ICD_10|2020|C50.921|Malignant neoplasm of unspecified site of right male breast||
CANCER|CANCER||ICD_10|2020|C50.922|Malignant neoplasm of unspecified site of left male breast||
CANCER|CANCER||ICD_10|2020|C50.929|Malignant neoplasm of unspecified site of unspecified male breast||
CANCER|CANCER||ICD_10|2020|C51.0|Malignant neoplasm of labium majus||
CANCER|CANCER||ICD_10|2020|C51.1|Malignant neoplasm of labium minus||
CANCER|CANCER||ICD_10|2020|C51.2|Malignant neoplasm of clitoris||
CANCER|CANCER||ICD_10|2020|C51.8|Malignant neoplasm of overlapping sites of vulva||
CANCER|CANCER||ICD_10|2020|C51.9|Malignant neoplasm of vulva, unspecified||
CANCER|CANCER||ICD_10|2020|C52|Malignant neoplasm of vagina||
CANCER|CANCER||ICD_10|2020|C53.0|Malignant neoplasm of endocervix||
CANCER|CANCER||ICD_10|2020|C53.1|Malignant neoplasm of exocervix||
CANCER|CANCER||ICD_10|2020|C53.8|Malignant neoplasm of overlapping sites of cervix uteri||
CANCER|CANCER||ICD_10|2020|C53.9|Malignant neoplasm of cervix uteri, unspecified||
CANCER|CANCER||ICD_10|2020|C54.0|Malignant neoplasm of isthmus uteri||
CANCER|CANCER||ICD_10|2020|C54.1|Malignant neoplasm of endometrium||
CANCER|CANCER||ICD_10|2020|C54.2|Malignant neoplasm of myometrium||
CANCER|CANCER||ICD_10|2020|C54.3|Malignant neoplasm of fundus uteri||
CANCER|CANCER||ICD_10|2020|C54.8|Malignant neoplasm of overlapping sites of corpus uteri||
CANCER|CANCER||ICD_10|2020|C54.9|Malignant neoplasm of corpus uteri, unspecified||
CANCER|CANCER||ICD_10|2020|C55|Malignant neoplasm of uterus, part unspecified||
CANCER|CANCER||ICD_10|2020|C56.1|Malignant neoplasm of right ovary||
CANCER|CANCER||ICD_10|2020|C56.2|Malignant neoplasm of left ovary||
CANCER|CANCER||ICD_10|2020|C56.9|Malignant neoplasm of unspecified ovary||
CANCER|CANCER||ICD_10|2020|C57.00|Malignant neoplasm of unspecified fallopian tube||
CANCER|CANCER||ICD_10|2020|C57.01|Malignant neoplasm of right fallopian tube||
CANCER|CANCER||ICD_10|2020|C57.02|Malignant neoplasm of left fallopian tube||
CANCER|CANCER||ICD_10|2020|C57.10|Malignant neoplasm of unspecified broad ligament||
CANCER|CANCER||ICD_10|2020|C57.11|Malignant neoplasm of right broad ligament||
CANCER|CANCER||ICD_10|2020|C57.12|Malignant neoplasm of left broad ligament||
CANCER|CANCER||ICD_10|2020|C57.20|Malignant neoplasm of unspecified round ligament||
CANCER|CANCER||ICD_10|2020|C57.21|Malignant neoplasm of right round ligament||
CANCER|CANCER||ICD_10|2020|C57.22|Malignant neoplasm of left round ligament||
CANCER|CANCER||ICD_10|2020|C57.3|Malignant neoplasm of parametrium||
CANCER|CANCER||ICD_10|2020|C57.4|Malignant neoplasm of uterine adnexa, unspecified||
CANCER|CANCER||ICD_10|2020|C57.7|Malignant neoplasm of other specified female genital organs||
CANCER|CANCER||ICD_10|2020|C57.8|Malignant neoplasm of overlapping sites of female genital organs||
CANCER|CANCER||ICD_10|2020|C57.9|Malignant neoplasm of female genital organ, unspecified||
CANCER|CANCER||ICD_10|2020|C58|Malignant neoplasm of placenta||
CANCER|CANCER||ICD_10|2020|C60.0|Malignant neoplasm of prepuce||
CANCER|CANCER||ICD_10|2020|C60.1|Malignant neoplasm of glans penis||
CANCER|CANCER||ICD_10|2020|C60.2|Malignant neoplasm of body of penis||
CANCER|CANCER||ICD_10|2020|C60.8|Malignant neoplasm of overlapping sites of penis||
CANCER|CANCER||ICD_10|2020|C60.9|Malignant neoplasm of penis, unspecified||
CANCER|CANCER||ICD_10|2020|C61|Malignant neoplasm of prostate||
CANCER|CANCER||ICD_10|2020|C62.00|Malignant neoplasm of unspecified undescended testis||
CANCER|CANCER||ICD_10|2020|C62.01|Malignant neoplasm of undescended right testis||
CANCER|CANCER||ICD_10|2020|C62.02|Malignant neoplasm of undescended left testis||
CANCER|CANCER||ICD_10|2020|C62.10|Malignant neoplasm of unspecified descended testis||
CANCER|CANCER||ICD_10|2020|C62.11|Malignant neoplasm of descended right testis||
CANCER|CANCER||ICD_10|2020|C62.12|Malignant neoplasm of descended left testis||
CANCER|CANCER||ICD_10|2020|C62.90|Malignant neoplasm of unspecified testis, unspecified whether descended or undescended||
CANCER|CANCER||ICD_10|2020|C62.91|Malignant neoplasm of right testis, unspecified whether descended or undescended||
CANCER|CANCER||ICD_10|2020|C62.92|Malignant neoplasm of left testis, unspecified whether descended or undescended||
CANCER|CANCER||ICD_10|2020|C63.00|Malignant neoplasm of unspecified epididymis||
CANCER|CANCER||ICD_10|2020|C63.01|Malignant neoplasm of right epididymis||
CANCER|CANCER||ICD_10|2020|C63.02|Malignant neoplasm of left epididymis||
CANCER|CANCER||ICD_10|2020|C63.10|Malignant neoplasm of unspecified spermatic cord||
CANCER|CANCER||ICD_10|2020|C63.11|Malignant neoplasm of right spermatic cord||
CANCER|CANCER||ICD_10|2020|C63.12|Malignant neoplasm of left spermatic cord||
CANCER|CANCER||ICD_10|2020|C63.2|Malignant neoplasm of scrotum||
CANCER|CANCER||ICD_10|2020|C63.7|Malignant neoplasm of other specified male genital organs||
CANCER|CANCER||ICD_10|2020|C63.8|Malignant neoplasm of overlapping sites of male genital organs||
CANCER|CANCER||ICD_10|2020|C63.9|Malignant neoplasm of male genital organ, unspecified||
CANCER|CANCER||ICD_10|2020|C64.1|Malignant neoplasm of right kidney, except renal pelvis||
CANCER|CANCER||ICD_10|2020|C64.2|Malignant neoplasm of left kidney, except renal pelvis||
CANCER|CANCER||ICD_10|2020|C64.9|Malignant neoplasm of unspecified kidney, except renal pelvis||
CANCER|CANCER||ICD_10|2020|C65.1|Malignant neoplasm of right renal pelvis||
CANCER|CANCER||ICD_10|2020|C65.2|Malignant neoplasm of left renal pelvis||
CANCER|CANCER||ICD_10|2020|C65.9|Malignant neoplasm of unspecified renal pelvis||
CANCER|CANCER||ICD_10|2020|C66.1|Malignant neoplasm of right ureter||
CANCER|CANCER||ICD_10|2020|C66.2|Malignant neoplasm of left ureter||
CANCER|CANCER||ICD_10|2020|C66.9|Malignant neoplasm of unspecified ureter||
CANCER|CANCER||ICD_10|2020|C67.0|Malignant neoplasm of trigone of bladder||
CANCER|CANCER||ICD_10|2020|C67.1|Malignant neoplasm of dome of bladder||
CANCER|CANCER||ICD_10|2020|C67.2|Malignant neoplasm of lateral wall of bladder||
CANCER|CANCER||ICD_10|2020|C67.3|Malignant neoplasm of anterior wall of bladder||
CANCER|CANCER||ICD_10|2020|C67.4|Malignant neoplasm of posterior wall of bladder||
CANCER|CANCER||ICD_10|2020|C67.5|Malignant neoplasm of bladder neck||
CANCER|CANCER||ICD_10|2020|C67.6|Malignant neoplasm of ureteric orifice||
CANCER|CANCER||ICD_10|2020|C67.7|Malignant neoplasm of urachus||
CANCER|CANCER||ICD_10|2020|C67.8|Malignant neoplasm of overlapping sites of bladder||
CANCER|CANCER||ICD_10|2020|C67.9|Malignant neoplasm of bladder, unspecified||
CANCER|CANCER||ICD_10|2020|C68.0|Malignant neoplasm of urethra||
CANCER|CANCER||ICD_10|2020|C68.1|Malignant neoplasm of paraurethral glands||
CANCER|CANCER||ICD_10|2020|C68.8|Malignant neoplasm of overlapping sites of urinary organs||
CANCER|CANCER||ICD_10|2020|C68.9|Malignant neoplasm of urinary organ, unspecified||
CANCER|CANCER||ICD_10|2020|C69.00|Malignant neoplasm of unspecified conjunctiva||
CANCER|CANCER||ICD_10|2020|C69.01|Malignant neoplasm of right conjunctiva||
CANCER|CANCER||ICD_10|2020|C69.02|Malignant neoplasm of left conjunctiva||
CANCER|CANCER||ICD_10|2020|C69.10|Malignant neoplasm of unspecified cornea||
CANCER|CANCER||ICD_10|2020|C69.11|Malignant neoplasm of right cornea||
CANCER|CANCER||ICD_10|2020|C69.12|Malignant neoplasm of left cornea||
CANCER|CANCER||ICD_10|2020|C69.20|Malignant neoplasm of unspecified retina||
CANCER|CANCER||ICD_10|2020|C69.21|Malignant neoplasm of right retina||
CANCER|CANCER||ICD_10|2020|C69.22|Malignant neoplasm of left retina||
CANCER|CANCER||ICD_10|2020|C69.30|Malignant neoplasm of unspecified choroid||
CANCER|CANCER||ICD_10|2020|C69.31|Malignant neoplasm of right choroid||
CANCER|CANCER||ICD_10|2020|C69.32|Malignant neoplasm of left choroid||
CANCER|CANCER||ICD_10|2020|C69.40|Malignant neoplasm of unspecified ciliary body||
CANCER|CANCER||ICD_10|2020|C69.41|Malignant neoplasm of right ciliary body||
CANCER|CANCER||ICD_10|2020|C69.42|Malignant neoplasm of left ciliary body||
CANCER|CANCER||ICD_10|2020|C69.50|Malignant neoplasm of unspecified lacrimal gland and duct||
CANCER|CANCER||ICD_10|2020|C69.51|Malignant neoplasm of right lacrimal gland and duct||
CANCER|CANCER||ICD_10|2020|C69.52|Malignant neoplasm of left lacrimal gland and duct||
CANCER|CANCER||ICD_10|2020|C69.60|Malignant neoplasm of unspecified orbit||
CANCER|CANCER||ICD_10|2020|C69.61|Malignant neoplasm of right orbit||
CANCER|CANCER||ICD_10|2020|C69.62|Malignant neoplasm of left orbit||
CANCER|CANCER||ICD_10|2020|C69.80|Malignant neoplasm of overlapping sites of unspecified eye and adnexa||
CANCER|CANCER||ICD_10|2020|C69.81|Malignant neoplasm of overlapping sites of right eye and adnexa||
CANCER|CANCER||ICD_10|2020|C69.82|Malignant neoplasm of overlapping sites of left eye and adnexa||
CANCER|CANCER||ICD_10|2020|C69.90|Malignant neoplasm of unspecified site of unspecified eye||
CANCER|CANCER||ICD_10|2020|C69.91|Malignant neoplasm of unspecified site of right eye||
CANCER|CANCER||ICD_10|2020|C69.92|Malignant neoplasm of unspecified site of left eye||
CANCER|CANCER||ICD_10|2020|C70.0|Malignant neoplasm of cerebral meninges||
CANCER|CANCER||ICD_10|2020|C70.1|Malignant neoplasm of spinal meninges||
CANCER|CANCER||ICD_10|2020|C70.9|Malignant neoplasm of meninges, unspecified||
CANCER|CANCER||ICD_10|2020|C71.0|Malignant neoplasm of cerebrum, except lobes and ventricles||
CANCER|CANCER||ICD_10|2020|C71.1|Malignant neoplasm of frontal lobe||
CANCER|CANCER||ICD_10|2020|C71.2|Malignant neoplasm of temporal lobe||
CANCER|CANCER||ICD_10|2020|C71.3|Malignant neoplasm of parietal lobe||
CANCER|CANCER||ICD_10|2020|C71.4|Malignant neoplasm of occipital lobe||
CANCER|CANCER||ICD_10|2020|C71.5|Malignant neoplasm of cerebral ventricle||
CANCER|CANCER||ICD_10|2020|C71.6|Malignant neoplasm of cerebellum||
CANCER|CANCER||ICD_10|2020|C71.7|Malignant neoplasm of brain stem||
CANCER|CANCER||ICD_10|2020|C71.8|Malignant neoplasm of overlapping sites of brain||
CANCER|CANCER||ICD_10|2020|C71.9|Malignant neoplasm of brain, unspecified||
CANCER|CANCER||ICD_10|2020|C72.0|Malignant neoplasm of spinal cord||
CANCER|CANCER||ICD_10|2020|C72.1|Malignant neoplasm of cauda equina||
CANCER|CANCER||ICD_10|2020|C72.20|Malignant neoplasm of unspecified olfactory nerve||
CANCER|CANCER||ICD_10|2020|C72.21|Malignant neoplasm of right olfactory nerve||
CANCER|CANCER||ICD_10|2020|C72.22|Malignant neoplasm of left olfactory nerve||
CANCER|CANCER||ICD_10|2020|C72.30|Malignant neoplasm of unspecified optic nerve||
CANCER|CANCER||ICD_10|2020|C72.31|Malignant neoplasm of right optic nerve||
CANCER|CANCER||ICD_10|2020|C72.32|Malignant neoplasm of left optic nerve||
CANCER|CANCER||ICD_10|2020|C72.40|Malignant neoplasm of unspecified acoustic nerve||
CANCER|CANCER||ICD_10|2020|C72.41|Malignant neoplasm of right acoustic nerve||
CANCER|CANCER||ICD_10|2020|C72.42|Malignant neoplasm of left acoustic nerve||
CANCER|CANCER||ICD_10|2020|C72.50|Malignant neoplasm of unspecified cranial nerve||
CANCER|CANCER||ICD_10|2020|C72.59|Malignant neoplasm of other cranial nerves||
CANCER|CANCER||ICD_10|2020|C72.9|Malignant neoplasm of central nervous system, unspecified||
CANCER|CANCER||ICD_10|2020|C73|Malignant neoplasm of thyroid gland||
CANCER|CANCER||ICD_10|2020|C74.00|Malignant neoplasm of cortex of unspecified adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.01|Malignant neoplasm of cortex of right adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.02|Malignant neoplasm of cortex of left adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.10|Malignant neoplasm of medulla of unspecified adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.11|Malignant neoplasm of medulla of right adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.12|Malignant neoplasm of medulla of left adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.90|Malignant neoplasm of unspecified part of unspecified adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.91|Malignant neoplasm of unspecified part of right adrenal gland||
CANCER|CANCER||ICD_10|2020|C74.92|Malignant neoplasm of unspecified part of left adrenal gland||
CANCER|CANCER||ICD_10|2020|C75.0|Malignant neoplasm of parathyroid gland||
CANCER|CANCER||ICD_10|2020|C75.1|Malignant neoplasm of pituitary gland||
CANCER|CANCER||ICD_10|2020|C75.2|Malignant neoplasm of craniopharyngeal duct||
CANCER|CANCER||ICD_10|2020|C75.3|Malignant neoplasm of pineal gland||
CANCER|CANCER||ICD_10|2020|C75.4|Malignant neoplasm of carotid body||
CANCER|CANCER||ICD_10|2020|C75.5|Malignant neoplasm of aortic body and other paraganglia||
CANCER|CANCER||ICD_10|2020|C75.8|Malignant neoplasm with pluriglandular involvement, unspecified||
CANCER|CANCER||ICD_10|2020|C75.9|Malignant neoplasm of endocrine gland, unspecified||
CANCER|CANCER||ICD_10|2020|C76.0|Malignant neoplasm of head, face and neck||
CANCER|CANCER||ICD_10|2020|C76.1|Malignant neoplasm of thorax||
CANCER|CANCER||ICD_10|2020|C76.2|Malignant neoplasm of abdomen||
CANCER|CANCER||ICD_10|2020|C76.3|Malignant neoplasm of pelvis||
CANCER|CANCER||ICD_10|2020|C76.40|Malignant neoplasm of unspecified upper limb||
CANCER|CANCER||ICD_10|2020|C76.41|Malignant neoplasm of right upper limb||
CANCER|CANCER||ICD_10|2020|C76.42|Malignant neoplasm of left upper limb||
CANCER|CANCER||ICD_10|2020|C76.50|Malignant neoplasm of unspecified lower limb||
CANCER|CANCER||ICD_10|2020|C76.51|Malignant neoplasm of right lower limb||
CANCER|CANCER||ICD_10|2020|C76.52|Malignant neoplasm of left lower limb||
CANCER|CANCER||ICD_10|2020|C76.8|Malignant neoplasm of other specified ill-defined sites||
CANCER|CANCER||ICD_10|2020|C77.0|Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck||
CANCER|CANCER||ICD_10|2020|C77.1|Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C77.2|Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C77.3|Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes||
CANCER|CANCER||ICD_10|2020|C77.4|Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes||
CANCER|CANCER||ICD_10|2020|C77.5|Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C77.8|Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions||
CANCER|CANCER||ICD_10|2020|C77.9|Secondary and unspecified malignant neoplasm of lymph node, unspecified||
CANCER|CANCER||ICD_10|2020|C78.00|Secondary malignant neoplasm of unspecified lung||
CANCER|CANCER||ICD_10|2020|C78.01|Secondary malignant neoplasm of right lung||
CANCER|CANCER||ICD_10|2020|C78.02|Secondary malignant neoplasm of left lung||
CANCER|CANCER||ICD_10|2020|C78.1|Secondary malignant neoplasm of mediastinum||
CANCER|CANCER||ICD_10|2020|C78.2|Secondary malignant neoplasm of pleura||
CANCER|CANCER||ICD_10|2020|C78.30|Secondary malignant neoplasm of unspecified respiratory organ||
CANCER|CANCER||ICD_10|2020|C78.39|Secondary malignant neoplasm of other respiratory organs||
CANCER|CANCER||ICD_10|2020|C78.4|Secondary malignant neoplasm of small intestine||
CANCER|CANCER||ICD_10|2020|C78.5|Secondary malignant neoplasm of large intestine and rectum||
CANCER|CANCER||ICD_10|2020|C78.6|Secondary malignant neoplasm of retroperitoneum and peritoneum||
CANCER|CANCER||ICD_10|2020|C78.7|Secondary malignant neoplasm of liver and intrahepatic bile duct||
CANCER|CANCER||ICD_10|2020|C78.80|Secondary malignant neoplasm of unspecified digestive organ||
CANCER|CANCER||ICD_10|2020|C78.89|Secondary malignant neoplasm of other digestive organs||
CANCER|CANCER||ICD_10|2020|C79.00|Secondary malignant neoplasm of unspecified kidney and renal pelvis||
CANCER|CANCER||ICD_10|2020|C79.01|Secondary malignant neoplasm of right kidney and renal pelvis||
CANCER|CANCER||ICD_10|2020|C79.02|Secondary malignant neoplasm of left kidney and renal pelvis||
CANCER|CANCER||ICD_10|2020|C79.10|Secondary malignant neoplasm of unspecified urinary organs||
CANCER|CANCER||ICD_10|2020|C79.11|Secondary malignant neoplasm of bladder||
CANCER|CANCER||ICD_10|2020|C79.19|Secondary malignant neoplasm of other urinary organs||
CANCER|CANCER||ICD_10|2020|C79.2|Secondary malignant neoplasm of skin||
CANCER|CANCER||ICD_10|2020|C79.31|Secondary malignant neoplasm of brain||
CANCER|CANCER||ICD_10|2020|C79.32|Secondary malignant neoplasm of cerebral meninges||
CANCER|CANCER||ICD_10|2020|C79.40|Secondary malignant neoplasm of unspecified part of nervous system||
CANCER|CANCER||ICD_10|2020|C79.49|Secondary malignant neoplasm of other parts of nervous system||
CANCER|CANCER||ICD_10|2020|C79.51|Secondary malignant neoplasm of bone||
CANCER|CANCER||ICD_10|2020|C79.52|Secondary malignant neoplasm of bone marrow||
CANCER|CANCER||ICD_10|2020|C79.60|Secondary malignant neoplasm of unspecified ovary||
CANCER|CANCER||ICD_10|2020|C79.61|Secondary malignant neoplasm of right ovary||
CANCER|CANCER||ICD_10|2020|C79.62|Secondary malignant neoplasm of left ovary||
CANCER|CANCER||ICD_10|2020|C79.70|Secondary malignant neoplasm of unspecified adrenal gland||
CANCER|CANCER||ICD_10|2020|C79.71|Secondary malignant neoplasm of right adrenal gland||
CANCER|CANCER||ICD_10|2020|C79.72|Secondary malignant neoplasm of left adrenal gland||
CANCER|CANCER||ICD_10|2020|C79.81|Secondary malignant neoplasm of breast||
CANCER|CANCER||ICD_10|2020|C79.82|Secondary malignant neoplasm of genital organs||
CANCER|CANCER||ICD_10|2020|C79.89|Secondary malignant neoplasm of other specified sites||
CANCER|CANCER||ICD_10|2020|C79.9|Secondary malignant neoplasm of unspecified site||
CANCER|CANCER||ICD_10|2020|C7A.00|Malignant carcinoid tumor of unspecified site||
CANCER|CANCER||ICD_10|2020|C7A.010|Malignant carcinoid tumor of the duodenum||
CANCER|CANCER||ICD_10|2020|C7A.011|Malignant carcinoid tumor of the jejunum||
CANCER|CANCER||ICD_10|2020|C7A.012|Malignant carcinoid tumor of the ileum||
CANCER|CANCER||ICD_10|2020|C7A.019|Malignant carcinoid tumor of the small intestine, unspecified portion||
CANCER|CANCER||ICD_10|2020|C7A.020|Malignant carcinoid tumor of the appendix||
CANCER|CANCER||ICD_10|2020|C7A.021|Malignant carcinoid tumor of the cecum||
CANCER|CANCER||ICD_10|2020|C7A.022|Malignant carcinoid tumor of the ascending colon||
CANCER|CANCER||ICD_10|2020|C7A.023|Malignant carcinoid tumor of the transverse colon||
CANCER|CANCER||ICD_10|2020|C7A.024|Malignant carcinoid tumor of the descending colon||
CANCER|CANCER||ICD_10|2020|C7A.025|Malignant carcinoid tumor of the sigmoid colon||
CANCER|CANCER||ICD_10|2020|C7A.026|Malignant carcinoid tumor of the rectum||
CANCER|CANCER||ICD_10|2020|C7A.029|Malignant carcinoid tumor of the large intestine, unspecified portion||
CANCER|CANCER||ICD_10|2020|C7A.090|Malignant carcinoid tumor of the bronchus and lung||
CANCER|CANCER||ICD_10|2020|C7A.091|Malignant carcinoid tumor of the thymus||
CANCER|CANCER||ICD_10|2020|C7A.092|Malignant carcinoid tumor of the stomach||
CANCER|CANCER||ICD_10|2020|C7A.093|Malignant carcinoid tumor of the kidney||
CANCER|CANCER||ICD_10|2020|C7A.094|Malignant carcinoid tumor of the foregut, unspecified||
CANCER|CANCER||ICD_10|2020|C7A.095|Malignant carcinoid tumor of the midgut, unspecified||
CANCER|CANCER||ICD_10|2020|C7A.096|Malignant carcinoid tumor of the hindgut, unspecified||
CANCER|CANCER||ICD_10|2020|C7A.098|Malignant carcinoid tumors of other sites||
CANCER|CANCER||ICD_10|2020|C7A.1|Malignant poorly differentiated neuroendocrine tumors||
CANCER|CANCER||ICD_10|2020|C7A.8|Other malignant neuroendocrine tumors||
CANCER|CANCER||ICD_10|2020|C7B.00|Secondary carcinoid tumors, unspecified site||
CANCER|CANCER||ICD_10|2020|C7B.01|Secondary carcinoid tumors of distant lymph nodes||
CANCER|CANCER||ICD_10|2020|C7B.02|Secondary carcinoid tumors of liver||
CANCER|CANCER||ICD_10|2020|C7B.03|Secondary carcinoid tumors of bone||
CANCER|CANCER||ICD_10|2020|C7B.04|Secondary carcinoid tumors of peritoneum||
CANCER|CANCER||ICD_10|2020|C7B.09|Secondary carcinoid tumors of other sites||
CANCER|CANCER||ICD_10|2020|C7B.1|Secondary Merkel cell carcinoma||
CANCER|CANCER||ICD_10|2020|C7B.8|Other secondary neuroendocrine tumors||
CANCER|CANCER||ICD_10|2020|C80.0|Disseminated malignant neoplasm, unspecified||
CANCER|CANCER||ICD_10|2020|C80.1|Malignant (primary) neoplasm, unspecified||
CANCER|CANCER||ICD_10|2020|C80.2|Malignant neoplasm associated with transplanted organ||
CANCER|CANCER||ICD_10|2020|C81.00|Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.01|Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.02|Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.03|Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.04|Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.05|Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.06|Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.07|Nodular lymphocyte predominant Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.08|Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.09|Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.10|Nodular sclerosis Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.11|Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.12|Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.13|Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.14|Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.15|Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.16|Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.17|Nodular sclerosis Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.18|Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.19|Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.20|Mixed cellularity Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.21|Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.22|Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.23|Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.24|Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.25|Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.26|Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.27|Mixed cellularity Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.28|Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.29|Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.30|Lymphocyte depleted Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.31|Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.32|Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.33|Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.34|Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.35|Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.36|Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.37|Lymphocyte depleted Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.38|Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.39|Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.40|Lymphocyte-rich Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.41|Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.42|Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.43|Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.44|Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.45|Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.46|Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.47|Lymphocyte-rich Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.48|Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.49|Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.70|Other Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.71|Other Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.72|Other Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.73|Other Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.74|Other Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.75|Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.76|Other Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.77|Other Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C81.78|Other Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.79|Other Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C81.90|Hodgkin lymphoma, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C81.91|Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C81.92|Hodgkin lymphoma, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.93|Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.94|Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C81.95|Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C81.96|Hodgkin lymphoma, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C81.97|Hodgkin lymphoma, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C81.98|Hodgkin lymphoma, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C81.99|Hodgkin lymphoma, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.00|Follicular lymphoma grade I, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.01|Follicular lymphoma grade I, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.02|Follicular lymphoma grade I, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.03|Follicular lymphoma grade I, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.04|Follicular lymphoma grade I, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.05|Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.06|Follicular lymphoma grade I, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.07|Follicular lymphoma grade I, spleen||
CANCER|CANCER||ICD_10|2020|C82.08|Follicular lymphoma grade I, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.09|Follicular lymphoma grade I, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.10|Follicular lymphoma grade II, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.11|Follicular lymphoma grade II, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.12|Follicular lymphoma grade II, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.13|Follicular lymphoma grade II, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.14|Follicular lymphoma grade II, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.15|Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.16|Follicular lymphoma grade II, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.17|Follicular lymphoma grade II, spleen||
CANCER|CANCER||ICD_10|2020|C82.18|Follicular lymphoma grade II, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.19|Follicular lymphoma grade II, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.20|Follicular lymphoma grade III, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.21|Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.22|Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.23|Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.24|Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.25|Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.26|Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.27|Follicular lymphoma grade III, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C82.28|Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.29|Follicular lymphoma grade III, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.30|Follicular lymphoma grade IIIa, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.31|Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.32|Follicular lymphoma grade IIIa, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.33|Follicular lymphoma grade IIIa, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.34|Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.35|Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.36|Follicular lymphoma grade IIIa, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.37|Follicular lymphoma grade IIIa, spleen||
CANCER|CANCER||ICD_10|2020|C82.38|Follicular lymphoma grade IIIa, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.39|Follicular lymphoma grade IIIa, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.40|Follicular lymphoma grade IIIb, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.41|Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.42|Follicular lymphoma grade IIIb, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.43|Follicular lymphoma grade IIIb, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.44|Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.45|Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.46|Follicular lymphoma grade IIIb, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.47|Follicular lymphoma grade IIIb, spleen||
CANCER|CANCER||ICD_10|2020|C82.48|Follicular lymphoma grade IIIb, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.49|Follicular lymphoma grade IIIb, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.50|Diffuse follicle center lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.51|Diffuse follicle center lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.52|Diffuse follicle center lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.53|Diffuse follicle center lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.54|Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.55|Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.56|Diffuse follicle center lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.57|Diffuse follicle center lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C82.58|Diffuse follicle center lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.59|Diffuse follicle center lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.60|Cutaneous follicle center lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.61|Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.62|Cutaneous follicle center lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.63|Cutaneous follicle center lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.64|Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.65|Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.66|Cutaneous follicle center lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.67|Cutaneous follicle center lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C82.68|Cutaneous follicle center lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.69|Cutaneous follicle center lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.80|Other types of follicular lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.81|Other types of follicular lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.82|Other types of follicular lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.83|Other types of follicular lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.84|Other types of follicular lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.85|Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.86|Other types of follicular lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.87|Other types of follicular lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C82.88|Other types of follicular lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.89|Other types of follicular lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C82.90|Follicular lymphoma, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C82.91|Follicular lymphoma, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C82.92|Follicular lymphoma, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.93|Follicular lymphoma, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.94|Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C82.95|Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C82.96|Follicular lymphoma, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C82.97|Follicular lymphoma, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C82.98|Follicular lymphoma, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C82.99|Follicular lymphoma, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.00|Small cell B-cell lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.01|Small cell B-cell lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.02|Small cell B-cell lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.03|Small cell B-cell lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.04|Small cell B-cell lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.05|Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.06|Small cell B-cell lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.07|Small cell B-cell lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.08|Small cell B-cell lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.09|Small cell B-cell lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.10|Mantle cell lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.11|Mantle cell lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.12|Mantle cell lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.13|Mantle cell lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.14|Mantle cell lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.15|Mantle cell lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.16|Mantle cell lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.17|Mantle cell lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.18|Mantle cell lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.19|Mantle cell lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.30|Diffuse large B-cell lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.31|Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.32|Diffuse large B-cell lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.33|Diffuse large B-cell lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.34|Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.35|Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.36|Diffuse large B-cell lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.37|Diffuse large B-cell lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.38|Diffuse large B-cell lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.39|Diffuse large B-cell lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.50|Lymphoblastic (diffuse) lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.51|Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.52|Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.53|Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.54|Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.55|Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.56|Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.57|Lymphoblastic (diffuse) lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.58|Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.59|Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.70|Burkitt lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.71|Burkitt lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.72|Burkitt lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.73|Burkitt lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.74|Burkitt lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.75|Burkitt lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.76|Burkitt lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.77|Burkitt lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.78|Burkitt lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.79|Burkitt lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.80|Other non-follicular lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.81|Other non-follicular lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.82|Other non-follicular lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.83|Other non-follicular lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.84|Other non-follicular lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.85|Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.86|Other non-follicular lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.87|Other non-follicular lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C83.88|Other non-follicular lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.89|Other non-follicular lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C83.90|Non-follicular (diffuse) lymphoma, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C83.91|Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C83.92|Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.93|Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.94|Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C83.95|Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C83.96|Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C83.97|Non-follicular (diffuse) lymphoma, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C83.98|Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C83.99|Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.00|Mycosis fungoides, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.01|Mycosis fungoides, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.02|Mycosis fungoides, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.03|Mycosis fungoides, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.04|Mycosis fungoides, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.05|Mycosis fungoides, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.06|Mycosis fungoides, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.07|Mycosis fungoides, spleen||
CANCER|CANCER||ICD_10|2020|C84.08|Mycosis fungoides, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.09|Mycosis fungoides, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.10|Sezary disease, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.11|Sezary disease, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.12|Sezary disease, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.13|Sezary disease, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.14|Sezary disease, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.15|Sezary disease, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.16|Sezary disease, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.17|Sezary disease, spleen||
CANCER|CANCER||ICD_10|2020|C84.18|Sezary disease, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.19|Sezary disease, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.40|Peripheral T-cell lymphoma, not classified, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.41|Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.42|Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.43|Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.44|Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.45|Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.46|Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.47|Peripheral T-cell lymphoma, not classified, spleen||
CANCER|CANCER||ICD_10|2020|C84.48|Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.49|Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.60|Anaplastic large cell lymphoma, ALK-positive, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.61|Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.62|Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.63|Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.64|Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.65|Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.66|Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.67|Anaplastic large cell lymphoma, ALK-positive, spleen||
CANCER|CANCER||ICD_10|2020|C84.68|Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.69|Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.70|Anaplastic large cell lymphoma, ALK-negative, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.71|Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.72|Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.73|Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.74|Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.75|Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.76|Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.77|Anaplastic large cell lymphoma, ALK-negative, spleen||
CANCER|CANCER||ICD_10|2020|C84.78|Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.79|Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.90|Mature T/NK-cell lymphomas, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.91|Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.92|Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.93|Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.94|Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.95|Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.96|Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.97|Mature T/NK-cell lymphomas, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C84.98|Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.99|Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.A0|Cutaneous T-cell lymphoma, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.A1|Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.A2|Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.A3|Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.A4|Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.A5|Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.A6|Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.A7|Cutaneous T-cell lymphoma, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C84.A8|Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.A9|Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C84.Z0|Other mature T/NK-cell lymphomas, unspecified site||
CANCER|CANCER||ICD_10|2020|C84.Z1|Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C84.Z2|Other mature T/NK-cell lymphomas, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.Z3|Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.Z4|Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C84.Z5|Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C84.Z6|Other mature T/NK-cell lymphomas, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C84.Z7|Other mature T/NK-cell lymphomas, spleen||
CANCER|CANCER||ICD_10|2020|C84.Z8|Other mature T/NK-cell lymphomas, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C84.Z9|Other mature T/NK-cell lymphomas, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C85.10|Unspecified B-cell lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C85.11|Unspecified B-cell lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C85.12|Unspecified B-cell lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.13|Unspecified B-cell lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.14|Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C85.15|Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C85.16|Unspecified B-cell lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.17|Unspecified B-cell lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C85.18|Unspecified B-cell lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C85.19|Unspecified B-cell lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C85.20|Mediastinal (thymic) large B-cell lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C85.21|Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C85.22|Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.23|Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.24|Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C85.25|Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C85.26|Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.27|Mediastinal (thymic) large B-cell lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C85.28|Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C85.29|Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C85.80|Other specified types of non-Hodgkin lymphoma, unspecified site||
CANCER|CANCER||ICD_10|2020|C85.81|Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C85.82|Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.83|Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.84|Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C85.85|Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C85.86|Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.87|Other specified types of non-Hodgkin lymphoma, spleen||
CANCER|CANCER||ICD_10|2020|C85.88|Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C85.89|Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C85.90|Non-Hodgkin lymphoma, unspecified, unspecified site||
CANCER|CANCER||ICD_10|2020|C85.91|Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck||
CANCER|CANCER||ICD_10|2020|C85.92|Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.93|Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.94|Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb||
CANCER|CANCER||ICD_10|2020|C85.95|Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb||
CANCER|CANCER||ICD_10|2020|C85.96|Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes||
CANCER|CANCER||ICD_10|2020|C85.97|Non-Hodgkin lymphoma, unspecified, spleen||
CANCER|CANCER||ICD_10|2020|C85.98|Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites||
CANCER|CANCER||ICD_10|2020|C85.99|Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites||
CANCER|CANCER||ICD_10|2020|C86.0|Extranodal NK/T-cell lymphoma, nasal type||
CANCER|CANCER||ICD_10|2020|C86.1|Hepatosplenic T-cell lymphoma||
CANCER|CANCER||ICD_10|2020|C86.2|Enteropathy-type (intestinal) T-cell lymphoma||
CANCER|CANCER||ICD_10|2020|C86.3|Subcutaneous panniculitis-like T-cell lymphoma||
CANCER|CANCER||ICD_10|2020|C86.4|Blastic NK-cell lymphoma||
CANCER|CANCER||ICD_10|2020|C86.5|Angioimmunoblastic T-cell lymphoma||
CANCER|CANCER||ICD_10|2020|C86.6|Primary cutaneous CD30-positive T-cell proliferations||
CANCER|CANCER||ICD_10|2020|C88.0|Waldenstrom macroglobulinemia||
CANCER|CANCER||ICD_10|2020|C88.2|Heavy chain disease||
CANCER|CANCER||ICD_10|2020|C88.3|Immunoproliferative small intestinal disease||
CANCER|CANCER||ICD_10|2020|C88.4|Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]||
CANCER|CANCER||ICD_10|2020|C88.8|Other malignant immunoproliferative diseases||
CANCER|CANCER||ICD_10|2020|C88.9|Malignant immunoproliferative disease, unspecified||
CANCER|CANCER||ICD_10|2020|C90.00|Multiple myeloma not having achieved remission||
CANCER|CANCER||ICD_10|2020|C90.01|Multiple myeloma in remission||
CANCER|CANCER||ICD_10|2020|C90.02|Multiple myeloma in relapse||
CANCER|CANCER||ICD_10|2020|C90.10|Plasma cell leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C90.11|Plasma cell leukemia in remission||
CANCER|CANCER||ICD_10|2020|C90.12|Plasma cell leukemia in relapse||
CANCER|CANCER||ICD_10|2020|C90.20|Extramedullary plasmacytoma not having achieved remission||
CANCER|CANCER||ICD_10|2020|C90.21|Extramedullary plasmacytoma in remission||
CANCER|CANCER||ICD_10|2020|C90.22|Extramedullary plasmacytoma in relapse||
CANCER|CANCER||ICD_10|2020|C90.30|Solitary plasmacytoma not having achieved remission||
CANCER|CANCER||ICD_10|2020|C90.31|Solitary plasmacytoma in remission||
CANCER|CANCER||ICD_10|2020|C90.32|Solitary plasmacytoma in relapse||
CANCER|CANCER||ICD_10|2020|C91.00|Acute lymphoblastic leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.01|Acute lymphoblastic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C91.02|Acute lymphoblastic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C91.10|Chronic lymphocytic leukemia of B-cell type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.11|Chronic lymphocytic leukemia of B-cell type in remission||
CANCER|CANCER||ICD_10|2020|C91.12|Chronic lymphocytic leukemia of B-cell type in relapse||
CANCER|CANCER||ICD_10|2020|C91.30|Prolymphocytic leukemia of B-cell type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.31|Prolymphocytic leukemia of B-cell type, in remission||
CANCER|CANCER||ICD_10|2020|C91.32|Prolymphocytic leukemia of B-cell type, in relapse||
CANCER|CANCER||ICD_10|2020|C91.40|Hairy cell leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.41|Hairy cell leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C91.42|Hairy cell leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C91.50|Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.51|Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission||
CANCER|CANCER||ICD_10|2020|C91.52|Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse||
CANCER|CANCER||ICD_10|2020|C91.60|Prolymphocytic leukemia of T-cell type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.61|Prolymphocytic leukemia of T-cell type, in remission||
CANCER|CANCER||ICD_10|2020|C91.62|Prolymphocytic leukemia of T-cell type, in relapse||
CANCER|CANCER||ICD_10|2020|C91.90|Lymphoid leukemia, unspecified not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.91|Lymphoid leukemia, unspecified, in remission||
CANCER|CANCER||ICD_10|2020|C91.92|Lymphoid leukemia, unspecified, in relapse||
CANCER|CANCER||ICD_10|2020|C91.A0|Mature B-cell leukemia Burkitt-type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.A1|Mature B-cell leukemia Burkitt-type, in remission||
CANCER|CANCER||ICD_10|2020|C91.A2|Mature B-cell leukemia Burkitt-type, in relapse||
CANCER|CANCER||ICD_10|2020|C91.Z0|Other lymphoid leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C91.Z1|Other lymphoid leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C91.Z2|Other lymphoid leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C92.00|Acute myeloblastic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.01|Acute myeloblastic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C92.02|Acute myeloblastic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C92.10|Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.11|Chronic myeloid leukemia, BCR/ABL-positive, in remission||
CANCER|CANCER||ICD_10|2020|C92.12|Chronic myeloid leukemia, BCR/ABL-positive, in relapse||
CANCER|CANCER||ICD_10|2020|C92.20|Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.21|Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission||
CANCER|CANCER||ICD_10|2020|C92.22|Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse||
CANCER|CANCER||ICD_10|2020|C92.30|Myeloid sarcoma, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.31|Myeloid sarcoma, in remission||
CANCER|CANCER||ICD_10|2020|C92.32|Myeloid sarcoma, in relapse||
CANCER|CANCER||ICD_10|2020|C92.40|Acute promyelocytic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.41|Acute promyelocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C92.42|Acute promyelocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C92.50|Acute myelomonocytic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.51|Acute myelomonocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C92.52|Acute myelomonocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C92.60|Acute myeloid leukemia with 11q23-abnormality not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.61|Acute myeloid leukemia with 11q23-abnormality in remission||
CANCER|CANCER||ICD_10|2020|C92.62|Acute myeloid leukemia with 11q23-abnormality in relapse||
CANCER|CANCER||ICD_10|2020|C92.90|Myeloid leukemia, unspecified, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.91|Myeloid leukemia, unspecified in remission||
CANCER|CANCER||ICD_10|2020|C92.92|Myeloid leukemia, unspecified in relapse||
CANCER|CANCER||ICD_10|2020|C92.A0|Acute myeloid leukemia with multilineage dysplasia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.A1|Acute myeloid leukemia with multilineage dysplasia, in remission||
CANCER|CANCER||ICD_10|2020|C92.A2|Acute myeloid leukemia with multilineage dysplasia, in relapse||
CANCER|CANCER||ICD_10|2020|C92.Z0|Other myeloid leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C92.Z1|Other myeloid leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C92.Z2|Other myeloid leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C93.00|Acute monoblastic/monocytic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C93.01|Acute monoblastic/monocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C93.02|Acute monoblastic/monocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C93.10|Chronic myelomonocytic leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C93.11|Chronic myelomonocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C93.12|Chronic myelomonocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C93.30|Juvenile myelomonocytic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C93.31|Juvenile myelomonocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C93.32|Juvenile myelomonocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C93.90|Monocytic leukemia, unspecified, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C93.91|Monocytic leukemia, unspecified in remission||
CANCER|CANCER||ICD_10|2020|C93.92|Monocytic leukemia, unspecified in relapse||
CANCER|CANCER||ICD_10|2020|C93.Z0|Other monocytic leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C93.Z1|Other monocytic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C93.Z2|Other monocytic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C94.00|Acute erythroid leukemia, not having achieved remission||
CANCER|CANCER||ICD_10|2020|C94.01|Acute erythroid leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C94.02|Acute erythroid leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C94.20|Acute megakaryoblastic leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C94.21|Acute megakaryoblastic leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C94.22|Acute megakaryoblastic leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C94.30|Mast cell leukemia not having achieved remission||
CANCER|CANCER||ICD_10|2020|C94.31|Mast cell leukemia, in remission||
CANCER|CANCER||ICD_10|2020|C94.32|Mast cell leukemia, in relapse||
CANCER|CANCER||ICD_10|2020|C94.40|Acute panmyelosis with myelofibrosis not having achieved remission||
CANCER|CANCER||ICD_10|2020|C94.41|Acute panmyelosis with myelofibrosis, in remission||
CANCER|CANCER||ICD_10|2020|C94.42|Acute panmyelosis with myelofibrosis, in relapse||
CANCER|CANCER||ICD_10|2020|C94.6|Myelodysplastic disease, not classified||
CANCER|CANCER||ICD_10|2020|C94.80|Other specified leukemias not having achieved remission||
CANCER|CANCER||ICD_10|2020|C94.81|Other specified leukemias, in remission||
CANCER|CANCER||ICD_10|2020|C94.82|Other specified leukemias, in relapse||
CANCER|CANCER||ICD_10|2020|C95.00|Acute leukemia of unspecified cell type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C95.01|Acute leukemia of unspecified cell type, in remission||
CANCER|CANCER||ICD_10|2020|C95.02|Acute leukemia of unspecified cell type, in relapse||
CANCER|CANCER||ICD_10|2020|C95.10|Chronic leukemia of unspecified cell type not having achieved remission||
CANCER|CANCER||ICD_10|2020|C95.11|Chronic leukemia of unspecified cell type, in remission||
CANCER|CANCER||ICD_10|2020|C95.12|Chronic leukemia of unspecified cell type, in relapse||
CANCER|CANCER||ICD_10|2020|C95.90|Leukemia, unspecified not having achieved remission||
CANCER|CANCER||ICD_10|2020|C95.91|Leukemia, unspecified, in remission||
CANCER|CANCER||ICD_10|2020|C95.92|Leukemia, unspecified, in relapse||
CANCER|CANCER||ICD_10|2020|C96.0|Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis||
CANCER|CANCER||ICD_10|2019|C96.2|Malignant mast cell tumor||
CANCER|CANCER||ICD_10|2020|C96.20|Malignant mast cell neoplasm, unspecified||
CANCER|CANCER||ICD_10|2020|C96.21|Aggressive systemic mastocytosis||
CANCER|CANCER||ICD_10|2020|C96.22|Mast cell sarcoma||
CANCER|CANCER||ICD_10|2020|C96.29|Other malignant mast cell neoplasm||
CANCER|CANCER||ICD_10|2020|C96.4|Sarcoma of dendritic cells (accessory cells)||
CANCER|CANCER||ICD_10|2020|C96.5|Multifocal and unisystemic Langerhans-cell histiocytosis||
CANCER|CANCER||ICD_10|2020|C96.6|Unifocal Langerhans-cell histiocytosis||
CANCER|CANCER||ICD_10|2020|C96.9|Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified||
CANCER|CANCER||ICD_10|2020|C96.A|Histiocytic sarcoma||
CANCER|CANCER||ICD_10|2020|C96.Z|Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue||
COPD|COPD||ICD_10|2020|J41.0|Simple chronic bronchitis||
COPD|COPD||ICD_10|2020|J41.1|Mucopurulent chronic bronchitis||
COPD|COPD||ICD_10|2020|J41.8|Mixed simple and mucopurulent chronic bronchitis||
COPD|COPD||ICD_10|2020|J42|Unspecified chronic bronchitis||
COPD|COPD||ICD_10|2020|J43.0|Unilateral pulmonary emphysema [MacLeod's syndrome]||
COPD|COPD||ICD_10|2020|J43.1|Panlobular emphysema||
COPD|COPD||ICD_10|2020|J43.2|Centrilobular emphysema||
COPD|COPD||ICD_10|2020|J43.8|Other emphysema||
COPD|COPD||ICD_10|2020|J43.9|Emphysema, unspecified||
COPD|COPD||ICD_10|2020|J44.0|Chronic obstructive pulmonary disease with acute lower respiratory infection||
COPD|COPD||ICD_10|2020|J44.1|Chronic obstructive pulmonary disease with (acute) exacerbation||
COPD|COPD||ICD_10|2020|J44.9|Chronic obstructive pulmonary disease, unspecified||
DEMENTIA|DEMENTIA||ICD_10|2020|A81.00|Creutzfeldt-Jakob unspecified||
DEMENTIA|DEMENTIA||ICD_10|2020|A81.01|Variant Creutzfeldt-Jakob disease||
DEMENTIA|DEMENTIA||ICD_10|2020|A81.09|Other Creutzfeldt-Jakob disease||
DEMENTIA|DEMENTIA||ICD_10|2020|F01.50|Vascular dementia without behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F01.51|Vascular dementia with behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F02.80|Dementia in other diseases classified elsewhere with behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F02.81|Dementia in other diseases classified elsewhere with behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F03.90|Unspecified dementia without behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F03.91|Unspecified dementia with behavioral disturbance||
DEMENTIA|DEMENTIA||ICD_10|2020|F10.27|Alcohol dependence with alcohol-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F10.97|Alcohol induced persistent dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F13.27|Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F13.97|Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F18.97|Inhalant use, unspecified with inhalant-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F19.17|Other psychoactive substance abuse with psychoactive substance-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F19.27|Other psychoactive substance dependence with psychoactive substance-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|F19.97|Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|G30.0|Alzheimer's disease with early onset||
DEMENTIA|DEMENTIA||ICD_10|2020|G30.1|Alzheimer's disease with late onset||
DEMENTIA|DEMENTIA||ICD_10|2020|G30.8|Other Alzheimer's disease||
DEMENTIA|DEMENTIA||ICD_10|2020|G30.9|Alzheimer's disease, unspecified||
DEMENTIA|DEMENTIA||ICD_10|2020|G31.01|Pick's disease||
DEMENTIA|DEMENTIA||ICD_10|2020|G31.09|Other frontotemporal dementia||
DEMENTIA|DEMENTIA||ICD_10|2020|G31.1|Senile degeneration of brain, not elsewhere specified||
DEMENTIA|DEMENTIA||ICD_10|2020|G31.83|Dementia with Lewy bodies||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80184|Phenobarbital||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80305|Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80306|Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; read by instrument assisted direct optical observation (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80307|Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80324|Amphetamines; 1 or 2||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80325|Amphetamines; 3 or 4||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80326|Amphetamines; 5 or more||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80345|Barbiturates||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80346|Benzodiazepines; 1-12||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80347|Benzodiazepines; 13 or more||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80348|Buprenorphine||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80349|Cannabinoids, natural||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80350|Cannabinoids, synthetic, 1-3||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80351|Cannabinoids, synthetic, 4-6||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80352|Cannabinoids, synthetic, 7 or more ||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80353|Cocaine||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80354|Fentanyl||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80356|Heroin metabolite||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80358|Methadone||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80359|Methylenedioxyamphetamines (MDA, MDEA, MDMA)||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80361|Opiates, 1 or more||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80362|Opioids and opiate analogs; 1 or 2||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80363|Opioids and Opiate analogs; 3 or 4||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80364|Opioids and Opiate analogs; 5 or more||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80365|Oxycodone||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80372|Tapentadol||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80373|Tramadol||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80375|Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 1-3||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80376|Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 4-6||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|80377|Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 7 or more||
DRUG_SCREEN|DRUG_SCREEN||CPT|2019|82542|Column chromatography, includes mass spectrometry, if performed (eg, HPLC, LC, LC/MS, LC/MS-MS, GC, GC/MS-MS, GC/MS, HPLC/MS), non-drug analyte(s) not elsewhere specified, qualitative or quantitative, each specimen||
DRUG_SCREEN|DRUG_SCREEN||HCPCS_CODE|2020|G0480|Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed||
DRUG_SCREEN|DRUG_SCREEN||HCPCS_CODE|2020|G0481|Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed||
DRUG_SCREEN|DRUG_SCREEN||HCPCS_CODE|2020|G0482|Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed||
DRUG_SCREEN|DRUG_SCREEN||HCPCS_CODE|2020|G0483|Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed||
DRUG_SCREEN|DRUG_SCREEN||HCPCS_CODE|2020|G0659|Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to, GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem), excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10338-2|Barbiturates [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10343-2|Temazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10530-4|Aprobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10542-9|Metharbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10547-8|Primidone+PHENobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10550-2|Deprecated Temazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10975-1|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10976-9|6-Monoacetylmorphine (6-MAM) [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10977-7|ALPRAZolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|10998-3|oxyCODONE [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11024-7|Benzodiazepines [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11071-8|Butalbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11072-6|Despropionylfentanyl [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11073-4|Despropionylfentanyl [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11074-2|Norfentanyl [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11075-9|Norfentanyl [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11230-0|Amobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11235-9|fentaNYL [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11238-3|Hydroxyalprazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11244-1|Morphine Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11246-6|oxyCODONE [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|11247-4|oxyMORphone [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12291-1|Mephentermine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12308-3|HYDROcodone [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12311-7|Prazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12313-3|Aprobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12314-1|Clorazepate [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12315-8|Mephobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12342-2|oxyMORphone [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12360-4|Barbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12361-2|Oxazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12362-0|Oxazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12370-3|Thiopental [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12373-7|Deprecated Norchlordiazepoxide [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12377-8|Demoxepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12379-4|Halazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12382-8|Temazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12403-2|Mephentermine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12432-1|Hydroxytriazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12437-0|traMADol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12438-8|Nortramadol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12477-6|Dextromethamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12478-4|Levomethamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12490-9|Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12493-3|Hexobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12602-9|Hydroxyethylflurazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12784-5|Codeine Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12785-2|Dihydrocodeine Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12786-0|HYDROcodone Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12787-8|HYDROmorphone Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12788-6|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|12789-4|oxyCODONE Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13478-3|Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13479-1|Benzoylecgonine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13497-3|Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13498-1|Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13545-9|ALPRAZolam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13550-9|clonazePAM [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13551-7|Clorazepate [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13553-3|Cocaethylene [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13556-6|Demoxepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13565-7|LORazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13568-1|N-desalkylflurazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13569-9|Norchlordiazepoxide [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13572-3|Nordiazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13576-4|oxyCODONE [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13580-6|Temazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13641-6|Codeine [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|13648-1|Morphine [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14066-5|Dihydrocodeine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14067-3|Dihydrocodeine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14069-9|Estazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14183-8|Aprobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14192-9|Triazolam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14267-9|Methylenedioxymethamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14308-1|Amphetamines [Presence] in Urine by Screen method >1000 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14309-9|Amphetamines [Presence] in Urine by Confirm method >200 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14312-3|Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14313-1|Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14314-9|Benzoylecgonine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14315-6|Benzoylecgonine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14316-4|Benzodiazepines [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14591-2|ALPRAZolam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14623-3|Barbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14655-5|clonazePAM [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14690-2|N-desalkylflurazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14697-7|diazePAM [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14729-8|Flurazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14730-6|Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14817-1|LORazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14844-5|6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14845-2|Deprecated Monoacetylmorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14849-4|Nitrazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14850-2|Nitrazepam [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14874-2|PHENobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|14926-0|Triazolam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15100-1|Barbiturates [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15102-7|Codeine [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15108-4|Methadone [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15109-2|Midazolam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15110-0|Morphine [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15366-8|Dextroamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15372-6|Nordiazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|15404-7|Levomethamphetamine/Amphetamines.total in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16150-5|Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16190-1|Amobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16191-9|Butabarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16192-7|PHENobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16193-5|PENTobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16194-3|Secobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16195-0|Benzodiazepines [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16196-8|Morphine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16197-6|Codeine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16198-4|Diamorphine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16199-2|Methadone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16201-6|Oxazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16202-4|Nordiazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16203-2|ALPRAZolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16204-0|clonazePAM [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16205-7|LORazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16206-5|Temazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16208-1|Buprenorphine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16211-5|Dihydrocodeine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16212-3|Ethylamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16215-6|Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16222-2|Phentermine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16223-0|Thiopental [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16224-8|Triazolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16226-3|Benzoylecgonine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16227-1|diazePAM [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16228-9|Nordiazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16229-7|clonazePAM [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16230-5|N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16231-3|Flurazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16232-1|Triazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16233-9|Midazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16234-7|Amphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16235-4|Methamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16236-2|Butabarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16237-0|Butalbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16238-8|Secobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16239-6|Amobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16240-4|PENTobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16241-2|PHENobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16243-8|Cannabinoids [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16245-3|Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16246-1|Methadone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16248-7|6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16249-5|oxyCODONE [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16250-3|Codeine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16251-1|Morphine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16252-9|HYDROcodone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16348-5|Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16367-5|Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16369-1|Amphetamines [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16429-3|Barbiturates [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16430-1|Barbiturates [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16446-7|Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16447-5|Cocaine [Units/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16448-3|Cocaine [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16495-4|Buprenorphine [Units/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16496-2|Buprenorphine [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16540-7|Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16542-3|Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16609-0|Chlorphentermine [Units/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16610-8|Chlorphentermine [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16632-2|Cocaethylene [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16633-0|Cocaine [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16644-7|Codeine Free [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16743-7|Deprecated Nordiazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16744-5|Deprecated Nordiazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16755-1|Diamorphine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16756-9|Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16757-7|Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16775-9|Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16851-8|Ethylmorphine [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|16998-7|HYDROmorphone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17002-7|Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17088-6|LORazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17250-2|Mephobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17259-3|Methadone.long acting metabolite [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17260-1|Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17275-9|Methylfentanyl [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17290-8|Morphine [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17363-3|Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17375-7|Norflunitrazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17384-9|Opiates [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17395-5|oxyMORphone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17443-3|Phenylpropanolamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17479-7|Prazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17718-8|traMADol [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17719-6|traMADol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|17872-3|Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18187-5|LORazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18282-4|Cannabinoids [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18325-1|oxyMORphone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18338-4|Nortramadol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18339-2|Nortramadol [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18340-0|Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18343-4|6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18355-8|Methylenedioxyamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18356-6|Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18357-4|Methylenedioxymethamphetamine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18358-2|Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18359-0|Methylenedioxyamphetamine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18384-8|Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18385-5|Butalbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18387-1|Diamorphine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18388-9|diazePAM [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18390-5|Opiates [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|18473-9|HYDROmorphone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19055-3|Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19245-0|clonazePAM [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19261-7|Amphetamines [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19262-5|Amphetamines tested for in Urine by Screen method Nominal||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19263-3|Amphetamines tested for in Urine by Screen method Narrative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19265-8|Amphetamines [Identifier] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19268-2|Amphetamines screen method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19269-0|Amphetamines confirm method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19270-8|Barbiturates [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19271-6|Barbiturates tested for in Urine by Screen method Nominal||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19272-4|Barbiturates tested for in Urine by Screen method Narrative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19274-0|Barbiturates positive [Identifier] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19277-3|Barbiturates screen method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19278-1|Barbiturates confirm method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19279-9|Benzodiazepines tested for in Urine by Screen method Nominal||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19280-7|Benzodiazepines tested for in Urine by Screen method Narrative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19282-3|Benzodiazepines positive [Identifier] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19285-6|Benzodiazepines screen method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19286-4|Benzodiazepines confirm method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19287-2|Cannabinoids tested for in Urine by Screen method Nominal||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19288-0|Cannabinoids tested for in Urine by Screen method Narrative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19289-8|Cannabinoids [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19290-6|Cannabinoids positive [Identifier] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19293-0|Cannabinoids screen method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19294-8|Cannabinoids confirm method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19295-5|Opiates [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19296-3|Opiates tested for in Urine by Screen method Nominal||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19297-1|Opiates tested for in Urine by Screen method Narrative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19298-9|Opiates positive [Identifier] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19301-1|Opiates screen method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19302-9|Opiates confirm method [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19321-9|6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19322-7|6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19325-0|Alpha hydroxyalprazolam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19326-8|Alpha hydroxyalprazolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19328-4|Alpha hydroxyalprazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19339-1|Amobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19343-3|Amphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19344-1|Amphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19346-6|Amphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19349-0|Aprobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19350-8|Aprobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19353-2|Barbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19354-0|Barbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19359-9|Cocaine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19360-7|Cocaine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19361-5|Deprecated Benzoylmethylecgonine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19364-9|Bromazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19365-6|Bromazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19368-0|Butabarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19370-6|Butabarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19373-0|Butalbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19381-3|Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19382-1|Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19385-4|chlordiazePOXIDE [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19386-2|chlordiazePOXIDE [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19399-5|clonazePAM [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19402-7|clonazePAM [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19405-0|Cocaethylene [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19406-8|Cocaethylene [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19408-4|Cocaethylene [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19411-8|Codeine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19415-9|Tetrahydrocannabinol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19416-7|Tetrahydrocannabinol [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19419-1|Dextroamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19420-9|Dextroamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19423-3|Dextromethamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19424-1|Dextromethamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19425-8|Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19426-6|Deprecated Dextromethamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19439-9|Diamorphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19443-1|diazePAM [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19446-4|Dihydrocodeine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19448-0|Dihydrocodeine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19449-8|Dihydrocodeine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19452-2|Dimetamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19453-0|Dimetamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19456-3|Ethylamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19458-9|Ethylamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19459-7|Ethylamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19462-1|Ethylmorphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19463-9|Ethylmorphine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19466-2|Flunitrazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19467-0|Flunitrazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19474-6|Flurazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19475-3|Flurazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19482-9|HYDROcodone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19483-7|HYDROcodone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19486-0|HYDROmorphone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19489-4|Hydroxyalprazolam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19490-2|Hydroxyalprazolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19493-6|Hydroxyethylflurazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19494-4|Hydroxyethylflurazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19497-7|Hydroxytriazolam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19510-7|Levomethamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19511-5|Levomethamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19512-3|Levomethamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19520-6|LORazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19524-8|Lormetazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19525-5|Lormetazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19536-2|Mephobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19537-0|Mephobarbital [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19539-6|Mephobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19550-3|Methadone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19554-5|Methamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19555-2|Methamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19565-1|Methylenedioxyamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19566-9|Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19568-5|Methylenedioxymethamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19569-3|Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19570-1|Methylenedioxymethamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19585-9|Midazolam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19586-7|Midazolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19588-3|Midazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19591-7|Deprecated 6-Monoacetylmorphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19592-5|Deprecated 6-Monoacetylmorphine [Presence] in Urine by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19593-3|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19594-1|Deprecated Monoacetylmorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19597-4|Morphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19601-4|Morphine Free [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19602-2|Morphine Free [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19614-7|N-desalkylflurazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19615-4|N-desalkylflurazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19617-0|N-desalkylflurazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19620-4|Nitrazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19621-2|Nitrazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19624-6|Nordiazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19638-6|Oxazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19639-4|Oxazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19642-8|oxyCODONE [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19643-6|oxyCODONE [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19646-9|oxyMORphone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19648-5|oxyMORphone [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19651-9|Para hydroxyamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19652-7|Para hydroxyamphetamine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19655-0|PENTobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19666-7|PHENobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19674-1|Phentermine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19678-2|Prazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19679-0|Prazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19692-3|Secobarbital [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19695-6|Secobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19698-0|Temazepam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19702-0|Deprecated Tetrahydrocannabinol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19703-8|Deprecated Tetrahydrocannabinol [Presence] in Urine by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19710-3|traMADol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|19714-5|Triazolam [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20410-7|Amphetamines [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20411-5|Barbiturates [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20412-3|Benzodiazepines [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20413-1|Cannabinoids [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20421-4|Barbiturates [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20500-5|Hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20501-3|Hydroxytriazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20514-6|Deprecated 6-Monoacetylmorphine [Mass/volume] in Urine Confirm||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20517-9|Aprobarbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20518-7|Barbital [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20519-5|Cocaine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20520-3|Bromazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20521-1|Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20522-9|chlordiazePOXIDE [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20524-5|Deprecated Tetrahydrocannabinol [Mass/volume] in Urine by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20525-2|Dextroamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20526-0|Dimetamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20527-8|Ethylmorphine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20528-6|Flunitrazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20531-0|Deprecated Hydroxyalprazolam [Mass/volume] in Urine by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20532-8|Hydroxyethylflurazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20533-6|Hydroxytriazolam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20534-4|Deprecated Hydroxytriazolam [Mass/volume] in Urine by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20541-9|Lormetazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20545-0|Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20550-0|Morphine Free [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20552-6|Nitrazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20554-2|Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20557-5|Phentermine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20559-1|Temazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20561-7|traMADol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|20664-9|Barbiturates [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21046-8|7-Aminoflunitrazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21050-0|Deprecated Acetylmorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21062-5|Allobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21091-4|Barbiturates present [Identifier] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21193-8|Chlordiazepoxide+Norchlordiazepoxide [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21239-9|Desalkylhalazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21241-5|Diazepam+Nordiazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21386-8|Methamphetamine [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21431-2|Opiates [Presence] in Urine by Screen method >2000 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21556-6|Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|21557-4|Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|23864-2|Flunitrazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|25309-6|Amobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|25357-5|Butabarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|25412-8|Flunitrazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|25520-8|Secobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|25560-4|Allobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26021-6|Nordiazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26039-8|Norflunitrazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26743-5|Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26747-6|Cannabinoids/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26760-9|Cannabinoids [Units/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26784-9|diazePAM [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26786-4|Mephentermine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|26995-1|Carboxy tetrahydrocannabinol [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27036-3|Norchlordiazepoxide [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27073-6|Deprecated acetylmorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27083-5|Norflunitrazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27084-3|7-Aminoflunitrazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27085-0|Methylenedioxyethylamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27165-0|Hexobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27226-0|Cocaethylene [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|27921-6|Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|28059-4|7-Aminoclonazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|28073-5|7-Aminoclonazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29356-3|fentaNYL [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29592-3|Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29597-2|Mephentermine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29598-0|Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29599-8|Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29601-2|Phenylpropanolamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29602-0|Chlorphentermine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29608-7|Phentermine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29619-4|Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29654-1|Temazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|29655-8|Oxazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|30107-7|Ecgonine methyl ester [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|30112-7|Amphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|30249-7|Barbiturates [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|30250-5|Benzodiazepines [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|31016-9|Levoamphetamine/Amphetamines.total in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|31025-0|Dextroamphetamine/Amphetamines.total in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|31026-8|Dextromethamphetamine/Amphetamines.total in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|31182-9|7-Aminonitrazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32050-7|Barbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32052-3|Benzodiazepines [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32055-6|Butalbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32056-4|Butalbital [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32059-8|chlordiazePOXIDE [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32064-8|Clorazepate [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32089-5|Mephobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32103-4|PENTobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32117-4|Thiopental [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32124-0|Bromazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32579-5|Phentermine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32642-1|Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32643-9|Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32648-8|Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32649-6|Hydroxytriazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|32650-4|Norflunitrazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|33016-7|Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|33060-5|chlordiazePOXIDE+Metabolites [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3312-6|ALPRAZolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3313-4|ALPRAZolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|33280-9|Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|33301-3|Norchlordiazepoxide [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3337-3|Amobarbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3338-1|Amobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3339-9|Amobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3348-0|Amphetamines [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3349-8|Amphetamines [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|33527-3|Methadone.long acting metabolite [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3370-4|Barbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3371-2|Barbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3372-0|Barbiturate screen absent [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3373-8|Deprecated Barbiturate screen absent [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3374-6|Barbiturate screen present [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3375-3|Deprecated Barbiturate screen present [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3376-1|Barbiturates [Presence] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3377-9|Barbiturates [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3385-2|Benzodiazepines negative [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3386-0|Deprecated Benzodiazepines negative [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3387-8|Benzodiazepines positive [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3388-6|Deprecated Benzodiazepines positive [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3389-4|Benzodiazepines [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3390-2|Benzodiazepines [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3391-0|Benzoylecgonine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3392-8|Benzoylecgonine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3393-6|Benzoylecgonine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3394-4|Benzoylecgonine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3395-1|Cocaine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3396-9|Cocaine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3397-7|Cocaine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3398-5|Cocaine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3405-8|Bromazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3406-6|Bromazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3413-2|Buprenorphine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3414-0|Buprenorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3415-7|Buprenorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3417-3|Butabarbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3418-1|Butabarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3419-9|Butabarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3420-7|Butalbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3421-5|Butalbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3425-6|Cannabinoids [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3426-4|Tetrahydrocannabinol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3427-2|Cannabinoids [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|34332-7|Lormetazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3435-5|Carboxy tetrahydrocannabinol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3436-3|Carboxy tetrahydrocannabinol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|34365-7|Primidone+PHENobarbital [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|34427-5|Methadone.R [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3456-1|chlordiazePOXIDE [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3457-9|chlordiazePOXIDE [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3458-7|chlordiazePOXIDE [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3459-5|chlordiazePOXIDE [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3468-6|Chlorphentermine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3469-4|Chlorphentermine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3470-2|Chlorphentermine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3494-2|clonazePAM [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3498-3|Clorazepate [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3505-5|Codeine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3506-3|Codeine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3507-1|Codeine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3508-9|Codeine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3528-7|Tetrahydrocannabinol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3529-5|Deprecated Tetrahydrocannabinol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3530-3|Tetrahydrocannabinol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3537-8|Nordiazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3546-9|Diamorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3547-7|Diamorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3548-5|diazePAM [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3549-3|diazePAM [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3550-1|diazePAM [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3551-9|diazePAM [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35598-2|Butalbital [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35600-6|chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35603-0|clonazePAM [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35605-5|N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35607-1|diazePAM [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35611-3|Flurazepam [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35616-2|LORazepam [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35618-8|Methadone [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35622-0|Nordiazepam [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35629-5|Oxazepam [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35630-3|PENTobarbital [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35631-1|PHENobarbital [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|35634-5|Secobarbital [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3564-2|Dimetamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3565-9|Dimetamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3598-0|Estazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3618-6|Ethylmorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3619-4|Ethylmorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3633-5|Fenproporex [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3634-3|Fenproporex [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3636-8|fentaNYL [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3637-6|fentaNYL [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3640-0|Flunitrazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3641-8|Flunitrazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3652-5|Flurazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3653-3|Flurazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3654-1|Flurazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3655-8|Flurazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3679-8|HYDROcodone [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3680-6|HYDROcodone [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3681-4|HYDROcodone [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3682-2|HYDROmorphone [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3683-0|HYDROmorphone [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3724-2|LORazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3725-9|LORazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3726-7|Lormetazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3739-0|Medazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3740-8|Medazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3750-7|Mephobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3751-5|Deprecated Mephobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3771-3|Methadone [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3772-1|Methadone [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3773-9|Methadone [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3774-7|Methadone [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3776-2|Methamphetamine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3777-0|Methamphetamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3778-8|Methamphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3779-6|Methamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3780-4|Methamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3821-6|Midazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3826-5|Morphine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3827-3|Morphine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3828-1|Morphine Free [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3829-9|Morphine Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3830-7|Morphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3831-5|Morphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|38373-7|Buprenorphine+Norbuprenorphine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3851-3|Nicomorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3858-8|Nitrazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3859-6|Nitrazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3861-2|Nordiazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3878-6|Opiates [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3879-4|Opiates [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3886-9|Oxazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3887-7|Oxazepam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3893-5|oxyCODONE [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3901-6|Para hydroxyamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3902-4|Para hydroxyamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3923-0|PENTobarbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3924-8|PENTobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3925-5|PENTobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3926-3|PENTobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3947-9|PHENobarbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3948-7|PHENobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|39487-4|PHENobarbital [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3949-5|PHENobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3950-3|PHENobarbital [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3951-1|PHENobarbital Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3956-0|Phentermine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3957-8|Phentermine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3958-6|Phentermine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3963-6|Phenylpropanolamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3964-4|Phenylpropanolamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3965-1|Phenylpropanolamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|3977-6|Prazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4027-9|Secobarbital [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4028-7|Secobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4029-5|Secobarbital [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40419-4|Amphetamine+Methamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40421-0|Amphetamine+Methamphetamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40493-9|Methylenedioxymethamphetamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4050-1|Thiopental [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4069-1|Triazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|4070-9|Triazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40799-9|Amphetamines [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40801-3|Cannabinoids [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40802-1|Cocaine [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40804-7|Methamphetamine [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40806-2|Opiates [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40839-3|fentaNYL [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|40864-1|11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41020-9|Flunitrazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41036-5|Cocaine [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41038-1|Codeine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41464-9|Amphetamines/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41465-6|Opiates/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41466-4|Methadone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41467-2|Benzodiazepines/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41468-0|Barbiturates/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41858-2|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|41860-8|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42235-2|Benzodiazepine metabolites [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42241-0|Cocaine+Benzoylecgonine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42251-9|Methadone+Metabolite [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42253-5|Methylenedioxyamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42491-1|Cannabinoids [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42492-9|Carboxy tetrahydrocannabinol [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42576-9|Amphetamine [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42582-7|Barbiturates [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42586-8|Benzodiazepines [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42630-4|Cannabinoids [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42662-7|Benzodiazepines [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42856-5|Benzoylecgonine [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42860-7|Cannabinoids [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|42901-9|Dihydrocodeine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43184-1|6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43199-9|Norfentanyl [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43200-5|Norfentanyl [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43219-5|traMADol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43719-4|Acetaminophen+oxyCODONE [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43720-2|Acetaminophen+Codeine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43983-6|Amphetamines [Presence] in Urine by Screen method >500 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43984-4|Benzoylecgonine [Presence] in Urine by Screen method >150 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|43985-1|Benzoylecgonine [Presence] in Urine by Screen method >300 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|44049-5|Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|44424-0|Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|45022-1|Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|45143-5|Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|45320-9|Ecgonine methyl ester [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46256-4|oxyCODONE Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46257-2|Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46258-0|oxyMORphone Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46259-8|Morphine Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46260-6|HYDROmorphone Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46261-4|HYDROcodone Free [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46262-2|Codeine Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46263-0|6-monoacetylmorphine free [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46703-5|Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46704-3|Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46971-8|HYDROmorphone Free [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46972-6|Deprecated 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46973-4|oxyCODONE Free [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46974-2|oxyMORphone Free [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46975-9|oxyMORphone Free [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46976-7|Benzodiazepines [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46977-5|Benzodiazepines [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46979-1|Flurazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|46980-9|N-desalkylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47004-7|6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47115-1|LORazepam [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47386-8|Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47400-7|Cocaine+Benzoylecgonine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47404-9|N-desalkylflurazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|47411-4|Methadone [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48355-2|traMADol [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48356-0|Prazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48363-6|Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48364-4|Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48365-1|Methadone.R [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|48403-0|Methadone+Metabolite [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49746-1|Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49747-9|Cocaine+Benzoylecgonine [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49749-5|6-monoacetylmorphine free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49750-3|Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49751-1|Norbuprenorphine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49752-9|Buprenorphine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49753-7|Norbuprenorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49829-5|Norcodeine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49830-3|Norcodeine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49831-1|Normorphine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|49876-6|Alpha hydroxytriazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50021-5|oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50542-0|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50592-5|Ecgonine methyl ester [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50593-3|3-Hydroxybenzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50594-1|3-Hydroxybenzoylecgonine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50843-2|clonazePAM [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50849-9|Diazepam+Nordiazepam [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|50966-1|Flunitrazepam [Presence] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51448-9|Dihydrocodeine+Hydrocodol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51690-6|Amphetamines [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51691-4|Opiates [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51736-7|oxyMORphone Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51737-5|HYDROmorphone Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51738-3|HYDROcodone Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51739-1|Codeine Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51740-9|6-monoacetylmorphine free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51765-6|Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51776-3|7-Aminoclonazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51777-1|7-Aminoflunitrazepam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51791-2|Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51954-6|oxyCODONE Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|51955-3|Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52952-9|Opiates [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52953-7|Cocaine [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52954-5|Cannabinoids [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52955-2|Benzodiazepines [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52956-0|Barbiturates [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52957-8|Amphetamine [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|52958-6|Methadone [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53735-7|Barbiturates.other [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53736-5|Benzodiazepines.other [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53743-1|Cocaine metabolites.other [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53816-5|Alpha hydroxytriazolam [Mass/volume] in Serum||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53846-2|Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53880-1|Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|53881-9|Norbuprenorphine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|54402-3|4-Hydroxymidazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|54943-6|N-methyldiethanolamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55520-1|6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55525-0|Benzoylecgonine [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55530-0|Cocaethylene [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55537-5|fentaNYL [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55551-6|Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55569-8|Phentermine [Moles/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|55587-0|Methamphetamine [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|56120-9|Amphetamine+Methamphetamine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5706-7|Opiates [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5707-5|Deprecated Opiates [Identifier] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|57300-6|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|57301-4|Benzoylecgonine [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|57302-2|Temazepam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|57303-0|7-Aminonitrazepam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|57304-8|Codeine [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58047-2|Tetrahydrocannabinol [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58357-5|Amphetamine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58358-3|Methamphetamine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58359-1|Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58360-9|Buprenorphine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58361-7|Norbuprenorphine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58362-5|Norbuprenorphine [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58363-3|Alpha hydroxyalprazolam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58364-1|7-Aminoclonazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58365-8|7-Aminoclonazepam [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58366-6|LORazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58367-4|Nordiazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58368-2|Oxazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58369-0|Temazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58379-9|Fentanyl+Norfentanyl [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58380-7|fentaNYL/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58381-5|fentaNYL [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58382-3|Norfentanyl/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58383-1|Norfentanyl [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58384-9|6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58390-6|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58391-4|Codeine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58392-2|Morphine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58393-0|HYDROcodone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58394-8|HYDROmorphone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58395-5|oxyCODONE/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58396-3|oxyMORphone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58401-1|Tapentadol [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58402-9|Tapentadol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58404-5|traMADol/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58428-4|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58429-2|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58430-0|oxyCODONE+Oxymorphone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|58925-9|Dextromethamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5935-2|Deprecated Benzoylecgonine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59352-5|Tapentadol [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59354-1|Tapentadol [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5937-8|Deprecated Cocaine [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5939-4|Deprecated Benzoylecgonine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5940-2|Deprecated Cocaine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|5941-0|Deprecated Cocaine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59589-2|1-Hydroxymidazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59590-0|1-Hydroxymidazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59591-8|7-Aminoclonazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59592-6|7-Aminoclonazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59595-9|7-Aminoclonazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59599-1|Alpha hydroxyalprazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59600-7|Alpha hydroxyalprazolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59604-9|Alpha hydroxyalprazolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59607-2|ALPRAZolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59611-4|ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59615-5|ALPRAZolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59616-3|Benzoylecgonine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59617-1|chlordiazePOXIDE [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59618-9|chlordiazePOXIDE [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59622-1|chlordiazePOXIDE [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59636-1|clonazePAM [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59637-9|clonazePAM [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59640-3|clonazePAM [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59643-7|Cocaethylene [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59644-5|Cocaine [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59647-8|N-desalkylflurazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59654-4|diazePAM [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59655-1|diazePAM [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59664-3|Estazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59665-0|Estazolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59668-4|Estazolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59672-6|Estazolam [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59673-4|fentaNYL [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59674-2|Flurazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59675-9|Flurazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59682-5|Hydroxyethylflurazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59683-3|Hydroxyethylflurazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59690-8|Hydroxytriazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59691-6|Hydroxytriazolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59699-9|LORazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59700-5|LORazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59703-9|LORazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59705-4|Methadone [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59707-0|Midazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59708-8|Midazolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59711-2|Midazolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59716-1|Nordiazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59717-9|Nordiazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59721-1|Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59725-2|Oxazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59726-0|Oxazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59730-2|Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59745-0|Temazepam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59746-8|Temazepam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59750-0|Temazepam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59758-3|Triazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59759-1|Triazolam [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59762-5|Triazolam [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59837-5|Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59844-1|Methylenedioxyethylamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59865-6|Amobarbital [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59872-2|Bromazepam [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|59879-7|chlordiazePOXIDE [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60071-8|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60151-8|PENTobarbital [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60467-8|oxyMORphone [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60468-6|PHENobarbital [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60514-7|6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|60677-2|Alpha hydroxytriazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61029-5|7-Aminoclonazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61030-3|7-Aminoclonazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61032-9|7-Aminoflunitrazepam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61033-7|7-Aminoflunitrazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61035-2|Alpha hydroxyalprazolam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61036-0|Alpha hydroxyalprazolam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61040-2|N-desalkylflurazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61045-1|Methylenedioxyamphetamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61047-7|Methylenedioxyethylamphetamine [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61048-5|Methylenedioxyethylamphetamine [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61052-7|Norfentanyl [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61060-0|Temazepam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61064-2|Triazolam [Presence] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61197-0|oxyCODONE+Oxymorphone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61420-6|Norhydrocodone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61421-4|Norhydrocodone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61422-2|Norhydrocodone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61423-0|Noroxycodone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61424-8|Noroxycodone [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61425-5|Noroxycodone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|61429-7|Tapentadol/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64127-4|Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64128-2|Amobarbital/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64129-0|N-desalkylflurazepam/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64130-8|diazePAM/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64131-6|Dihydrocodeine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64132-4|PENTobarbital/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64133-2|PHENobarbital/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64134-0|Phentermine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64135-7|Secobarbital/Creatinine [Mass Ratio] of Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64138-1|Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|64139-9|Butalbital/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|65807-0|Tapentadol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|65808-8|Nortapentadol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|66127-2|Amphetamine [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|66128-0|chlordiazePOXIDE/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|66129-8|Fentanyl+Norfentanyl [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|66130-6|Fentanyl+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|66131-4|Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|6895-7|Butalbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|69033-9|Buprenorphine and Norbuprenorphine panel - Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|69356-4|oxyCODONE [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|69797-9|1-Hydroxymidazolam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70138-3|Amphetamines [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70139-1|Barbiturates [Presence] in Urine by Screen method >300 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70140-9|Benzodiazepines [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70141-7|Benzodiazepines [Presence] in Urine by Screen method >200 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70142-5|Benzodiazepines [Presence] in Urine by Screen method >300 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70143-3|Cannabinoids [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70144-1|Cannabinoids [Presence] in Urine by Screen method >20 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70145-8|Cannabinoids [Presence] in Urine by Screen method >50 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70146-6|Benzoylecgonine [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70147-4|Methadone [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70148-2|Methadone [Presence] in Urine by Screen method >150 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70149-0|Methadone [Presence] in Urine by Screen method >300 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70150-8|Opiates [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70151-6|Opiates [Presence] in Urine by Screen method >300 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70155-7|Barbiturates [Presence] in Urine by Screen method >200 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70178-9|11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70197-9|6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70205-0|clonazePAM [Moles/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70206-8|Codeine [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70210-0|Morphine [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70212-6|Nordiazepam [Moles/volume] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70213-4|Nordiazepam [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70214-2|Oxazepam [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|70215-9|oxyCODONE [Moles/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|71430-3|oxyCODONE+Oxymorphone [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72377-5|Nordiazepam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72378-3|Oxazepam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72380-9|LORazepam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72381-7|ALPRAZolam [Mass/volume] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72385-8|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72386-6|2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72387-4|Methadone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72388-2|Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72396-5|PHENobarbital [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72397-3|Secobarbital [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72398-1|Butalbital [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72399-9|Amobarbital [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72400-5|Methadone [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72402-1|oxyCODONE [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72405-4|Cocaine [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72406-2|Norchlordiazepoxide [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72407-0|Benzoylecgonine [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72451-8|Barbiturates [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72452-6|Secobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72453-4|PHENobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72454-2|Butalbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72455-9|Amobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72456-7|Benzodiazepines [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72475-7|Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72485-6|Tapentadol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72610-9|diazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72611-7|diazePAM [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72612-5|ALPRAZolam [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72613-3|Oxazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72614-1|Oxazepam [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72615-8|Nordiazepam [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72616-6|Benzodiazepines [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72626-5|Methadone [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72627-3|Barbiturates [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72628-1|PHENobarbital [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72629-9|Secobarbital [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72630-7|PENTobarbital [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72631-5|Amobarbital [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72632-3|Butalbital [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72633-1|Benzodiazepines [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72634-9|Temazepam [Presence] in Saliva (oral fluid)||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72635-6|PENTobarbital [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72733-9|HYDROmorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72734-7|Methadone [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72735-4|Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72736-2|Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72737-0|Cocaine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72738-8|Temazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72739-6|Nordiazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72740-4|traMADol [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72741-2|Nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72742-0|Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72744-6|Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72745-3|Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72746-1|Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72747-9|N-nortramadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72750-3|oxyCODONE [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72751-1|oxyCODONE [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72752-9|Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72753-7|HYDROcodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72754-5|LORazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72755-2|clonazePAM [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72756-0|ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72757-8|Benzodiazepines [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72758-6|Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72759-4|Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72760-2|fentaNYL [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72762-8|Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72763-6|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72764-4|Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72766-9|oxyMORphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72793-3|Methylone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72794-1|Methylone/Creatinine [Mass Ratio] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|72928-5|Secobarbital [Moles/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73686-8|Methylone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73823-7|Cocaine+Benzoylecgonine [Presence] in Serum, Plasma or Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73826-0|Flurazepam+N-desalkylflurazepam [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73828-6|Flunitrazepam [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73829-4|7-Aminoflunitrazepam [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73932-6|traMADol [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73935-9|Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73936-7|fentaNYL [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73937-5|Norfentanyl [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73938-3|fentaNYL [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73939-1|HYDROcodone Free [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73940-9|HYDROmorphone Free [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73941-7|6-monoacetylmorphine free [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73942-5|Buprenorphine [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73971-4|Methylenedioxymethamphetamine(MDMA)+Methylenedioxyethylamphetamine (MDEA)+Methylenedioxyamphetamine(MDA) [Interpretation] in Urine Qualitative||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73972-2|Morphine Free [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|73973-0|O-nortramadol [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74110-8|traMADol [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74130-6|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74131-4|Morphine [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74136-3|fentaNYL [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74137-1|Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74157-9|Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74167-8|Opiates [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74168-6|Barbiturates [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74169-4|Cocaine [Mass/volume] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74372-4|Acetyl fentaNYL [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74644-6|HYDROcodone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74645-3|HYDROmorphone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74646-1|Methamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74647-9|Methylenedioxyamphetamine [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74648-7|Methylenedioxyamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74649-5|Methylenedioxyethylamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74650-3|Methylenedioxyethylamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74651-1|Methylenedioxymethamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74652-9|Methylenedioxymethamphetamine [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74653-7|Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74654-5|Morphine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74656-0|Opiates [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74657-8|oxyCODONE [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74658-6|oxyCODONE+Oxymorphone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74659-4|oxyMORphone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74670-1|Cocaine+Metabolites [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74671-9|Cocaine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74675-0|Codeine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74677-6|6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74678-4|Carboxy tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74679-2|Benzoylecgonine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74680-0|Amphetamine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74681-8|Amphetamines [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74810-3|Acetyl fentaNYL [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|74811-1|Dihydrocodeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75347-5|Tapentadol [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75362-4|Tapentadol glucuronide [Mass/volume] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75368-1|Buprenorphine [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75370-7|Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75644-5|Amphetamine+Methamphetamine [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75645-2|Butabarbital [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|75648-6|Methylenedioxymethamphetamine+Methylenedioxyamphetamine [Presence] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|76492-8|Amphetamine+Methamphetamine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|77201-2|Buprenorphine+Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|77204-6|Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|77206-1|Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|77729-2|oxyMORphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|77730-0|oxyCODONE [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78363-9|Norhydrocodone [Presence] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78753-1|11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78754-9|11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78755-6|1-Hydroxymidazolam [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78758-0|4-Hydroxymidazolam [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78759-8|6-Monoacetylmorphine (6-MAM) [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78765-5|oxyMORphone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78766-3|fentaNYL [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78767-1|oxyCODONE [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78768-9|Morphine [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78769-7|HYDROcodone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78770-5|Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78804-2|Barbital [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78808-3|Benzodiazepines [Presence] in Serum or Plasma by Screen method >200 ng/mL||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78828-1|fentaNYL [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78830-7|HYDROcodone [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78857-0|Methadone [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78861-2|Morphine [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78873-7|oxyCODONE [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78874-5|oxyMORphone [Z-score] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|78883-6|Triazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79138-4|Buprenorphine [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79139-2|Buprenorphine [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79145-9|Tapentadol [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79146-7|Tapentadol [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79147-5|traMADol [Presence] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79148-3|traMADol [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|79243-2|Ethylone [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80111-8|11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80113-4|11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80115-9|6-Monoacetylmorphine (6-MAM) [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80144-9|Ecgonine methyl ester [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80193-6|Ecgonine methyl ester [Mass/volume] in Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80195-1|Ecgonine methyl ester [Mass/volume] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80196-9|Ecgonine methyl ester [Presence] in Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80532-5|Methadone [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|80536-6|Methylenedioxyethylamphetamine [Mass/volume] in Blood||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8147-1|Amphetamines [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8148-9|Amphetamines [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8149-7|Amphetamines [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8150-5|Amphetamines [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8151-3|Amphetamines [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8152-1|Amphetamines [Presence] in Urine by SAMHSA screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8170-3|Cannabinoids [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8171-1|Cannabinoids [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8172-9|Cannabinoids [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8173-7|Deprecated Tetrahydrocannabinol [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8174-5|Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8175-2|Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|81754-4|Nortapentadol [Mass/volume] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8190-1|Cocaine [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8191-9|Cocaine [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8192-7|Benzoylecgonine [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8193-5|Benzoylecgonine [Presence] in Urine by SAMHSA screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8217-2|Opiates [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8218-0|Opiates [Presence] in Serum or Plasma by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8219-8|Opiates [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8220-6|Opiates [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8221-4|Opiates [Presence] in Urine by SAMHSA confirm method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|8222-2|Opiates [Presence] in Urine by SAMHSA screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82369-0|Buprenorphine [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82371-6|Norbuprenorphine [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82374-0|Norbuprenorphine [Presence] in Serum or Plasma by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82723-8|Cocaine+Benzoylecgonine+Cocaethylene [Presence] in Urine by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82873-1|Brallobarbital [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82964-8|Cannabidiol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82965-5|Methylenedioxyethylamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82966-3|Methamphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82967-1|Amphetamine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82968-9|Secobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82969-7|PENTobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82970-5|PHENobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82971-3|Butalbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82972-1|Butabarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82973-9|Amobarbital [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|82974-7|O-nortramadol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86226-8|Codeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86227-6|Dihydrocodeine [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86229-2|HYDROcodone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86230-0|HYDROmorphone [Mass/volume] in Serum, Plasma or Blood by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86453-8|O-nortramadol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|86454-6|N-nortramadol [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87808-2|chlordiazePOXIDE [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87809-0|Benzoylecgonine [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87810-8|Methylenedioxymethamphetamine [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87812-4|Flunitrazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87813-2|Flurazepam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87814-0|Midazolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87815-7|fentaNYL [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87816-5|6-Monoacetylmorphine (6-MAM) [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87818-1|Tapentadol [Presence] in Saliva (oral fluid) by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|87819-9|Tapentadol [Mass/volume] in Saliva (oral fluid) by Confirmatory method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|89300-8|Tapentadol glucuronide [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|89303-2|Noroxycodone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|89304-0|Norhydrocodone [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|89306-5|Nortapentadol [Presence] in Urine by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|91033-1|Methadone+Metabolite [Presence] in Serum, Plasma or Blood by Screen method||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9351-8|ALPRAZolam [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9391-4|Quazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9426-8|Barbiturates [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9428-4|Benzodiazepines [Mass/volume] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9652-9|N-desalkylflurazepam [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9776-6|Norchlordiazepoxide [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9814-5|Dextroamphetamine [Mass/volume] in Serum or Plasma||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9834-3|HYDROmorphone [Presence] in Urine||
DRUG_SCREEN|DRUG_SCREEN||LOINC|2.66|9835-0|HYDROmorphone [Mass/volume] in Urine||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.101|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.109|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.111|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.119|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.201|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.209|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.211|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.219|Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.301|Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.309|Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.311|Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.319|Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.501|Epileptic seizures related to external causes, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.509|Epileptic seizures related to external causes, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.802|Other epilepsy, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.804|Other epilepsy, intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.821|Epileptic spasms, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.822|Epileptic spasms, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.823|Epileptic spasms, intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.824|Epileptic spasms, intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.901|Epilepsy, unspecified, not intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.909|Epilepsy, unspecified, not intractable, without status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.911|Epilepsy, unspecified, intractable, with status epilepticus||
EPILEPSY|EPILEPSY||ICD_10|2019|G40.919|Epilepsy, unspecified, intractable, without status epilepticus||
ESRD|ESRD||ICD_10|2020|I12.0|Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease||
ESRD|ESRD||ICD_10|2020|I13.11|Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease||
ESRD|ESRD||ICD_10|2020|I13.2|Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease||
ESRD|ESRD||ICD_10|2020|N18.5|Chronic kidney disease, stage 5||
ESRD|ESRD||ICD_10|2020|N18.6|End stage renal disease||
ESRD|ESRD||ICD_10|2020|N19|Renal failure, unspecified||
ESRD|ESRD||ICD_10|2020|Z91.15|Patient's noncompliance with renal dialysis ||
ESRD|ESRD||ICD_10|2020|Z99.2|Dependence on renal dialysis||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I09.81|Rheumatic heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I11.0|Hypertensive heart disease with heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I13.0|Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I13.2|Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.1|Left ventricular failure, unspecified||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.20|Unspecified systolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.21|Acute systolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.22|Chronic systolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.23|Acute on chronic systolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.30|Unspecified diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.31|Acute diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.32|Chronic diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.33|Acute on chronic diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.40|Unspecified combined systolic (congestive) and diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.41|Acute combined systolic (congestive) and diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.42|Chronic combined systolic (congestive) and diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.43|Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.810|Right heart failure, unspecified||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.811|Acute right heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.812|Chronic right heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.813|Acute on chronic right heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.814|Right heart failure due to left heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.82|Biventricular heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.83|High output heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.84|End stage heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.89|Other heart failure||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I50.9|Heart failure, unspecified||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I97.130|Postprocedural heart failure following cardiac surgery||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|I97.131|Postprocedural heart failure following other surgery||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|O29.121|Cardiac Failure due to anesthesia during pregnancy ; first trimester||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|O29.122|Cardiac Failure due to anesthesia during pregnancy ; second  trimester||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|O29.123|Cardiac Failure due to anesthesia during pregnancy ; third  trimester||
HEART_FAILURE|HEART_FAILURE||ICD_10|2020|O29.129|Cardiac Failure due to anesthesia during pregnancy ;unspecified trimester||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9473|Services performed by chaplain in the hospice setting, each 15 minutes (G9473)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9474|Services performed by dietary counselor in the hospice setting, each 15 minutes (G9474)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9475|Services performed by other counselor in the hospice setting, each 15 minutes (G9475)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9476|Services performed by volunteer in the hospice setting, each 15 minutes (G9476)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9477|Services performed by care coordinator in the hospice setting, each 15 minutes (G9477)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9478|Services performed by other qualified therapist in the hospice setting, each 15 minutes (G9478)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|G9479|Services performed by qualified pharmacist in the hospice setting, each 15 minutes (G9479)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5003|Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf) (Q5003)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5004|Hospice care provided in skilled nursing facility (snf) (Q5004)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5005|Hospice care provided in inpatient hospital (Q5005)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5006|Hospice care provided in inpatient hospice facility (Q5006)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5007|Hospice care provided in long term care facility (Q5007)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5008|Hospice care provided in inpatient psychiatric facility (Q5008)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|Q5010|Hospice home care provided in a hospice facility (Q5010)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|S9126|Hospice care, in the home, per diem (S9126)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|T2042|Hospice routine home care; per diem (T2042)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|T2043|Hospice continuous home care; per hour (T2043)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|T2044|Hospice inpatient respite care; per diem (T2044)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|T2045|Hospice general inpatient care; per diem (T2045)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||HCPCS_CODE|2019|T2046|Hospice long term care, room and board only; per diem (T2046)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||SNOMED_CT|2019-03|183919006|Urgent admission to hospice (procedure)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||SNOMED_CT|2019-03|183920000|Routine admission to hospice (procedure)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||SNOMED_CT|2019-03|183921001|Admission to hospice for respite (procedure)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||SNOMED_CT|2019-03|305336008|Admission to hospice (procedure)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||SNOMED_CT|2019-03|305911006|Seen in hospice (finding)||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0115|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0125|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0135|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0145|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0155|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0235|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0650|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0651|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0652|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0655|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0656|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0657|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0658|||
HOSPICE_ENCOUNTER|HOSPICE_ENCOUNTER||UBREV|2012.05|0659|||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||CPT|2019-06|99377|||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||CPT|2019-06|99378|||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||HCPCS_CODE|2019|G0182|Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more (G0182)||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||SNOMED_CT|2019-03|170935008|Full care by hospice (finding)||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||SNOMED_CT|2019-03|170936009|Shared care - hospice and general practitioner (finding)||
HOSPICE_INTERVENTION|HOSPICE_INTERVENTION||SNOMED_CT|2019-03|385763009|Hospice care (regime/therapy)||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0024|Inpatient Rehabilitation Facility (IRF) PPS||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0100|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0101|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0110|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0111|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0112|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0113|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0114|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0116|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0117|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0118|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0119|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0120|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0121|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0122|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0123|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0124|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0126|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0127|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0128|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0129|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0130|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0131|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0132|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0133|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0134|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0136|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0137|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0138|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0139|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0140|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0141|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0142|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0143|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0144|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0146|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0147|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0148|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0149|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0150|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0151|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0152|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0153|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0154|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0156|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0157|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0158|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0159|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0160|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0164|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0167|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0169|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0170|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0171|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0172|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0173|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0174|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0179|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0190|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0191|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0192|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0193|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0194|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0199|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0200|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0201|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0202|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0203|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0204|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0206|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0207|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0208|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0209|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0210|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0211|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0212|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0213|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0214|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|0219|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|1000|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|1001|||
HOSPITAL_STAY|HOSPITAL_STAY||UBREV|2018-09|1002|||
INR_HOME_MONITORING|INR_HOME_MONITORING||CPT|2019|1031025|Home and Outpatient International Normalized Ratio (INR) Monitoring Services||
INR_HOME_MONITORING|INR_HOME_MONITORING||CPT|2019|93792|Patient/caregiver training for initiation of home international normalized ratio (INR) monitoring under the direction of a physician or other qualified health care professional, face-to-face, including use and care of the INR monitor, obtaining blood sample, instructions for reporting home INR test results, and documentation of patient's/caregiver's ability to perform testing and report results||
INR_HOME_MONITORING|INR_HOME_MONITORING||CPT|2019|93793|Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed||
INR_HOME_MONITORING|INR_HOME_MONITORING||HCPCS_CODE|2020|G0248|Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results||
INR_HOME_MONITORING|INR_HOME_MONITORING||HCPCS_CODE|2020|G0249|Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests||
INR_HOME_MONITORING|INR_HOME_MONITORING||HCPCS_CODE|2020|G0250|Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests||
INR_TEST|INR_TEST||CPT|2019|3555F|Patient had International Normalized Ratio (INR) measurement performed (AFIB)||
INR_TEST|INR_TEST||CPT|2019|85610|Prothrombin time||
INR_TEST|INR_TEST||LOINC|2.66|34714-6|INR in Blood by Coagulation assay||
INR_TEST|INR_TEST||LOINC|2.66|38875-1|INR in Platelet poor plasma or blood by Coagulation assay||
INR_TEST|INR_TEST||LOINC|2.66|46418-0|INR in Capillary blood by Coagulation assay||
INR_TEST|INR_TEST||LOINC|2.66|52129-4|INR in Platelet poor plasma by Coagulation assay --post heparin adsorption   ||
INR_TEST|INR_TEST||LOINC|2.66|5896-5|Deprecated reverse INR in Platelet poor plasma by Coagulation assay||
INR_TEST|INR_TEST||LOINC|2.66|6301-6|INR in Platelet poor plasma by Coagulation assay||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.0|Acute delta-(super) infection of hepatitis B carrier||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.10|Acute hepatitis C without hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.11|Acute hepatitis C with hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.2|Acute hepatitis E||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.8|Other specified acute viral hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B17.9|Acute viral hepatitis, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B18.2|Chronic viral hepatitis C||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B18.8|Other chronic viral hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B18.9|Chronic viral hepatitis, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B19.0|Unspecified viral hepatitis with hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B19.20|Unspecified viral hepatitis C without hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B19.21|Unspecified viral hepatitis C with hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|B19.9|Unspecified viral hepatitis without hepatic coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.0|Alcoholic fatty liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.10|Alcoholic hepatitis without ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.11|Alcoholic hepatitis with ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.2|Alcoholic fibrosis and sclerosis of liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.30|Alcoholic cirrhosis of liver without ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.31|Alcoholic cirrhosis of liver with ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.40|Alcoholic hepatic failure without coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.41|Alcoholic hepatic failure with coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K70.9|Alcoholic liver disease, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.0|Toxic liver disease with cholestasis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.10|Toxic liver disease with hepatic necrosis, without coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.11|Toxic liver disease with hepatic necrosis, with coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.2|Toxic liver disease with acute hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.3|Toxic liver disease with chronic persistent hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.4|Toxic liver disease with chronic lobular hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.50|Toxic liver disease with chronic active hepatitis without ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.51|Toxic liver disease with chronic active hepatitis with ascites||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.6|Toxic liver disease with hepatitis, not elsewhere classified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.7|Toxic liver disease with fibrosis and cirrhosis of liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.8|Toxic liver disease with other disorders of liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K71.9|Toxic liver disease, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.00|Acute and subacute hepatic failure without coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.01|Acute and subacute hepatic failure with coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.10|Chronic hepatic failure without coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.11|Chronic hepatic failure with coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.90|Hepatic failure, unspecified without coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K72.91|Hepatic failure, unspecified with coma||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K73.0|Chronic persistent hepatitis, not elsewhere classified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K73.1|Chronic lobular hepatitis, not elsewhere classified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K73.2|Chronic active hepatitis, not elsewhere classified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K73.8|Other chronic hepatitis, not elsewhere classified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K73.9|Chronic hepatitis, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.0|Hepatic fibrosis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.1|Hepatic sclerosis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.2|Hepatic fibrosis with hepatic sclerosis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.3|Primary biliary cirrhosis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.4|Secondary biliary cirrhosis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.5|Biliary cirrhosis, unspecified||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.60|Unspecified cirrhosis of liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K74.69|Other cirrhosis of liver||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|K75.4|Autoimmune hepatitis||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|O98.411|Viral hepatitis complicating pregnancy, first trimester||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|O98.412|Viral hepatitis complicating pregnancy, second trimester||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|O98.413|Viral hepatitis complicating pregnancy, third trimester||
LIVER_DISEASE|LIVER_DISEASE||ICD_10|2019|O98.419|Viral hepatitis complicating pregnancy, unspecified trimester||
MEDICATION_THERAPY_PROBLEM_RESOLUTION_MTI_STATUS|MEDICATION THERAPY INTERVENTIONS STATUS|INTERVENTION NOT PERFORMED|SNOMED_CT|2019-09|262008008|Not performed (qualifier value)|NUMERATOR_COMPLIANT_RESOLVED|NO
MEDICATION_THERAPY_PROBLEM_RESOLUTION_MTI_STATUS|MEDICATION THERAPY INTERVENTIONS STATUS|INTERVENTION PERFORMED|SNOMED_CT|2019-09|398166005|Performed (qualifier value)|NUMERATOR_COMPLIANT_RESOLVED|YES
MEDICATION_THERAPY_PROBLEM_RESOLUTION_MTI_STATUS|MEDICATION THERAPY INTERVENTIONS STATUS|INTERVENTION REFUSED|SNOMED_CT|2019-09|443390004|Refused (qualifier value)|NUMERATOR_COMPLIANT_RESOLVED|NO
MEDICATION_THERAPY_PROBLEM_RESOLUTION_MTI_STATUS|MEDICATION THERAPY INTERVENTIONS STATUS|VACCINE REFUSED BY PARENT|SNOMED_CT|2019-09|921000119109|Vaccine refused by parent (situation)|NUMERATOR_COMPLIANT_RESOLVED|NO
MEDICATION_THERAPY_PROBLEM_RESOLUTION_MTI_STATUS|MEDICATION THERAPY INTERVENTIONS STATUS|VACCINE REFUSED BY PATIENT|SNOMED_CT|2019-09|591000119102|Vaccine refused by patient (status)|NUMERATOR_COMPLIANT_RESOLVED|NO
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION|SNOMED_CT|2019-09|407611006|Medication change to generic (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION|SNOMED_CT|2019-09|432701000124107|Medication therapy changed (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION COURSE|SNOMED_CT|2019-09|432811000124101|Medication course duration changed (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION COURSE|SNOMED_CT|2019-09|432821000124109|Medication course duration lengthened (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION COURSE|SNOMED_CT|2019-09|432831000124107|Medication course duration shortened (situation) ||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSAGE FORM|SNOMED_CT|2019-09|432841000124102|Medication dosage form changed (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSE|SNOMED_CT|2019-09|432751000124106|Medication dose changed (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSE|SNOMED_CT|2019-09|432761000124108|Medication dose increased (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSE|SNOMED_CT|2019-09|432771000124101|Medication dose decreased (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSING INTERVAL|SNOMED_CT|2019-09|432781000124103|Medication dosing interval changed (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSING INTERVAL|SNOMED_CT|2019-09|432791000124100|Medication dosing interval decreased (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|CHANGE MEDICATION DOSING INTERVAL|SNOMED_CT|2019-09|432801000124104|Medication dosing interval increased (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|DISCONTINUE MEDICATION|SNOMED_CT|2019-09|274512008|Drug therapy discontinued (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|DISCONTINUE MEDICATION|SNOMED_CT|2019-09|4721000124109|Herbal supplement discontinued (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|DISCONTINUE MEDICATION|SNOMED_CT|2019-09|4731000124107 |Dietary supplement discontinued (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|DISCONTINUE MEDICATION|SNOMED_CT|2019-09|4741000124102|Over-the counter medication discontinued (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|DISCONTINUE MEDICATION|SNOMED_CT|2019-09|4751000124100|Prescription medication discontinued (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|127785005|Administration of substance to produce immunity, either active or passive (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|12866006|Pneumococcal vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|16584000|Hepatitis B vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|243789007|Hepatitis A immunization (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|266709005|Medication commenced (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|34631000|Rabies vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|38598009|Measles-mumps-rubella vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|41088001|Meningococcus vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|428251000124104|Tetanus, diphtheria and acellular pertussis vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|428570002|Vaccination for human papillomavirus (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|432636005|Administration of measles, mumps, rubella, and varicella vaccine||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|432851000124100|Over-the-counter medication started (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|432861000124103|Prescription medication started (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|432871000124105|Dietary supplement started (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|432881000124108|Herbal supplement started (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|51572002|Haemophilus influenzae immunization (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|67308009|Yellow fever vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|68525005|Varicella vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INITIATE MEDICATION|SNOMED_CT|2019-09|86198006|Influenza vaccination (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INTERVENTIONS RELATED TO MONITORING|SNOMED_CT|2019-09|370836008|Monitoring physiological parameters (regime/therapy)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INTERVENTIONS RELATED TO MONITORING|SNOMED_CT|2019-09|395170001|Medication monitoring (regime/therapy)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|INTERVENTIONS RELATED TO MONITORING|SNOMED_CT|2019-09|431561000124105|Monitoring of laboratory results (regime/therapy)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY INTERVENTION|MEDICATION EDUCATION|SNOMED_CT|2019-09|967006|Medication education (procedure)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|ADHERENCE|SNOMED_CT|2019-09|129834002|Noncompliance with medication regimen (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|ADHERENCE|SNOMED_CT|2019-09|697958005|Suspected noncompliance with therapeutic regimen (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|ADVERSE MEDICATION EVENT|SNOMED_CT|2019-09|62014003|Adverse reaction caused by drug (disorder)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|COST|SNOMED_CT|2019-09|160932005|Financial problem (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|DOSAGE TOO HIGH|SNOMED_CT|2019-09|448089004|Medication dose too high (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|DOSAGE TOO LOW|SNOMED_CT|2019-09|448152000|Medication dose too low (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|INEFFECTIVE MEDICATION|SNOMED_CT|2019-09|435501000124106|Medication not effective (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|NEEDS ADDITIONAL MEDICATION THERAPY|SNOMED_CT|2019-09|428981000124101|Additional medication therapy required (finding)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|NEEDS ADDITIONAL MONITORING|SNOMED_CT|2019-09|165348004|Laboratory test due (situation)||
MEDICATION_THERAPY_PROBLEMS_AND_MEDICATION_THERAPY_INTERVENTIONS|MEDICATION THERAPY PROBLEM CATEGORY|UNNECESSARY MEDICATION THERAPY|SNOMED_CT|2019-09|429621000124102|Medication therapy unnecessary (finding)||
PCOS|PCOS||ICD_10|2019|E28.2|Polycystic ovarian syndrome||
PREDIABETES|PREDIABETES||ICD_10|2019|R73.03|Prediabetes||
PREDIABETES|PREDIABETES||ICD_10|2019|R73.09|Other abnormal blood glucose||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|A34|Obstetrical tetanus||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.00|Abdominal pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.01|Abdominal pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.101|Right tubal pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.102|Left tubal pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.109|Unspecified tubal pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.111|Right tubal pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.112|Left tubal pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.119|Unspecified tubal pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.201|Right ovarian pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.202|Left ovarian pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.209|Unspecified ovarian pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.211|Right ovarian pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.212|Left ovarian pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.219|Unspecified ovarian pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.80|Other ectopic pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.81|Other ectopic pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.90|Unspecified ectopic pregnancy without intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O00.91|Unspecified ectopic pregnancy with intrauterine pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O01.9|Hydatidiform mole, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O02.0|Blighted ovum and nonhydatidiform mole||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O02.1|Missed abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.0|Genital tract and pelvic infection following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.1|Delayed or excessive hemorrhage following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.2|Embolism following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.30|Unspecified complication following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.31|Shock following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.32|Renal failure following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.33|Metabolic disorder following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.34|Damage to pelvic organs following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.37|Sepsis following incomplete spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.39|Incomplete spontaneous abortion with other complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.4|Incomplete spontaneous abortion without complication||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.5|Genital tract and pelvic infection following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.6|Delayed or excessive hemorrhage following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.7|Embolism following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.80|Unspecified complication following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.81|Shock following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.82|Renal failure following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.83|Metabolic disorder following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.84|Damage to pelvic organs following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.85|Other venous complications following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.86|Cardiac arrest following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.87|Sepsis following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.88|Urinary tract infection following complete or unspecified spontaneous abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.89|Complete or unspecified spontaneous abortion with other complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O03.9|Complete or unspecified spontaneous abortion without complication||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.5|Genital tract and pelvic infection following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.6|Delayed or excessive hemorrhage following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.7|Embolism following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.80|(Induced) termination of pregnancy with unspecified complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.81|Shock following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.82|Renal failure following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.83|Metabolic disorder following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.84|Damage to pelvic organs following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.85|Other venous complications following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.86|Cardiac arrest following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.87|Sepsis following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.88|Urinary tract infection following (induced) termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O04.89|(Induced) termination of pregnancy with other complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.0|Genital tract and pelvic infection following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.1|Delayed or excessive hemorrhage following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.2|Embolism following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.30|Failed attempted termination of pregnancy with unspecified complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.31|Shock following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.32|Renal failure following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.33|Metabolic disorder following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.34|Damage to pelvic organs following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.35|Other venous complications following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.36|Cardiac arrest following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.37|Sepsis following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.38|Urinary tract infection following failed attempted termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.39|Failed attempted termination of pregnancy with other complications||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O07.4|Failed attempted termination of pregnancy without complication||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.0|Genital tract and pelvic infection following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.1|Delayed or excessive hemorrhage following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.2|Embolism following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.3|Shock following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.4|Renal failure following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.5|Metabolic disorders following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.6|Damage to pelvic organs and tissues following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.7|Other venous complications following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.81|Cardiac arrest following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.82|Sepsis following ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.83|Urinary tract infection following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.89|Other complications following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O08.9|Unspecified complication following an ectopic and molar pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.00|Supervision of pregnancy with history of infertility, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.10|Supervision of pregnancy with history of ectopic pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.11|Supervision of pregnancy with history of ectopic pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.12|Supervision of pregnancy with history of ectopic pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.13|Supervision of pregnancy with history of ectopic pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.211|Supervision of pregnancy with history of pre-term labor, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.291|Supervision of pregnancy with other poor reproductive or obstetric history, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.30|Supervision of pregnancy with insufficient antenatal care, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.40|Supervision of pregnancy with grand multiparity, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.41|Supervision of pregnancy with grand multiparity, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.42|Supervision of pregnancy with grand multiparity, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.43|Supervision of pregnancy with grand multiparity, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.511|Supervision of elderly primigravida, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.512|Supervision of elderly primigravida, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.513|Supervision of elderly primigravida, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.519|Supervision of elderly primigravida, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.521|Supervision of elderly multigravida, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.522|Supervision of elderly multigravida, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.523|Supervision of elderly multigravida, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.529|Supervision of elderly multigravida, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.611|Supervision of young primigravida, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.621|Supervision of young multigravida, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.819|Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.821|Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.822|Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.823|Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.829|Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.891|Supervision of other high risk pregnancies, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.892|Supervision of other high risk pregnancies, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.893|Supervision of other high risk pregnancies, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.899|Supervision of other high risk pregnancies, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.90|Supervision of high risk pregnancy, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.91|Supervision of high risk pregnancy, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.92|Supervision of high risk pregnancy, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.93|Supervision of high risk pregnancy, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.A0|Supervision of pregnancy with history of molar pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.A1|Supervision of pregnancy with history of molar pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.A2|Supervision of pregnancy with history of molar pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O09.A3|Supervision of pregnancy with history of molar pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.011|Pre-existing essential hypertension complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.012|Pre-existing essential hypertension complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.013|Pre-existing essential hypertension complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.019|Pre-existing essential hypertension complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.03|Pre-existing essential hypertension complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.111|Pre-existing hypertensive heart disease complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.112|Pre-existing hypertensive heart disease complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.113|Pre-existing hypertensive heart disease complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.119|Pre-existing hypertensive heart disease complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.12|Pre-existing hypertensive heart disease complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.13|Pre-existing hypertensive heart disease complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.211|Pre-existing hypertensive chronic kidney disease complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.212|Pre-existing hypertensive chronic kidney disease complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.213|Pre-existing hypertensive chronic kidney disease complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.219|Pre-existing hypertensive chronic kidney disease complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.22|Pre-existing hypertensive chronic kidney disease complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.23|Pre-existing hypertensive chronic kidney disease complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.311|Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.312|Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.313|Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.319|Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.32|Pre-existing hypertensive heart and chronic kidney disease complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.33|Pre-existing hypertensive heart and chronic kidney disease complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.411|Pre-existing secondary hypertension complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.412|Pre-existing secondary hypertension complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.413|Pre-existing secondary hypertension complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.419|Pre-existing secondary hypertension complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.42|Pre-existing secondary hypertension complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.43|Pre-existing secondary hypertension complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.911|Unspecified pre-existing hypertension complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.912|Unspecified pre-existing hypertension complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.913|Unspecified pre-existing hypertension complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.919|Unspecified pre-existing hypertension complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.92|Unspecified pre-existing hypertension complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O10.93|Unspecified pre-existing hypertension complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.1|Pre-existing hypertension with pre-eclampsia, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.2|Pre-existing hypertension with pre-eclampsia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.3|Pre-existing hypertension with pre-eclampsia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.4|Pre-existing hypertension with pre-eclampsia, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.5|Pre-existing hypertension with pre-eclampsia, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O11.9|Pre-existing hypertension with pre-eclampsia, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.00|Gestational edema, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.01|Gestational edema, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.02|Gestational edema, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.03|Gestational edema, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.04|Gestational edema, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.05|Gestational edema, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.10|Gestational proteinuria, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.11|Gestational proteinuria, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.12|Gestational proteinuria, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.13|Gestational proteinuria, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.20|Gestational edema with proteinuria, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.21|Gestational edema with proteinuria, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.22|Gestational edema with proteinuria, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.23|Gestational edema with proteinuria, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.24|Gestational edema with proteinuria, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O12.25|Gestational edema with proteinuria, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.1|Gestational [pregnancy-induced] hypertension without significant proteinuria, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.2|Gestational [pregnancy-induced] hypertension without significant proteinuria, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.3|Gestational [pregnancy-induced] hypertension without significant proteinuria, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.4|Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.5|Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O13.9|Gestational [pregnancy-induced] hypertension without significant proteinuria, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.00|Mild to moderate pre-eclampsia, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.02|Mild to moderate pre-eclampsia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.03|Mild to moderate pre-eclampsia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.04|Mild to moderate pre-eclampsia, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.05|Mild to moderate pre-eclampsia, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.10|Severe pre-eclampsia, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.12|Severe pre-eclampsia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.13|Severe pre-eclampsia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.14|Severe pre-eclampsia complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.15|Severe pre-eclampsia, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.20|HELLP syndrome (HELLP), unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.22|HELLP syndrome (HELLP), second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.23|HELLP syndrome (HELLP), third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.24|HELLP syndrome, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.25|HELLP syndrome, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.90|Unspecified pre-eclampsia, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.92|Unspecified pre-eclampsia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.93|Unspecified pre-eclampsia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.94|Unspecified pre-eclampsia, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O14.95|Unspecified pre-eclampsia, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O15.02|Eclampsia complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O15.03|Eclampsia complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O15.1|Eclampsia complicating labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O15.2|Eclampsia complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.1|Unspecified maternal hypertension, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.2|Unspecified maternal hypertension, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.3|Unspecified maternal hypertension, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.4|Unspecified maternal hypertension, complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.5|Unspecified maternal hypertension, complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O16.9|Unspecified maternal hypertension, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O20.0|Threatened abortion||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O20.8|Other hemorrhage in early pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O20.9|Hemorrhage in early pregnancy, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O21.0|Mild hyperemesis gravidarum||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O21.2|Late vomiting of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O21.8|Other vomiting complicating pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O21.9|Vomiting of pregnancy, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.00|Varicose veins of lower extremity in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.01|Varicose veins of lower extremity in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.02|Varicose veins of lower extremity in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.03|Varicose veins of lower extremity in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.10|Genital varices in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.11|Genital varices in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.12|Genital varices in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.13|Genital varices in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.20|Superficial thrombophlebitis in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.21|Superficial thrombophlebitis in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.22|Superficial thrombophlebitis in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.23|Superficial thrombophlebitis in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.30|Deep phlebothrombosis in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.31|Deep phlebothrombosis in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.32|Deep phlebothrombosis in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.33|Deep phlebothrombosis in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.40|Hemorrhoids in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.41|Hemorrhoids in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.42|Hemorrhoids in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.43|Hemorrhoids in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.50|Cerebral venous thrombosis in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.51|Cerebral venous thrombosis in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.52|Cerebral venous thrombosis in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.53|Cerebral venous thrombosis in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.90|Venous complication in pregnancy, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.91|Venous complication in pregnancy, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.92|Venous complication in pregnancy, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O22.93|Venous complication in pregnancy, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.00|Infections of kidney in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.10|Infections of bladder in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.20|Infections of urethra in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.30|Infections of other parts of urinary tract in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.40|Unspecified infection of urinary tract in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.41|Unspecified infection of urinary tract in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.42|Unspecified infection of urinary tract in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.43|Unspecified infection of urinary tract in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.519|Infections of cervix in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.529|Salpingo-oophoritis in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.599|Infection of other part of genital tract in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.90|Unspecified genitourinary tract infection in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.91|Unspecified genitourinary tract infection in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.92|Unspecified genitourinary tract infection in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O23.93|Unspecified genitourinary tract infection in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.319|Unspecified pre-existing diabetes mellitus in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.32|Unspecified pre-existing diabetes mellitus in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.415|Gestational diabetes mellitus in pregnancy, controlled by oral hypoglycemic drugs||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.419|Gestational diabetes mellitus in pregnancy, unspecified control||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.425|Gestational diabetes mellitus in childbirth, controlled by oral hypoglycemic drugs||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.429|Gestational diabetes mellitus in childbirth, unspecified control||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.435|Gestational diabetes mellitus in puerperium, controlled by oral hypoglycemic drugs||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.439|Gestational diabetes mellitus in the puerperium, unspecified control||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.911|Unspecified diabetes mellitus in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.912|Unspecified diabetes mellitus in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.913|Unspecified diabetes mellitus in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.92|Unspecified diabetes mellitus in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O24.93|Unspecified diabetes mellitus in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.10|Malnutrition in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.11|Malnutrition in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.12|Malnutrition in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.13|Malnutrition in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.2|Malnutrition in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O25.3|Malnutrition in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.00|Excessive weight gain in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.01|Excessive weight gain in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.02|Excessive weight gain in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.03|Excessive weight gain in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.11|Low weight gain in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.12|Low weight gain in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.13|Low weight gain in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.20|Pregnancy care for patient with recurrent pregnancy loss, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.21|Pregnancy care for patient with recurrent pregnancy loss, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.22|Pregnancy care for patient with recurrent pregnancy loss, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.23|Pregnancy care for patient with recurrent pregnancy loss, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.41|Herpes gestationis, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.42|Herpes gestationis, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.43|Herpes gestationis, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.50|Maternal hypotension syndrome, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.51|Maternal hypotension syndrome, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.52|Maternal hypotension syndrome, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.53|Maternal hypotension syndrome, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.611|Liver and biliary tract disorders in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.612|Liver and biliary tract disorders in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.613|Liver and biliary tract disorders in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.619|Liver and biliary tract disorders in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.62|Liver and biliary tract disorders in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.811|Pregnancy related exhaustion and fatigue, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.812|Pregnancy related exhaustion and fatigue, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.813|Pregnancy related exhaustion and fatigue, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.819|Pregnancy related exhaustion and fatigue, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.821|Pregnancy related peripheral neuritis, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.822|Pregnancy related peripheral neuritis, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.823|Pregnancy related peripheral neuritis, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.829|Pregnancy related peripheral neuritis, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.831|Pregnancy related renal disease, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.832|Pregnancy related renal disease, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.833|Pregnancy related renal disease, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.839|Pregnancy related renal disease, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.841|Uterine size-date discrepancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.842|Uterine size-date discrepancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.843|Uterine size-date discrepancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.849|Uterine size-date discrepancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.851|Spotting complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.852|Spotting complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.853|Spotting complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.859|Spotting complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.872|Cervical shortening, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.873|Cervical shortening, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.879|Cervical shortening, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.891|Other specified pregnancy related conditions, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.892|Other specified pregnancy related conditions, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.893|Other specified pregnancy related conditions, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.899|Other specified pregnancy related conditions, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O26.90|Pregnancy related conditions, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.001|Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.002|Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.003|Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.009|Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.021|Conjoined twin pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.022|Conjoined twin pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.023|Conjoined twin pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.029|Conjoined twin pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.101|Triplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.102|Triplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.103|Triplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.109|Triplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.201|Quadruplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.202|Quadruplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.203|Quadruplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.209|Quadruplet pregnancy, unspecified number of placenta and unspecified number of amniotic sacs, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.801|Other specified multiple gestation, unspecified number of placenta and unspecified number of amniotic sacs, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.802|Other specified multiple gestation, unspecified number of placenta and unspecified number of amniotic sacs, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.803|Other specified multiple gestation, unspecified number of placenta and unspecified number of amniotic sacs, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.809|Other specified multiple gestation, unspecified number of placenta and unspecified number of amniotic sacs, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.90|Multiple gestation, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.91|Multiple gestation, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.92|Multiple gestation, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O30.93|Multiple gestation, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.0|Maternal care for disproportion due to deformity of maternal pelvic bones||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.1|Maternal care for disproportion due to generally contracted pelvis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.2|Maternal care for disproportion due to inlet contraction of pelvis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX0|Maternal care for disproportion due to other fetal deformities, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX1|Maternal care for disproportion due to other fetal deformities, fetus 1||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX2|Maternal care for disproportion due to other fetal deformities, fetus 2||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX3|Maternal care for disproportion due to other fetal deformities, fetus 3||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX4|Maternal care for disproportion due to other fetal deformities, fetus 4||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX5|Maternal care for disproportion due to other fetal deformities, fetus 5||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.7XX9|Maternal care for disproportion due to other fetal deformities, other fetus||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.8|Maternal care for disproportion of other origin||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O33.9|Maternal care for disproportion, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.00|Maternal care for unspecified congenital malformation of uterus, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.01|Maternal care for unspecified congenital malformation of uterus, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.02|Maternal care for unspecified congenital malformation of uterus, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.03|Maternal care for unspecified congenital malformation of uterus, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.10|Maternal care for benign tumor of corpus uteri, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.11|Maternal care for benign tumor of corpus uteri, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.12|Maternal care for benign tumor of corpus uteri, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.13|Maternal care for benign tumor of corpus uteri, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.211|Maternal care for low transverse scar from previous cesarean delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.212|Maternal care for vertical scar from previous cesarean delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.219|Maternal care for unspecified type scar from previous cesarean delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.29|Maternal care due to uterine scar from other previous surgery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.30|Maternal care for cervical incompetence, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.31|Maternal care for cervical incompetence, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.32|Maternal care for cervical incompetence, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.33|Maternal care for cervical incompetence, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.40|Maternal care for other abnormalities of cervix, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.41|Maternal care for other abnormalities of cervix, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.42|Maternal care for other abnormalities of cervix, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.43|Maternal care for other abnormalities of cervix, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.511|Maternal care for incarceration of gravid uterus, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.512|Maternal care for incarceration of gravid uterus, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.513|Maternal care for incarceration of gravid uterus, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.519|Maternal care for incarceration of gravid uterus, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.521|Maternal care for prolapse of gravid uterus, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.522|Maternal care for prolapse of gravid uterus, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.523|Maternal care for prolapse of gravid uterus, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.529|Maternal care for prolapse of gravid uterus, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.531|Maternal care for retroversion of gravid uterus, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.532|Maternal care for retroversion of gravid uterus, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.533|Maternal care for retroversion of gravid uterus, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.539|Maternal care for retroversion of gravid uterus, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.591|Maternal care for other abnormalities of gravid uterus, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.592|Maternal care for other abnormalities of gravid uterus, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.593|Maternal care for other abnormalities of gravid uterus, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.599|Maternal care for other abnormalities of gravid uterus, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.60|Maternal care for abnormality of vagina, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.61|Maternal care for abnormality of vagina, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.62|Maternal care for abnormality of vagina, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.63|Maternal care for abnormality of vagina, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.70|Maternal care for abnormality of vulva and perineum, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.71|Maternal care for abnormality of vulva and perineum, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.72|Maternal care for abnormality of vulva and perineum, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.73|Maternal care for abnormality of vulva and perineum, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.80|Maternal care for other abnormalities of pelvic organs, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.81|Maternal care for other abnormalities of pelvic organs, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.82|Maternal care for other abnormalities of pelvic organs, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.83|Maternal care for other abnormalities of pelvic organs, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.90|Maternal care for abnormality of pelvic organ, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.91|Maternal care for abnormality of pelvic organ, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.92|Maternal care for abnormality of pelvic organ, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O34.93|Maternal care for abnormality of pelvic organ, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX0|Maternal care for (suspected) damage to fetus by other medical procedures, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX1|Maternal care for (suspected) damage to fetus by other medical procedures, fetus 1||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX2|Maternal care for (suspected) damage to fetus by other medical procedures, fetus 2||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX3|Maternal care for (suspected) damage to fetus by other medical procedures, fetus 3||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX4|Maternal care for (suspected) damage to fetus by other medical procedures, fetus 4||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX5|Maternal care for (suspected) damage to fetus by other medical procedures, fetus 5||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.7XX9|Maternal care for (suspected) damage to fetus by other medical procedures, other fetus||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX0|Maternal care for other (suspected) fetal abnormality and damage, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX1|Maternal care for other (suspected) fetal abnormality and damage, fetus 1||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX2|Maternal care for other (suspected) fetal abnormality and damage, fetus 2||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX3|Maternal care for other (suspected) fetal abnormality and damage, fetus 3||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX4|Maternal care for other (suspected) fetal abnormality and damage, fetus 4||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX5|Maternal care for other (suspected) fetal abnormality and damage, fetus 5||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O35.8XX9|Maternal care for other (suspected) fetal abnormality and damage, other fetus||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0110|Maternal care for anti-D [Rh] antibodies, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0120|Maternal care for anti-D [Rh] antibodies, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0130|Maternal care for anti-D [Rh] antibodies, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0190|Maternal care for anti-D [Rh] antibodies, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0910|Maternal care for other rhesus isoimmunization, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0920|Maternal care for other rhesus isoimmunization, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0930|Maternal care for other rhesus isoimmunization, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.0990|Maternal care for other rhesus isoimmunization, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1110|Maternal care for Anti-A sensitization, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1120|Maternal care for Anti-A sensitization, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1130|Maternal care for Anti-A sensitization, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1190|Maternal care for Anti-A sensitization, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1910|Maternal care for other isoimmunization, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1920|Maternal care for other isoimmunization, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1930|Maternal care for other isoimmunization, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.1990|Maternal care for other isoimmunization, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5110|Maternal care for known or suspected placental insufficiency, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5120|Maternal care for known or suspected placental insufficiency, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5130|Maternal care for known or suspected placental insufficiency, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5190|Maternal care for known or suspected placental insufficiency, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5910|Maternal care for other known or suspected poor fetal growth, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5920|Maternal care for other known or suspected poor fetal growth, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5930|Maternal care for other known or suspected poor fetal growth, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.5990|Maternal care for other known or suspected poor fetal growth, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8120|Decreased fetal movements, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8130|Decreased fetal movements, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8190|Decreased fetal movements, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8210|Fetal anemia and thrombocytopenia, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8220|Fetal anemia and thrombocytopenia, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8230|Fetal anemia and thrombocytopenia, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8290|Fetal anemia and thrombocytopenia, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8910|Maternal care for other specified fetal problems, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8920|Maternal care for other specified fetal problems, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8930|Maternal care for other specified fetal problems, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O36.8990|Maternal care for other specified fetal problems, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1010|Infection of amniotic sac and membranes, unspecified, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1020|Infection of amniotic sac and membranes, unspecified, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1030|Infection of amniotic sac and membranes, unspecified, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1090|Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1210|Chorioamnionitis, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1220|Chorioamnionitis, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1230|Chorioamnionitis, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1290|Chorioamnionitis, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1410|Placentitis, first trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1420|Placentitis, second trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1430|Placentitis, third trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O41.1490|Placentitis, unspecified trimester, not applicable or unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.00|Premature rupture of membranes, onset of labor within 24 hours of rupture, unspecified weeks of gestation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.011|Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.012|Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.013|Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.02|Full-term premature rupture of membranes, onset of labor within 24 hours of rupture||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.10|Premature rupture of membranes, onset of labor more than 24 hours following rupture, unspecified weeks of gestation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.111|Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.112|Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.113|Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O42.12|Full-term premature rupture of membranes, onset of labor more than 24 hours following rupture||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.011|Fetomaternal placental transfusion syndrome, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.019|Fetomaternal placental transfusion syndrome, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.101|Malformation of placenta, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.102|Malformation of placenta, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.103|Malformation of placenta, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.199|Other malformation of placenta, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.211|Placenta accreta, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.212|Placenta accreta, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.213|Placenta accreta, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.221|Placenta increta, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.222|Placenta increta, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.223|Placenta increta, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.231|Placenta percreta, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.232|Placenta percreta, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.233|Placenta percreta, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.239|Placenta percreta, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.811|Placental infarction, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.812|Placental infarction, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.813|Placental infarction, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.819|Placental infarction, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.91|Unspecified placental disorder, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.92|Unspecified placental disorder, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O43.93|Unspecified placental disorder, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.00|Complete placenta previa NOS or without hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.01|Complete placenta previa NOS or without hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.02|Complete placenta previa NOS or without hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.03|Complete placenta previa NOS or without hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.10|Complete placenta previa with hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.11|Complete placenta previa with hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.12|Complete placenta previa with hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.13|Complete placenta previa with hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.20|Partial placenta previa NOS or without hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.21|Partial placenta previa NOS or without hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.22|Partial placenta previa NOS or without hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.23|Partial placenta previa NOS or without hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.30|Partial placenta previa with hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.31|Partial placenta previa with hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.32|Partial placenta previa with hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.33|Partial placenta previa with hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.40|Low lying placenta NOS or without hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.41|Low lying placenta NOS or without hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.42|Low lying placenta NOS or without hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.43|Low lying placenta NOS or without hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.50|Low lying placenta with hemorrhage, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.51|Low lying placenta with hemorrhage, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.52|Low lying placenta with hemorrhage, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O44.53|Low lying placenta with hemorrhage, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.001|Premature separation of placenta with coagulation defect, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.002|Premature separation of placenta with coagulation defect, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.003|Premature separation of placenta with coagulation defect, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.011|Premature separation of placenta with afibrinogenemia, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.012|Premature separation of placenta with afibrinogenemia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.013|Premature separation of placenta with afibrinogenemia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.021|Premature separation of placenta with disseminated intravascular coagulation, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.022|Premature separation of placenta with disseminated intravascular coagulation, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.023|Premature separation of placenta with disseminated intravascular coagulation, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.091|Premature separation of placenta with other coagulation defect, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.092|Premature separation of placenta with other coagulation defect, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.093|Premature separation of placenta with other coagulation defect, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.91|Premature separation of placenta, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.92|Premature separation of placenta, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O45.93|Premature separation of placenta, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.001|Antepartum hemorrhage with coagulation defect, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.002|Antepartum hemorrhage with coagulation defect, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.003|Antepartum hemorrhage with coagulation defect, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.009|Antepartum hemorrhage with coagulation defect, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.011|Antepartum hemorrhage with afibrinogenemia, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.012|Antepartum hemorrhage with afibrinogenemia, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.013|Antepartum hemorrhage with afibrinogenemia, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.019|Antepartum hemorrhage with afibrinogenemia, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.021|Antepartum hemorrhage with disseminated intravascular coagulation, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.022|Antepartum hemorrhage with disseminated intravascular coagulation, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.023|Antepartum hemorrhage with disseminated intravascular coagulation, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.029|Antepartum hemorrhage with disseminated intravascular coagulation, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.091|Antepartum hemorrhage with other coagulation defect, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.092|Antepartum hemorrhage with other coagulation defect, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.093|Antepartum hemorrhage with other coagulation defect, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.099|Antepartum hemorrhage with other coagulation defect, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.90|Antepartum hemorrhage, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.91|Antepartum hemorrhage, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.92|Antepartum hemorrhage, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O46.93|Antepartum hemorrhage, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O47.00|False labor before 37 completed weeks of gestation, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O47.02|False labor before 37 completed weeks of gestation, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O47.03|False labor before 37 completed weeks of gestation, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O47.1|False labor at or after 37 completed weeks of gestation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O47.9|False labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O48.0|Post-term pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O48.1|Prolonged pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O60.00|Preterm labor without delivery, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O60.02|Preterm labor without delivery, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O60.03|Preterm labor without delivery, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O61.0|Failed medical induction of labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O61.1|Failed instrumental induction of labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O61.9|Failed induction of labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.0|Primary inadequate contractions||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.1|Secondary uterine inertia||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.2|Other uterine inertia||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.3|Precipitate labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.4|Hypertonic, incoordinate, and prolonged uterine contractions||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O62.9|Abnormality of forces of labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O63.0|Prolonged first stage (of labor)||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O63.1|Prolonged second stage (of labor)||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O63.2|Delayed delivery of second twin, triplet, etc.||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O63.9|Long labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O65.4|Obstructed labor due to fetopelvic disproportion, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O65.5|Obstructed labor due to abnormality of maternal pelvic organs||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O65.9|Obstructed labor due to maternal pelvic abnormality, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.0|Obstructed labor due to shoulder dystocia||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.1|Obstructed labor due to locked twins||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.40|Failed trial of labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.5|Attempted application of vacuum extractor and forceps||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.8|Other specified obstructed labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O66.9|Obstructed labor, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O67.0|Intrapartum hemorrhage with coagulation defect||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O67.8|Other intrapartum hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O67.9|Intrapartum hemorrhage, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O68|Labor and delivery complicated by abnormality of fetal acid-base balance||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.0|First degree perineal laceration during delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.1|Second degree perineal laceration during delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.20|Third degree perineal laceration during delivery, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.21|Third degree perineal laceration during delivery, IIIa||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.22|Third degree perineal laceration during delivery, IIIb||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.23|Third degree perineal laceration during delivery, IIIc||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.3|Fourth degree perineal laceration during delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.4|Anal sphincter tear complicating delivery, not associated with third degree laceration||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O70.9|Perineal laceration during delivery, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.00|Rupture of uterus before onset of labor, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.02|Rupture of uterus before onset of labor, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.03|Rupture of uterus before onset of labor, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.1|Rupture of uterus during labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.2|Postpartum inversion of uterus||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.3|Obstetric laceration of cervix||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.4|Obstetric high vaginal laceration alone||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.5|Other obstetric injury to pelvic organs||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.6|Obstetric damage to pelvic joints and ligaments||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.7|Obstetric hematoma of pelvis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.82|Other specified trauma to perineum and vulva||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.89|Other specified obstetric trauma||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O71.9|Obstetric trauma, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O72.0|Third-stage hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O72.1|Other immediate postpartum hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O72.2|Delayed and secondary postpartum hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O72.3|Postpartum coagulation defects||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O73.0|Retained placenta without hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O73.1|Retained portions of placenta and membranes, without hemorrhage||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O74.1|Other pulmonary complications of anesthesia during labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O74.2|Cardiac complications of anesthesia during labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O74.3|Central nervous system complications of anesthesia during labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O74.8|Other complications of anesthesia during labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O74.9|Complication of anesthesia during labor and delivery, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.0|Maternal distress during labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.1|Shock during or following labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.2|Pyrexia during labor, not elsewhere classified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.3|Other infection during labor||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.4|Other complications of obstetric surgery and procedures||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.5|Delayed delivery after artificial rupture of membranes||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.81|Maternal exhaustion complicating labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.89|Other specified complications of labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O75.9|Complication of labor and delivery, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O76|Abnormality in fetal heart rate and rhythm complicating labor and delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O77.0|Labor and delivery complicated by meconium in amniotic fluid||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O80|Encounter for full-term uncomplicated delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O82|Encounter for cesarean delivery without indication||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O85|Puerperal sepsis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.00|Infection of obstetric surgical wound, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.01|Infection of obstetric surgical wound, superficial incisional site||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.02|Infection of obstetric surgical wound, deep incisional site||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.03|Infection of obstetric surgical wound, organ and space site||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.04|Sepsis following an obstetrical procedure||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.09|Infection of obstetric surgical wound, other surgical site||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.11|Cervicitis following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.12|Endometritis following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.13|Vaginitis following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.19|Other infection of genital tract following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.20|Urinary tract infection following delivery, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.21|Infection of kidney following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.22|Infection of bladder following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.29|Other urinary tract infection following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.4|Pyrexia of unknown origin following delivery||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.81|Puerperal septic thrombophlebitis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O86.89|Other specified puerperal infections||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.0|Superficial thrombophlebitis in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.1|Deep phlebothrombosis in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.2|Hemorrhoids in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.3|Cerebral venous thrombosis in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.4|Varicose veins of lower extremity in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.8|Other venous complications in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O87.9|Venous complication in the puerperium, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.011|Air embolism in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.012|Air embolism in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.013|Air embolism in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.019|Air embolism in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.02|Air embolism in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.03|Air embolism in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.111|Amniotic fluid embolism in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.112|Amniotic fluid embolism in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.113|Amniotic fluid embolism in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.119|Amniotic fluid embolism in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.12|Amniotic fluid embolism in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.13|Amniotic fluid embolism in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.211|Thromboembolism in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.212|Thromboembolism in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.213|Thromboembolism in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.219|Thromboembolism in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.22|Thromboembolism in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.23|Thromboembolism in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.311|Pyemic and septic embolism in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.312|Pyemic and septic embolism in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.313|Pyemic and septic embolism in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.319|Pyemic and septic embolism in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.32|Pyemic and septic embolism in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.33|Pyemic and septic embolism in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.811|Other embolism in pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.812|Other embolism in pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.813|Other embolism in pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.819|Other embolism in pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.82|Other embolism in childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O88.83|Other embolism in the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O89.09|Other pulmonary complications of anesthesia during the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O89.1|Cardiac complications of anesthesia during the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O89.2|Central nervous system complications of anesthesia during the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O89.8|Other complications of anesthesia during the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O89.9|Complication of anesthesia during the puerperium, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.0|Disruption of cesarean delivery wound||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.1|Disruption of perineal obstetric wound||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.2|Hematoma of obstetric wound||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.3|Peripartum cardiomyopathy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.4|Postpartum acute kidney failure||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.5|Postpartum thyroiditis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.6|Postpartum mood disturbance||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.81|Anemia of the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.89|Other complications of the puerperium, not elsewhere classified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O90.9|Complication of the puerperium, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.011|Infection of nipple associated with pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.012|Infection of nipple associated with pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.013|Infection of nipple associated with pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.019|Infection of nipple associated with pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.02|Infection of nipple associated with the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.03|Infection of nipple associated with lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.111|Abscess of breast associated with pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.112|Abscess of breast associated with pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.113|Abscess of breast associated with pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.119|Abscess of breast associated with pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.12|Abscess of breast associated with the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.13|Abscess of breast associated with lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.211|Nonpurulent mastitis associated with pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.212|Nonpurulent mastitis associated with pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.213|Nonpurulent mastitis associated with pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.219|Nonpurulent mastitis associated with pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.22|Nonpurulent mastitis associated with the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O91.23|Nonpurulent mastitis associated with lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.011|Retracted nipple associated with pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.012|Retracted nipple associated with pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.013|Retracted nipple associated with pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.019|Retracted nipple associated with pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.03|Retracted nipple associated with lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.111|Cracked nipple associated with pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.112|Cracked nipple associated with pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.113|Cracked nipple associated with pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.119|Cracked nipple associated with pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.13|Cracked nipple associated with lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.20|Unspecified disorder of breast associated with pregnancy and the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.29|Other disorders of breast associated with pregnancy and the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.3|Agalactia||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.5|Suppressed lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.6|Galactorrhea||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.70|Unspecified disorders of lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O92.79|Other disorders of lactation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O94|Sequelae of complication of pregnancy, childbirth, and the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.011|Tuberculosis complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.012|Tuberculosis complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.013|Tuberculosis complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.019|Tuberculosis complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.02|Tuberculosis complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.03|Tuberculosis complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.111|Syphilis complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.112|Syphilis complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.113|Syphilis complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.119|Syphilis complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.12|Syphilis complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.13|Syphilis complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.211|Gonorrhea complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.212|Gonorrhea complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.213|Gonorrhea complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.219|Gonorrhea complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.22|Gonorrhea complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.23|Gonorrhea complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.311|Other infections with a predominantly sexual mode of transmission complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.312|Other infections with a predominantly sexual mode of transmission complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.313|Other infections with a predominantly sexual mode of transmission complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.319|Other infections with a predominantly sexual mode of transmission complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.32|Other infections with a predominantly sexual mode of transmission complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.33|Other infections with a predominantly sexual mode of transmission complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.42|Viral hepatitis complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.43|Viral hepatitis complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.511|Other viral diseases complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.512|Other viral diseases complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.513|Other viral diseases complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.519|Other viral diseases complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.52|Other viral diseases complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.53|Other viral diseases complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.611|Protozoal diseases complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.612|Protozoal diseases complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.613|Protozoal diseases complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.619|Protozoal diseases complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.62|Protozoal diseases complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.63|Protozoal diseases complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.811|Other maternal infectious and parasitic diseases complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.812|Other maternal infectious and parasitic diseases complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.813|Other maternal infectious and parasitic diseases complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.819|Other maternal infectious and parasitic diseases complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.82|Other maternal infectious and parasitic diseases complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.83|Other maternal infectious and parasitic diseases complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.911|Unspecified maternal infectious and parasitic disease complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.912|Unspecified maternal infectious and parasitic disease complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.913|Unspecified maternal infectious and parasitic disease complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.919|Unspecified maternal infectious and parasitic disease complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.92|Unspecified maternal infectious and parasitic disease complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O98.93|Unspecified maternal infectious and parasitic disease complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.011|Anemia complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.012|Anemia complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.013|Anemia complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.019|Anemia complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.02|Anemia complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.03|Anemia complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.111|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.112|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.113|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.119|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.12|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.13|Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.210|Obesity complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.211|Obesity complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.212|Obesity complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.213|Obesity complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.214|Obesity complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.215|Obesity complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.280|Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.281|Endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.282|Endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.283|Endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.284|Endocrine, nutritional and metabolic diseases complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.285|Endocrine, nutritional and metabolic diseases complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.320|Drug use complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.321|Drug use complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.322|Drug use complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.323|Drug use complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.324|Drug use complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.325|Drug use complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.330|Smoking (tobacco) complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.331|Smoking (tobacco) complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.332|Smoking (tobacco) complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.333|Smoking (tobacco) complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.334|Smoking (tobacco) complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.335|Smoking (tobacco) complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.340|Other mental disorders complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.341|Other mental disorders complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.342|Other mental disorders complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.343|Other mental disorders complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.344|Other mental disorders complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.345|Other mental disorders complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.350|Diseases of the nervous system complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.351|Diseases of the nervous system complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.352|Diseases of the nervous system complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.353|Diseases of the nervous system complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.354|Diseases of the nervous system complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.355|Diseases of the nervous system complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.411|Diseases of the circulatory system complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.412|Diseases of the circulatory system complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.413|Diseases of the circulatory system complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.419|Diseases of the circulatory system complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.42|Diseases of the circulatory system complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.43|Diseases of the circulatory system complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.810|Abnormal glucose complicating pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.814|Abnormal glucose complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.815|Abnormal glucose complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.834|Other infection carrier state complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.835|Other infection carrier state complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.840|Bariatric surgery status complicating pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.841|Bariatric surgery status complicating pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.842|Bariatric surgery status complicating pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.843|Bariatric surgery status complicating pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.844|Bariatric surgery status complicating childbirth||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.845|Bariatric surgery status complicating the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|O99.89|Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z33.1|Pregnant state, incidental||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z33.2|Encounter for elective termination of pregnancy||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z33.3|Pregnant state, gestational carrier||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.00|Encounter for supervision of normal first pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.01|Encounter for supervision of normal first pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.02|Encounter for supervision of normal first pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.03|Encounter for supervision of normal first pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.80|Encounter for supervision of other normal pregnancy, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.81|Encounter for supervision of other normal pregnancy, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.82|Encounter for supervision of other normal pregnancy, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.83|Encounter for supervision of other normal pregnancy, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.90|Encounter for supervision of normal pregnancy, unspecified, unspecified trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.91|Encounter for supervision of normal pregnancy, unspecified, first trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.92|Encounter for supervision of normal pregnancy, unspecified, second trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z34.93|Encounter for supervision of normal pregnancy, unspecified, third trimester||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.0|Encounter for antenatal screening for chromosomal anomalies||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.1|Encounter for antenatal screening for raised alphafetoprotein level||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.2|Encounter for other antenatal screening follow-up||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.3|Encounter for antenatal screening for malformations||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.4|Encounter for antenatal screening for fetal growth retardation||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.5|Encounter for antenatal screening for isoimmunization||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.81|Encounter for antenatal screening for hydrops fetalis||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.82|Encounter for antenatal screening for nuchal translucency||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.84|Encounter for antenatal screening for fetal lung maturity||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.85|Encounter for antenatal screening for Streptococcus B||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.86|Encounter for antenatal screening for cervical length||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.87|Encounter for antenatal screening for uncertain dates||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.88|Encounter for antenatal screening for fetal macrosomia||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.89|Encounter for other specified antenatal screening||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.8A|Encounter for antenatal screening for other genetic defects||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z36.9|Encounter for antenatal screening, unspecified||
PREGNANCY_LACTATION|PREGNANCY_LACTATION||ICD_10|2019|Z39.1|Encounter for care and examination of lactating mother||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|G72.0 |Drug-induced myopathy ||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|G72.89 |Other specified myopathies Â ||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|G72.9 |Myopathy, unspecified||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|M60.80 |Other myositis, unspecified site||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|M60.9|Myositis ||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|M62.82|Rhabdomyolysis||
RHABDOMYOLYSIS_MYOPATHY|RHABDOMYOLYSIS_MYOPATHY||ICD_10|2019|T46.6X5A|Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.00|Felty's syndrome, unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.011|Felty's syndrome, right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.012|Felty's syndrome, left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.019|Felty's syndrome, unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.021|Felty's syndrome, right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.022|Felty's syndrome, left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.029|Felty's syndrome, unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.031|Felty's syndrome, right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.032|Felty's syndrome, left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.039|Felty's syndrome, unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.041|Felty's syndrome, right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.042|Felty's syndrome, left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.049|Felty's syndrome, unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.05|Felty's syndrome, hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.051|Felty's syndrome, right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.052|Felty's syndrome, left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.059|Felty's syndrome, unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.061|Felty's syndrome, right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.062|Felty's syndrome, left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.069|Felty's syndrome, unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.071|Felty's syndrome, right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.072|Felty's syndrome, left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.079|Felty's syndrome, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.09|Felty's syndrome, multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.10|Rheumatoid lung disease with rheumatoid arthritis of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.111|Rheumatoid lung disease with rheumatoid arthritis of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.112|Rheumatoid lung disease with rheumatoid arthritis of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.119|Rheumatoid lung disease with rheumatoid arthritis of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.121|Rheumatoid lung disease with rheumatoid arthritis of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.122|Rheumatoid lung disease with rheumatoid arthritis of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.129|Rheumatoid lung disease with rheumatoid arthritis of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.131|Rheumatoid lung disease with rheumatoid arthritis of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.132|Rheumatoid lung disease with rheumatoid arthritis of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.139|Rheumatoid lung disease with rheumatoid arthritis of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.141|Rheumatoid lung disease with rheumatoid arthritis of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.142|Rheumatoid lung disease with rheumatoid arthritis of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.149|Rheumatoid lung disease with rheumatoid arthritis of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.151|Rheumatoid lung disease with rheumatoid arthritis of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.152Â |Rheumatoid lung disease with rheumatoid arthritis of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.159|Rheumatoid lung disease with rheumatoid arthritis of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.161|Rheumatoid lung disease with rheumatoid arthritis of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.162|Rheumatoid lung disease with rheumatoid arthritis of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.169|Rheumatoid lung disease with rheumatoid arthritis of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.171|Rheumatoid lung disease with rheumatoid arthritis of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.172|Rheumatoid lung disease with rheumatoid arthritis of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.179|Rheumatoid lung disease with rheumatoid arthritis of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.19|Rheumatoid lung disease with rheumatoid arthritis of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.20|Rheumatoid vasculitis with rheumatoid arthritis of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.211|Rheumatoid vasculitis with rheumatoid arthritis of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.212|Rheumatoid vasculitis with rheumatoid arthritis of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.219|Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.221|Rheumatoid vasculitis with rheumatoid arthritis of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.222|Rheumatoid vasculitis with rheumatoid arthritis of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.229|Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.231|Rheumatoid vasculitis with rheumatoid arthritis of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.232|Rheumatoid vasculitis with rheumatoid arthritis of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.239|Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.241|Â Rheumatoid vasculitis with rheumatoid arthritis of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.242|Rheumatoid vasculitis with rheumatoid arthritis of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.249|Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.251|Rheumatoid vasculitis with rheumatoid arthritis of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.252|Rheumatoid vasculitis with rheumatoid arthritis of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.259|Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.261|Rheumatoid vasculitis with rheumatoid arthritis of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.262|Rheumatoid vasculitis with rheumatoid arthritis of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.269|Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.271|Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.272|Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.279|Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.29|Rheumatoid vasculitis with rheumatoid arthritis of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.30|Rheumatoid heart disease with rheumatoid arthritis of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.311|Rheumatoid heart disease with rheumatoid arthritis of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.312|Rheumatoid heart disease with rheumatoid arthritis of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.319|Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.321|Rheumatoid heart disease with rheumatoid arthritis of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.321|Rheumatoid heart disease with rheumatoid arthritis of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.329|Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.331|Rheumatoid heart disease with rheumatoid arthritis of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.332|Rheumatoid heart disease with rheumatoid arthritis of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.339|Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.341|Rheumatoid heart disease with rheumatoid arthritis of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.342|Rheumatoid heart disease with rheumatoid arthritis of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.349|Rheumatoid heart disease with rheumatoid arthritis of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.351|Rheumatoid heart disease with rheumatoid arthritis of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.352|Rheumatoid heart disease with rheumatoid arthritis of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.359|Rheumatoid heart disease with rheumatoid arthritis of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.361|Rheumatoid heart disease with rheumatoid arthritis of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.362|Rheumatoid heart disease with rheumatoid arthritis of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.369|Rheumatoid heart disease with rheumatoid arthritis of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.371|Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.372|Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.379|Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.39|Rheumatoid heart disease with rheumatoid arthritis of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.40|Rheumatoid myopathy with rheumatoid arthritis of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.411|Rheumatoid myopathy with rheumatoid arthritis of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.412|Rheumatoid myopathy with rheumatoid arthritis of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.419|Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.421|Rheumatoid myopathy with rheumatoid arthritis of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.422|Rheumatoid myopathy with rheumatoid arthritis of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.429|Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.431|Rheumatoid myopathy with rheumatoid arthritis of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.432|Rheumatoid myopathy with rheumatoid arthritis of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.439|Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.441|Rheumatoid myopathy with rheumatoid arthritis of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.442|Rheumatoid myopathy with rheumatoid arthritis of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.449|Rheumatoid myopathy with rheumatoid arthritis of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.451|Rheumatoid myopathy with rheumatoid arthritis of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.452|Rheumatoid myopathy with rheumatoid arthritis of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.459|Rheumatoid myopathy with rheumatoid arthritis of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.461|Rheumatoid myopathy with rheumatoid arthritis of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.462|Rheumatoid myopathy with rheumatoid arthritis of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.469|Rheumatoid myopathy with rheumatoid arthritis of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.471|Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.472|Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.479|Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.49|Rheumatoid myopathy with rheumatoid arthritis of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.50|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.511|Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.512Â |Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.519|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.521|Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.522|Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.529|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.531|Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.532|Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.539|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.541|Rheumatoid polyneuropathy with rheumatoid arthritis of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.542|Rheumatoid polyneuropathy with rheumatoid arthritis of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.549|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.551|Rheumatoid polyneuropathy with rheumatoid arthritis of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.552|Rheumatoid polyneuropathy with rheumatoid arthritis of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.559|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.561|Rheumatoid polyneuropathy with rheumatoid arthritis of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.562|Rheumatoid polyneuropathy with rheumatoid arthritis of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.569|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.571|Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.572|Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.579|Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.59|Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.60|Rheumatoid arthritis of unspecified site with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.611|Rheumatoid arthritis of right shoulder with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.612|Rheumatoid arthritis of left shoulder with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.619|Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.621|Rheumatoid arthritis of right elbow with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.622|Rheumatoid arthritis of left elbow with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.629|Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.631|Rheumatoid arthritis of right wrist with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.632|Rheumatoid arthritis of left wrist with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.639|Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.641|Rheumatoid arthritis of right hand with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.642|Rheumatoid arthritis of left hand with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.649|Rheumatoid arthritis of unspecified hand with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.651|Rheumatoid arthritis of right hip with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.652|Rheumatoid arthritis of left hip with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.659|Rheumatoid arthritis of unspecified hip with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.661|Rheumatoid arthritis of right knee with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.662|Rheumatoid arthritis of left knee with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.669|Rheumatoid arthritis of unspecified knee with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.671|Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.672|Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.679|Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.69|Rheumatoid arthritis of multiple sites with involvement of other organs and systems||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.70|Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.711|Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.712|Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.719|Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.721|Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.722|Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.729|Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.731|Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.732|Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.739|Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.741|Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.742|Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.749|Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.751|Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.752|Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.759|Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.761|Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.762|Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.769|Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.771|Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.772|Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.779|Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.79|Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systens involvement||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.80|Other rheumatoid arthritis with rheumatoid factor of unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.811|Other rheumatoid arthritis with rheumatoid factor of right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.812|Other rheumatoid arthritis with rheumatoid factor of left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.819|Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.821|Other rheumatoid arthritis with rheumatoid factor of right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.822|Other rheumatoid arthritis with rheumatoid factor of left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.829|Other rheumatoid arthritis with rheumatoid factor of unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.831|Other rheumatoid arthritis with rheumatoid factor of right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.832|Other rheumatoid arthritis with rheumatoid factor of left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.839|Other rheumatoid arthritis with rheumatoid factor of unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.841|Other rheumatoid arthritis with rheumatoid factor of right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.842|Other rheumatoid arthritis with rheumatoid factor of left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.849|Other rheumatoid arthritis with rheumatoid factor of unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.851|Other rheumatoid arthritis with rheumatoid factor of right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.852|Other rheumatoid arthritis with rheumatoid factor of left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.859|Other rheumatoid arthritis with rheumatoid factor of unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.861|Other rheumatoid arthritis with rheumatoid factor of right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.862|Other rheumatoid arthritis with rheumatoid factor of left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.869|Other rheumatoid arthritis with rheumatoid factor of unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.871|Other rheumatoid arthritis with rheumatoid factor of right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.872|Other rheumatoid arthritis with rheumatoid factor of left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.879|Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.89|Other rheumatoid arthritis with rheumatoid factor of multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M05.9|Rheumatoid arthritis with rheumatoid factor, unspecified||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.00|Rheumatoid arthritis without rheumatoid factor, unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.011|Rheumatoid arthritis without rheumatoid factor, right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.012|Rheumatoid arthritis without rheumatoid factor, left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.019|Rheumatoid arthritis without rheumatoid factor, unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.021|Rheumatoid arthritis without rheumatoid factor, right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.022|Rheumatoid arthritis without rheumatoid factor, left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.029|Rheumatoid arthritis without rheumatoid factor, unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.031|Rheumatoid arthritis without rheumatoid factor, right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.032|Rheumatoid arthritis without rheumatoid factor, left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.039|Rheumatoid arthritis without rheumatoid factor, unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.041|Rheumatoid arthritis without rheumatoid factor, right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.042|Rheumatoid arthritis without rheumatoid factor, left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.049|Rheumatoid arthritis without rheumatoid factor, unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.051|Rheumatoid arthritis without rheumatoid factor, right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.052|Rheumatoid arthritis without rheumatoid factor, left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.059|Rheumatoid arthritis without rheumatoid factor, unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.061|Rheumatoid arthritis without rheumatoid factor, right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.062|Rheumatoid arthritis without rheumatoid factor, left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.069|Rheumatoid arthritis without rheumatoid factor, unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.071|Rheumatoid arthritis without rheumatoid factor, right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.072|Rheumatoid arthritis without rheumatoid factor, left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.079|Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.08|Rheumatoid arthritis without rheumatoid factor, vertebrae||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.09|Rheumatoid arthritis without rheumatoid factor, multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.1|Adult-onset Still's disease||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.20|Rheumatoid bursitis, unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.211|Rheumatoid bursitis, right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.212|Rheumatoid bursitis, left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.219|Rheumatoid bursitis, unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.221|Rheumatoid bursitis, right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.222|Rheumatoid bursitis, left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.231|Rheumatoid bursitis, right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.232|Rheumatoid bursitis, left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.239|Rheumatoid bursitis, unspecified||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.241|Rheumatoid bursitis, right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.242|Rheumatoid bursitis, left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.249|Rheumatoid bursitis, unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.251|Rheumatoid bursitis, right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.252 |Rheumatoid bursitis, left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.259 |Rheumatoid bursitis, unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.261|Rheumatoid bursitis, right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.262 |Rheumatoid bursitis, left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.269 |Rheumatoid bursitis, unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.271|Rheumatoid bursitis, right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.272|Rheumatoid bursitis, left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.279 |Rheumatoid bursitis, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.28|Rheumatoid bursitis, vertebrae||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.29|Rheumatoid bursitis, multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.30|Rheumatoid nodule, unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.311 |Rheumatoid nodule, right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.312|Rheumatoid nodule, left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.319|Rheumatoid nodule, unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.321|Rheumatoid nodule, right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.322|Rheumatoid nodule, left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.329|Rheumatoid nodule, unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.331|Rheumatoid nodule, right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.332|Rheumatoid nodule, left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.339|Rheumatoid nodule, unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.341 |Rheumatoid nodule, right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.342 |Rheumatoid nodule, left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.349|Rheumatoid nodule, unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.351 |Rheumatoid nodule, right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.352|Rheumatoid nodule, left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.359|Rheumatoid nodule, unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.361 |Rheumatoid nodule, right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.362|Rheumatoid nodule, left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.369 |Rheumatoid nodule, unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.371|Rheumatoid nodule, right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.372|Rheumatoid nodule, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.379|Rheumatoid nodule, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.38|Rheumatoid nodule, vertebrae||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.39|Rheumatoid nodule, multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.80|Other specified rheumatoid arthritis, unspecified site||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.811|Other specified rheumatoid arthritis, right shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.812|Other specified rheumatoid arthritis, left shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.819|Other specified rheumatoid arthritis, unspecified shoulder||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.821|Other specified rheumatoid arthritis, right elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.822|Other specified rheumatoid arthritis, left elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.829|Other specified rheumatoid arthritis, unspecified elbow||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.831|Other specified rheumatoid arthritis, right wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.832|Other specified rheumatoid arthritis, left wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.839|Other specified rheumatoid arthritis, unspecified wrist||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.841|Other specified rheumatoid arthritis, right hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.842|Other specified rheumatoid arthritis, left hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.849|Other specified rheumatoid arthritis, unspecified hand||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.851|Other specified rheumatoid arthritis, right hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.852|Other specified rheumatoid arthritis, left hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.859|Other specified rheumatoid arthritis, unspecified hip||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.861|Other specified rheumatoid arthritis, right knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.862|Other specified rheumatoid arthritis, left knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.869|Other specified rheumatoid arthritis, unspecified knee||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.871|Other specified rheumatoid arthritis, right ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.872|Other specified rheumatoid arthritis, left ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.879|Other specified rheumatoid arthritis, unspecified ankle and foot||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.88|Other specified rheumatoid arthritis, vertebrae||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.89|Other specified rheumatoid arthritis, multiple sites||
RHEUMATOID_ARTHRITIS|RHEUMATOID_ARTHRITIS||ICD_10|2020|M06.9|Rheumatoid arthritis, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F06.0|Psychotic disorder with hallucinations due to known physiological condition||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F06.2|Psychotic disorder with delusions due to known physiological condition||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F06.33|Mood disorder due to known physiological condition with manic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.0|Paranoid schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.1|Disorganized schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.2|Catatonic schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.3|Undifferentiated schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.5|Residual schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.81|Schizophreniform disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.89|Other schizophrenia||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F20.9|Schizophrenia, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F21|Schizotypal disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F23|Brief psychotic disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F24|Shared psychotic disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F25.0|Schizoaffective disorder, bipolar type||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F25.1|Schizoaffective disorder, depressive type||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F25.8|Other schizoaffective disorders||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F25.9|Schizoaffective disorder, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F28|Other psychotic disorder not due to a substance or known physiological condition||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F29|Unspecified psychosis not due to a substance or known physiological condition||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.10|Manic episode without psychotic symptoms, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.11|Manic episode without psychotic symptoms, mild||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.12|Manic episode without psychotic symptoms, moderate||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.13|Manic episode, severe, without psychotic symptoms||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.2|Manic episode, severe with psychotic symptoms||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.3|Manic episode in partial remission||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.4|Manic episode in full remission||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.8|Other manic episodes||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F30.9|Manic episode, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.0|Bipolar disorder, current episode hypomanic||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.10|Bipolar disorder, current episode manic without psychotic features, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.11|Bipolar disorder, current episode manic without psychotic features, mild||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.12|Bipolar disorder, current episode manic without psychotic features, moderate||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.13|Bipolar disorder, current episode manic without psychotic features, severe||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.2|Bipolar disorder, current episode manic severe with psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.30|Bipolar disorder, current episode depressed, mild or moderate severity, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.31|Bipolar disorder, current episode depressed, mild||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.32|Bipolar disorder, current episode depressed, moderate||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.4|Bipolar disorder, current episode depressed, severe, without psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.5|Bipolar disorder, current episode depressed, severe, with psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.60|Bipolar disorder, current episode mixed, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.61|Bipolar disorder, current episode mixed, mild||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.62|Bipolar disorder, current episode mixed, moderate||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.63|Bipolar disorder, current episode mixed, severe, without psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.64|Bipolar disorder, current episode mixed, severe, with psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.70|Bipolar disorder, currently in remission, most recent episode unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.71|Bipolar disorder, in partial remission, most recent episode hypomanic||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.72|Bipolar disorder, in full remission, most recent episode hypomanic||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.73|Bipolar disorder, in partial remission, most recent episode manic||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.74|Bipolar disorder, in full remission, most recent episode manic||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.75|Bipolar disorder, in partial remission, most recent episode depressed||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.76|Bipolar disorder, in full remission, most recent episode depressed||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.77|Bipolar disorder, in partial remission, most recent episode mixed||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.78|Bipolar disorder, in full remission, most recent episode mixed||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.81|Bipolar II disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.89|Other bipolar disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F31.9|Bipolar disorder, unspecified||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F32.3|Major depressive disorder, single episode, severe with psychotic features||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F33.3|Major depressive disorder, recurrent, severe with psychotic symptoms||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F53|Puerperal psychosis||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F53.1|Puerperal psychosis||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|F95.2|Tourette's disorder||
SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME|SCHIZOPHRENIA_BIPOLAR_DISORDER_HUNTINGTONS_DISEASE_OR_ TOURETTES_SYNDROME||ICD_10|2020|G10|G10 Huntingtonâs disease||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.00|HB-SS disease with crisis, unspecified||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.01|Hb-SS disease with acute chest syndrome||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.02|Hb-SS disease with splenic sequestration||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.1|Sickle-cell disease without crisis||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.20|Sickle-cell/Hb-C disease without crisis||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.211|Sickle-cell/Hb-C disease with acute chest syndrome||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.212|Sickle-cell/Hb-C disease with splenic sequestration||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.219|Sickle-cell/Hb-C disease with crisis, unspecified||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.40|Sickle-cell thalassemia without crisis||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.411|Sickle-cell thalassemia with acute chest syndrome||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.412|Sickle-cell thalassemia with splenic sequestration||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.419|Sickle-cell thalassemia with crisis, unspecified||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.80|Other sickle-cell disorders without crisis||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.811|Other sickle-cell disorders with acute chest syndrome||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.812|Other sickle-cell disorders with splenic sequestration||
SICKLE_CELL_DISEASE|SICKLE_CELL_DISEASE||ICD_10|2020|D57.819|Other sickle-cell disorders with crisis, unspecified||
